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Abstract 
Telomeres are the very ends of linear eukaryotic chromosomes and when too short 
or dysfunctional they can trigger senescence (ageing). If the cell can bypass 
senescence, it can lead to genetic instability or cancer. Telomere capping proteins 
such as the CST (Cdc13, Stn1 and Ten1) complex and Yku70 are essential for the 
telomeres not to be recognised as double strand breaks.  
In this thesis I have used published yeast genome-wide screens to identify genes 
that are relevant to cancer and telomere biology. Overall 14 out of 19 genetic 
interactions identified by genome-wide screens could be confirmed by small scale 
experiments. This work mainly focuses on the telomeric roles of VPS74 and the 
PAF1 complex. 
Here, I show that the Golgi gene VPS74, whose human orthologue, GOLPH3, is an 
oncogene, genetically interacts with telomere capping genes and DNA damage 
response genes. I demonstrate that Vps74 is important for cell fitness of yku70Δ cells 
and that the low fitness of Vps74 depleted cells is dependent on the presence of 
DNA damage checkpoint proteins. 
I have also systematically investigated the roles of PAF1 complex (Cdc73, Paf1, Ctr9, 
Leo1 and Rtf1, in yeast) components on telomere biology. The conserved PAF1 
complex affects RNA abundance in eukaryotes. I demonstrate that individual PAF1 
complex components perform different functions at telomeres. I show that loss of 
Cdc73 improves fitness of telomere defective yeast cells, while loss of other PAF1 
components has the opposite effect. Moreover, I show that Paf1 and Ctr9 strongly 
reduce telomeric repeat-containing non-coding RNA (TERRA), while Cdc73, Leo1 
and Rtf1 have little effect. Paf1 and Ctr9 function independently of Sir4 to regulate 
TERRA and this is because they stimulate TERRA decay, as well as decay of other 
RNAs. Additionally, I found that Paf1 and Ctr9 decrease TEN1 and STN1 mRNA 
levels. I suggest that the PAF1 complex plays a specialized role at telomeres, with 
Paf1 and Ctr9 maintaining telomere integrity and Cdc73 decreasing the fitness of 
telomere defective cells.  
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1. Introduction 
1.1. Telomeres, double-strand breaks and the DNA damage response 
Telomeres are the protein/nucleic acid structures at the ends of chromosomes that 
help confer stability to linear chromosomes (Muller 1938). In most human somatic 
cells, telomeric DNA gets shorter every cell division due to the end-replication 
problem (Olovnikov 1973; Harley et al. 1990). Telomerase facilitates telomere 
elongation in stem and cancer cell types (or yeast cells) but is less active in most 
somatic human cells (Shukla et al. 2010; Zvereva et al. 2010).  
Loss of telomere protection and/or excessive telomere shortening causes genome 
instability leading to very drastic phenotypes like chromosome fusions, cell cycle 
arrest or apoptosis (Bekaert et al. 2005; Donate and Blasco 2011). Gross 
chromosome rearrangements such as chromosome fusions are often present in 
cancer cells, and are associated with uncontrolled cell division. On the other hand, 
cell cycle arrest and apoptosis are associated with ageing organisms. Therefore 
telomeres are attractive targets for both anti-cancer and anti-ageing therapies 
(Stewart and Weinberg 2006).  
Notably, regardless of the strong similarity between telomeres and double-strand 
breaks, the cell reacts differently to these two types of DNA ends. While telomeres 
are maintained as DNA ends, double-strand breaks in more internal regions of the 
chromosome tend to be fixed by the cell. How the cell distinguishes telomeres and 
double-strand breaks is thought to be mainly related to the proteins that are present 
at each end. Telomeres have a particular and repetitive DNA sequence which is 
responsible to bind specific proteins that in turn protect the telomere against DNA 
damage response proteins (Webb et al. 2013). Human and mouse telomeric DNA is 
composed of TTAGGG repeats while S. cerevisiae telomeric repeats consist of TG(1-
3) (de Lange 2005; Wellinger and Zakian 2012). Importantly, subtelomeric regions in 
both mammals and yeast are composed of silent chromatin, which permits telomere 
erosion without the danger of losing essential genetic information (Tham and Zakian 
2002; Wood and Sinclair 2002). Thus, the telomeres have evolved to protect the 
chromosome, having the “power” to sacrifice the cell to preserve genome stability. 
17 
1.1.1. Human telomeres 
Human telomeric DNA is associated with a protein complex called shelterin (de 
Lange 2005). TRF1, TRF2, TIN2, RAP1, TPP1 and POT1 are the six components of 
the human shelterin (Figure 1-1A) (de Lange 2005). All of them negatively regulate 
telomerase (Smogorzewska and de Lange 2004).  
TRF1 and TRF2 (TTAGGG repeat-binding factors 1 and 2) bind to telomeric dsDNA, 
and other members of the shelterin but they do not interact with each other (Broccoli 
et al. 1997; Walker and Zhu 2012). TRF1 and TRF2 have in common the TRF 
homology (TRFH) domain and a C-terminal SANT/Myb DNA-binding domain (Palm 
and de Lange 2008). Additionally, TRF2 is important for the formation of the t-loop in 
vitro (further details on the t-loop can be found later on) (Stansel et al. 2001). TIN2 
(TRF1 interacting nuclear protein 2) is able to interact with TRF1, TRF2 and TPP1 
(Palm and de Lange 2008). TIN2 does not interact directly with DNA but can interact 
with both TRF1 and TRF2 simultaneously being considered as an important bridge 
between the two (Ye et al. 2004a; Palm and de Lange 2008; Hadjiliadis and Sletten 
2009). RAP1 (repressor activator protein 1) lacks the capacity to bind DNA, is directly 
involved in telomere length regulation and its telomeric localisation depends on an 
interaction with TRF2 (Li et al. 2000; Palm and de Lange 2008; Duong and Sahin 
2013). TPP1 does not directly interact with telomeric DNA but keeps POT1 and TIN2 
together and has the ability to interact with telomerase, being an important 
intermediate between shelterin and telomerase (Cristofari et al. 2007). POT1 is the 
shelterin member able to bind to the telomeric ssDNA and TPP1 simultaneously, 
inhibiting telomerase action. Importantly, the TPP1-POT1 interaction is necessary to 
the localisation of POT1 at the 3’ overhang (Ye et al. 2004b). Finally, at the end of 
the double stranded DNA, the Ku heterodimer is essential to maintain telomere 
integrity (Indiviglio and Bertuch 2009). Ku, composed of Ku70/Ku86, is a part of 
NHEJ (non-homologous end joining) response, however it is thought that its loss is 
lethal due to its role at telomeres instead of NHEJ (Wang et al. 2009). One 
characteristic of human telomeres is the presence of the t-loop (Griffith et al. 1999). 
The t-loop is a secondary DNA structure and its function is to protect the 
chromosome ends (de Lange 2002). It is formed by the folding of the 3’ overhang in 
such way that the extremity replaces the G-rich strand, base pairing with the C-rich  
18 
Figure 1-1 Telomere structure in yeast and humans.  A) In humans, the telomeric 
dsDNA is bound by TRF1 and TRF2 (held together by TIN2) and TRF2 recruits RAP1 
to telomeres. The telomeric ssDNA is bound by POT1 which is linked to TRF1–
TRF2–TIN2 by TPP1. Human telomerase consists of EST1A, TER, and TERT 
subunits. Human TPP1 and yeast Est3 have structural similarities but appear to 
perform different roles (Lee et al. 2008). B) In budding yeast, the telomeric dsDNA is 
bound by Rap1, which recruits the accessory factors Rif1, Rif2, Sir3 and Sir4. Cdc13 
binds the telomeric ssDNA and recruits Stn1 and Ten1 to form the CST complex. 
Yeast telomerase consists of Est1, Tert (Est2), Est3 and TER (TLC1, Telomerase 
RNA). Figure taken from (Lue 2010). 
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strand (the unpaired DNA strand forms a D-loop) (Figure 1-2) (Palm and de Lange 
2008). The loop sizes are variable, and because of that it appears not to be 
functional (de Lange 2002). Also there are subtelomeric regions with (TTAGGG)n-like 
sequences (which are present along the genome, but enriched close to the 
telomeres) and duplicons (Riethman 2008). 
1.1.2. Yeast telomeres 
Yeast telomeres have many similarities with human telomeres (Figure 1-1). The 
yeast single stranded G tail is usually very short (around 300 bp against the more 
than 10kb of mammals) and is bound by Cdc13, which forms a complex with Stn1 
and Ten1 (the CST complex) (Price et al. 2010; Wellinger and Zakian 2012; Webb et 
al. 2013). Yeast possesses well-defined subtelomeric regions (Figure 1-3A, B) or 
TAS elements (telomeric associated sequences), the X and Y’ elements (Chan and 
Tye 1983) that contain autonomously replicating sequences (ARS) (origins of 
replication) (Wellinger and Zakian 2012). The X element is closer to the centromere 
and is present in all the chromosomes while the Y’ element is missing in about half of 
the chromosomes (Jager and Philippsen 1989; Wellinger and Zakian 2012). These 
subtelomeric regions (X and Y’) are organized in nucleosomes, however the histone 
content in the core X region is lower than in the distal Y’ (Wellinger and Zakian 2012). 
The X region is enriched in proteins responsible for DNA silencing such as Sir2, 
Rap1 (Zhu and Gustafsson 2009) and Sir3 (Takahashi et al. 2011b). The Y’ region, 
on the other hand, does not bind these proteins and is much more similar to 
euchromatin (Zhu and Gustafsson 2009; Wellinger and Zakian 2012).  
Rap1 (Repressor Activator Protein 1) is present in the double-stranded telomeric 
DNA repeats, where it binds with high affinity (Wellinger and Zakian 2012). Rap1 is 
able to interact with Sir2, Sir3 and Sir4 (transcription repressors, part of the Sir 
complex) and with Rif1 and Rif2 (Rap1 interacting factor proteins 1 and 2) (Moretti et 
al. 1994; Wotton and Shore 1997; Allison 2009). Together with Rif1/Rif2, Rap1 has 
an important role in telomere length maintenance and protection (Gallardo et al. 
2011; Wellinger and Zakian 2012). Regardless of its high telomere binding affinity, 
most of Rap1 is not associated to telomeres (Wellinger and Zakian 2012). 
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Figure 1-2 Secondary structure of human telomeres. Telomere repeats at 
chromosome ends fold back to form a lariat structure (t-loop). The 3′ telomeric DNA 
overhang invades the double-stranded DNA region of telomeric repeats to form a 
displacement-loop (d-loop). Figure and legend taken from (Tamakawa et al. 2013) 
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Another complex that is involved in telomere maintenance is RPA (Replication 
Protein A). RPA is a heterotrimeric complex (composed of Rfa1, Rfa2 and Rfa3) that 
binds ssDNA (Braun et al. 1997). RPA does not specifically bind to telomeric ssDNA 
but mutations in RFA2 decrease telomere length (Schramke et al. 2004). Since RFA2 
mutations decreased the binding of Est1 to telomeres during S-phase, it was 
suggested that RPA recruits telomerase to telomeres (Schramke et al. 2004). 
Throughout the genome, RPA plays an essential role in the DNA damage repair and 
stimulates the DNA damage response (Marechal and Zou 2015). For instance, RPA 
helps to load the 9-1-1 complex to lesion sites and is phosphorylated by checkpoint 
kinases in response to DNA damage (Mec1) (Brush et al. 1996; Majka et al. 2006). 
The replacement of RPA by Rad51 is essential for HR (homologous recombination) 
and the presence of RPA at lesion sites is essential to dismantle DNA secondary 
structures that could interfere with Rad51 action (Krejci et al. 2012). Additionally, 
RPA stimulates the Sgs1 helicase, promoting Dna2-dependent resection and 
formation of ssDNA (that stimulates the DNA damage response) (Krejci et al. 2012). 
The conserved Ku complex binds the double-stranded telomeric DNA. The yKu 
complex is composed of Yku70 and Yku80 (Gallardo et al. 2011; Wellinger and 
Zakian 2012). This complex protects the telomeres against Exo1 (Exonuclease 1) 
degradation (Maringele and Lydall 2002; Bertuch and Lundblad 2004) and it is 
thought to recruit telomerase to the telomeres through its ability to interact with the 
telomerase RNA (Peterson et al. 2001). The Ku complex has also an important role 
regulating NHEJ and in the repair of double stranded breaks (DSBs), having the 
potential to modulate checkpoint activation (Balestrini et al. 2013). Chromatin 
immunoprecipitation studies showed that Yku80 preferentially binds to regions of 
repressed chromatin (at telomeres) in a Sir4-dependent manner (Martin et al. 1999). 
Interestingly, upon exposure to bleomycin (DNA damaging agent), Yku80 was shown 
to relocate from the telomere to a more centromeric position in a manner dependent 
on the Rad9 checkpoint protein (Martin et al. 1999). Finally, the yKu complex was 
also shown to be important for proper telomere silencing (Martin et al. 1999). 
Telomerase is the reverse transcriptase responsible for maintaining the telomere 
length by adding the G rich repetitive DNA sequences to the telomere end (Taggart 
and Zakian 2003; Churikov et al. 2013). In yeast, telomerase is composed of Est1, 
Est2, Est3 and TLC1 (RNA molecule used as template for the 3’ extension of 
telomere) (Taggart and Zakian 2003). The lack of any member of the telomerase 
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complex causes the same growth defects and decreased telomere length (Lendvay 
et al. 1996). Both Est1 and Est2 directly bind TLC1 and Est3 is recruited by the Est2-
TLC1 complex (Gallardo and Chartrand 2008). Est2 has the catalytic site of the 
reverse transcriptase enzyme (Wellinger and Zakian 2012). Est1 abundance varies 
throughout the cell cycle having a peak during S/G2 (Taggart et al. 2002). In late 
S/G2 phase, an Est1-TLC1 interaction is required for Est1 binding to telomeres which 
in turn promotes Est2 binding to telomeres (Chan et al. 2008). Est3 is dependent on 
Est1 and Est2 for its association to the telomerase complex. TLC1 RNA exists in both 
polyadenylated and non polyadenylated forms and only the latter is used by 
telomerase as template (Wellinger and Zakian 2012; Webb et al. 2013).  
Finally, the CST (Cdc13-Stn1-Ten1) complex is essential to yeast cell survival as the 
lack of any of its components leads to death (Wellinger and Zakian 2012). This 
complex shares some functional and structural properties with RPA (Wellinger and 
Zakian 2012). Cdc13 is able to specifically bind to the G-rich single stranded 
telomeric overhang and is the only CST subunit with the capacity to bind DNA 
directly in vivo (Lin and Zakian 1996; Qi and Zakian 2000). Thus, Cdc13 is the CST 
component responsible to keep the whole complex at telomeres where it exerts its 
capping function, protecting the telomere (Giraud-Panis et al. 2010). Importantly, 
both Stn1 and Ten1 show DNA binding activity in vitro with preference to telomeric 
DNA and can act apart from Cdc13 as chromosome caps (Petreaca et al. 2006; Gao 
et al. 2007; Holstein et al. 2014). Together with a capping role, the CST complex also 
plays an important role in telomere replication. For instance, Cdc13 interacts with 
Est1, promoting the recruitment of telomerase to telomeres (Grandin et al. 2000; Wu 
and Zakian 2011). To counteract telomerase recruitment by Cdc13, Stn1 competes 
with Est1 to bind Cdc13, repressing telomerase (Grandin et al. 2000; Chandra et al. 
2001). Cdc13 phosphorylation by Cdk1 promotes the Stn1-Cdc13 interaction in a 
cell-cycle dependent manner and Cdk1 inhibition stalls the de novo addition of 
telomere repeats possibly by disrupting the timing of telomere elongation (Frank et al. 
2006; Liu et al. 2014). Additionally, SUMOylation of the Cdc13 Stn1-binding domain 
increases Cdc13-Stn1 affinity leading to repression of telomerase action (Hang et al. 
2011). In yeast, a role for Ten1 in telomerase recruitment has not been described 
and Ten1 was shown to enhance the DNA-binding activity of Cdc13 (Qian et al. 
2009b). Interestingly, CST complex proteins show no direct orthology to any of the 
mammalian shelterin members (Price et al. 2010). Instead, the human CST complex 
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(CTC1, STN1 and TEN1) independently contributes to telomere maintenance by 
interacting with the ssDNA overhang of the human telomeres (Rice and Skordalakes 
2016). 
1.1.3. Alternative ways of maintaining telomere length 
When telomerase is not active, there are other ways that cells use in order to 
preserve their telomeres. This mechanism was first described in yeast by Lundblad 
and Blackburn in 1993, and in human cells in 1995 by Bryan et al., who gave it the 
name of ALT (alternative lengthening of telomeres) (Lundblad and Blackburn 1993; 
Bryan et al. 1995; Bryan and Reddel 1997). The ALT mechanism is important in 
some types of cancer development and maintenance (Grach 2011). APBs (ALT-
associated promyelocytic leukaemia (PML) bodies) are very common in cells that use 
ALT and contain telomeric DNA, DNA repair proteins and recombination proteins 
(Grach 2011).  
ALT- positive cells are dependent on DNA recombination, and consequently on 
recombination proteins like Rad52 (present in both humans and yeast) (Teng and 
Zakian 1999). In yeast, Rad52 has an extremely important role in DNA recombination 
and repair while in humans its role is more modest, sharing functions with other 
proteins (BRCA2 for example) (Mortensen et al. 2009). The yeast Rad52 is 
expressed throughout the cell cycle, showing an increase during meiosis and in 
response to DNA damage (Cole et al. 1987; Cole et al. 1989). This protein is also 
recruited to (lesion) sites coated with RPA and can interact with Rad51 (Mortensen et 
al. 2009). Yeast cells that bypass senescence using ALT mechanisms can be divided 
into two major groups: type I survivors and type II survivors (Wellinger and Zakian 
2012) (Figure 1-3). Type I survivors are mostly characterized by the amplification of 
the Y’ regions, while the ends of the telomeres are maintained more or less stable 
with the repetitive dsDNA and the ssDNA overhang (Figure 1-3C) (Wellinger and 
Zakian 2012). The genes described as being involved in the formation of these 
survivors are: RAD52, POL32, RAD54, RAD57 and RAD55 (Le et al. 1999; Chen et 
al. 2001). In contrast, type II survivors show amplifications in the telomeric repeats 
which are very heterogeneous (Figure 1-3D, E) (Wellinger and Zakian 2012). Indeed, 
the telomere length of type II survivors can vary from very short to the very long 
telomeres with more than 10kb that are very unstable (Wellinger and Zakian 2012). 
In the formation of type II survivors, the Rad50/Mre11/Xrs2 pathway is involved as 
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well as Rad52, Rad59, Srs2, Sgs1 and Tid1 (Chen et al. 2001; Signon et al. 2001). 
Maringele and Lydall described an important role for EXO1 in the formation of both 
type I and type II survivors in yku70Δ mre11Δ and tlc1Δ backgrounds (Maringele and 
Lydall 2004).  
1.1.4. Telomere silencing 
Transcription from telomeres happens at low rates and in an intermittent manner, a 
phenomenon described as telomere silencing (Gottschling et al. 1990). Telomere 
silencing is promoted mainly by the Sir complex and Rap1 (Cockell et al. 1995; 
Strahl-Bolsinger et al. 1997). The Sir complex is composed of Sir2, Sir3 and Sir4 and 
promotes histone deacetylation (Hoppe et al. 2002). Hyperacetylation is associated 
with transcriptional activity, therefore, histone deacetylases like the Sir complex 
inhibit transcription (Shahbazian and Grunstein 2007). Rap1 binds the DNA, with a 
strong affinity to telomeric DNA, and its interaction with Sir3 and Sir4 positions the Sir 
complex at telomeres (Moretti et al. 1994). The Sir complex is also essential for the 
silencing at the mating type loci (Rine and Herskowitz 1987; Kueng et al. 2013).  
1.1.5. Telomeric repeat containing RNA (TERRA) 
Regardless of the strong transcriptional repression observed at telomeres, some 
residual transcription still occurs, for example, to generate the non-coding RNA, 
TERRA (telomeric repeat containing RNA) (Azzalin et al. 2007). TERRA is 
transcribed mainly by RNA polymerase II, from subtelomeric regions towards the 
chromosome end (Azzalin and Lingner 2015). In yeast, Rif1/Rif2 and the Sir 
complex were shown to repress TERRA expression (mainly in X telomeres) and Rat1 
actively degrades TERRA (X and Y’ telomeres) (Iglesias et al. 2011). Almost all 
TERRA is polyadenylated, and loss of TERRA polyadenylation has been 
suggested to destabilize it (Azzalin and Lingner 2015). In S. pombe, 
polyadenylated TERRA was shown to diffuse and interact with the catalytic 
subunit of telomerase (Moravec et al. 2016). TERRA also has the capacity to 
interact with TLC1 in vitro (Cusanelli et al. 2013). In humans, not all TERRA is 
polyadenylated and only the non-polyadenylated TERRA is bound to chromatin 
(Porro et al. 2010). 
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Figure 1-3 Changes in yeast telomeres. A-B) Yeast telomeres can be subdivided 
into Y’ telomeres or X telomeres. C) Type I survivors amplify the Y’ elements. D-E) 
Type II survivors amplify G-rich sequences. Taken from (Lydall 2003). 
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The exact functions of TERRA at telomeres (and perhaps elsewhere) are still 
being addressed, however a role in telomere length regulation and recombination 
facilitation was shown (Balk et al. 2013). Interestingly, telomere shortening was 
shown to induce TERRA expression (Cusanelli et al. 2013) and TERRA 
overexpression (by the insertion of an artificial promoter in subtelomeric regions) 
led to telomere shortening and senescence (Maicher et al. 2012; Pfeiffer and 
Lingner 2012). However, a more recent study in S. pombe, showed that induction 
of TERRA expression caused telomere elongation in cis, instead of shortening 
(Moravec et al. 2016). Due to the nature of TERRA (complementary to telomeric 
DNA) it has the capacity to form RNA:DNA hybrids at the telomeres (Balk et al. 
2013). The RNA molecule of a RNA:DNA hybrid is hydrolysed by Ribonucleases 
H. The two main yeast Ribonucleases H are RNase H1 (encoded by RNH1) and 
RNase H2 (whose catalytic subunit is encoded by RNH201) (Cerritelli and Crouch 
2009). RNA:DNA hybrids are suggested to promote recombination, since one 
DNA strand of the RNA:DNA hybrids stays single-stranded stimulating HR events 
(Balk et al. 2013). Indeed, ALT cells were shown to have high TERRA levels and 
overexpression of RNase H1 decreased telomere recombination in both human 
tumour cells and yeast (Balk et al. 2013; Arora et al. 2014).  
1.2. DNA damage response to double-strand breaks 
Double stranded breaks (DSBs), like telomeres, contain the end of a DNA molecule. 
However the way the cell perceives each of these DNA termini is different. While 
DSBs need to be eliminated/repaired mainly by homologous recombination (HR) or 
non-homologous end joining (NHEJ), telomeres need to be maintained and protected 
from the repair mechanisms that act on DSBs (Karran 2000). DNA lesion repair by 
HR is dependent on resection at the break, which creates single stranded overhangs 
that can search for regions of homology in the genome. After finding homology, the 
“healthy” region is used as a template for error-free repair. During NHEJ the break is 
simply aligned and ligated, thus this pathway can introduce errors (Marcomini and 
Gasser 2015). 
During the cell cycle there are many checkpoints that can be activated upon DNA 
damage. When the DNA damage checkpoint is activated, there is typically cell cycle 
arrest that can be temporary or permanent. During this pause in the cell cycle, the 
DNA repair machinery is activated in order to repair the damage and restore 
27 
normality (Zhou and Elledge 2000). DNA damage sensors are the first to respond to 
DNA damage sites, followed by the action of the transduction and effector proteins 
(Longhese et al. 1998). The initial steps of the DNA damage response is dependent 
on the presence of blunt ends or ssDNA and is initiated by ATM (Tel1 in yeast) 
and/or ATR (Mec1) (Hurley and Bunz 2007). ATM/Tel1 is more prone to respond to 
dsDNA while ATR/Mec1 is activated by the presence of ssDNA (Jazayeri et al. 2006; 
Gravel et al. 2008; Shiotani and Zou 2009). Figure 1-4 shows the DNA damage 
checkpoint activation upon DNA damage. 
1.2.1. Resection  
The first step to resolve double-strand breaks consists of DNA resection and initially 
involves the MRX complex (Mre11, Rad50 and Xrs2) and the endonuclease Sae2 
(Chapman et al. 2012; Cannavo and Cejka 2014). MRX (MRN in mammals) and 
Sae2 (CtIP in mammals) are responsible for the generation of short ssDNA at DSB. 
Sae2 is suggested to promote 50-100 bp long cuts in the 5’ strand and Mre11 
mediates the nuclease activity of the MRX complex, having both 3’-5’ exonuclease 
activity and an endonuclease activity (Trujillo and Sung 2001; Mimitou and 
Symington 2008; Garcia et al. 2011) (Figure 1-5). The MRX complex is important for 
DSB repair through HR and NHEJ pathways (Symington 2002; Zhang and Paull 
2005). Importantly, Sae2 is thought to limit the MRX checkpoint activation since in 
sae2Δ cells Mre11 stays longer at DSB (Clerici et al. 2006). At telomeres, Mre11 is 
dispensable for ssDNA generation (Maringele and Lydall 2002), but MRX appears to 
be important for telomere maintenance, as mrx mutants have short telomeres (Wilson 
et al. 1999; Ritchie and Petes 2000; Tsubouchi and Ogawa 2000). 
After initial MRX/Sae2 resection, Exo1 together with Sgs1-Dna2 are responsible for 
more extensive resection (Tsubouchi and Ogawa 2000; Llorente and Symington 
2004; Zhu et al. 2008; Shiotani and Zou 2009) (Figure 1-5). Exo1 (EXO1 in 
mammals) is a 5’-3’ flap endonuclease (can cut branched DNA) and was shown to be 
important for the ssDNA regulation of uncapped telomeres (Maringele and Lydall 
2002). Exo1 plays a major role in DNA repair and mismatch repair throughout the 
genome (Amin et al. 2001; Tran et al. 2004). Sgs1 (BLM in mammals), a helicase, 
acts together with Dna2 (DNA2 in mammals), a nuclease (with helicase function), to 
promote both initial and extensive resection (Mimitou and Symington 2008; Zhu et al. 
2008; Bonetti et al. 2009). Sgs1 was shown to associate with recombination proteins  
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Figure 1-4 DNA damage checkpoint in S. cerevisiae.  Resection of the DSB end 
yields long 3’-ended ssDNA tails that trigger the Mec1-Ddc2-dependent DNA 
damage checkpoint kinase cascade. Mec1 is also activated by ssDNA gaps arising 
by nucleotide excision repair (NER) or base excision repair (BER). Unresected, 
blunt-ended DNA also activates a DNA damage response, primarily through the Tel1 
protein kinase and its associated MRX complex. Kinases in the cascade are 
indicated in red. Under some circumstances where Mec1 is absent, Tel1 can 
activate the S-phase checkpoint involving Rad53 and other kinases, as indicated by 
a dotted line. There are three important outputs of DNA damage signalling: 
phosphorylation of histone H2AX (γ-H2AX) and associated increases in some DSB 
repair events; arrest of the cell cycle prior to anaphase (G2/M arrest); and induction 
of damage-inducible genes as well as posttranslational regulation of ribonucleotide 
reductase (RNR). Black arrows indicate protein kinase phosphorylation of several 
target proteins that activate downstream events, whereas a black line terminated in 
a bar indicates an inhibitory modification. Gray arrows protein interactions that 
facilitate checkpoint activation. Figure and legend taken from (Harrison and Haber 
2006). 
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Figure 1-5 Model for bidirectional processing of DSBs by Mre11 and Exo1. After 
DSB formation with blocked ends (hatched squares), Mre11/Sae2-dependent nicks 
flanking the DSB ends create initiation sites for bidirectional resection by Exo1 
and/or Sgs1–Dna2 away from the DSB, and by Mre11 towards the DSB end. Such 
terminal blocks could arise after base damage, trapping of a topoisomerase, or by 
avid binding of the NHEJ complex. 3′ ends are marked with triangles. Mre11/Sae2 
may make multiple nicks on the 5′ strand (light grey arrows), facilitating resection. 
Figure and legend taken from (Garcia et al. 2011). 
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responsible for ALT and to play a role in G-quadruplex unwinding (Sun et al. 1999; 
Lu et al. 2010). An increase in mitotic hyperrecombination in sgs1Δ cells suggested 
that Sgs1 is important to maintain genomic stability (Watt et al. 1996). 
Finally, in vitro studies showed that FEN1, a 5’ to 3’ flap endonuclease (the human 
orthologue of the yeast Rad27) is able to process DNA substrates similar to those 
observed during NHEJ (Tseng and Tomkinson 2004). In yeast, rad27Δ cells are 
viable but require the HR machinery to be present (Symington 1998; Debrauwere et 
al. 2001). Although Rad27 was implicated in DSB repair through NHEJ, its main role 
is in Okazaki fragment processing (Tseng and Tomkinson 2004; Rossi and Bambara 
2006). While Rad27 is not thought to be an active part of the response to DSB, 
Rad27 depletion can lead to DSB and trigger HR events (due to non-cleaved DNA 
flap) (Lopes et al. 2006). 
1.2.2. Checkpoint activation 
After resection, RPA capped ssDNA recruits Mec1/Ddc2 (ATR-ATRIP in humans) to 
sites of DNA damage (Paciotti et al. 2000; Zou and Elledge 2003). Mec1 is an 
essential protein kinase and it phosphorylates a diversity of DNA damage response 
proteins, like Rad9, Rad55 and Chk1 (Emili 1998; Sanchez et al. 1999; Bashkirov et 
al. 2000). Signal amplification is achieved through Dpb11 phosphorylation by Mec1, 
which in turn increases the capacity of Dpb11 to activate Mec1 (Mordes et al. 2008). 
RPA-capped ssDNA recognition by Mec1/Ddc2 is essential for checkpoint activation 
(Paciotti et al. 2000). Mec1 has also been shown to associate with telomeres that 
carry structural abnormalities and to promote telomere silencing (Craven and Petes 
2000; Takata et al. 2004). 
In parallel to Mec1/Ddc2, the 9-1-1 complex (Rad17/Mec3/Ddc1) plays a non-
essential but very important role in checkpoint activation (Lisby et al. 2004). The 9-1-
1 complex was named after its mammalian orthologue, which is composed of Rad9-
Hus1-Rad1. Rad24, a checkpoint “clamp loader”, loads the 9-1-1 complex to the 
DNA where the latter aids DSB repair (Majka and Burgers 2003). The 9-1-1 complex 
can be loaded to short ssDNA overhangs (produced by MRX/Sae2), promoting the 
loading of Rad9 near DSBs where the latter inhibits resection (Mimitou and 
Symington 2008; Ngo and Lydall 2015). On the other hand, the 9-1-1 complex 
promotes the recruitment of Dna2-Sgs1 and Exo1 to DSBs, which places the 9-1-1 
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complex in a central position in the coordination of DNA resection, both inhibiting and 
stimulating resection (Ngo et al. 2014; Ngo and Lydall 2015). Deletion of 9-1-1 
complex components leads to reduced phosphorylation of Rad9 and Rad53, 
indicating the importance of this complex to the DNA damage response (Emili 1998).  
A second sensor kinase that can be activated in response to DSB is Tel1. Tel1 has 
an important role in DNA damage response and it is redundant to Mec1 (Morrow et 
al. 1995). Tel1 loss does not increase sensitivity to DNA damaging agents, however 
when deleted in a Mec1 mutant background this sensitivity is significantly increased 
(Morrow et al. 1995). Importantly, Tel1 seems to act in the absence of ssDNA, when 
the MRX complex remains associated with the lesion site (Lisby et al. 2004). 
Additionally, the presence of Xrs2 (part of the MRX complex) seems to be important 
for Tel1 recruitment to DSB (Nakada et al. 2003). Tel1 promotes phosphorylation of 
Rad9 and Rad53 and does not rely on the 9-1-1 complex for such function 
(Giannattasio et al. 2002; Nakada et al. 2003). 
The Rad9 checkpoint protein is part of a pathway that acts parallel to the Rad24 
pathway (de la Torre-Ruiz et al. 1998). Rad9 is a mediator that promotes Rad53 and 
Chk1 phosphorylation by Mec1 after DNA damage (Blankley and Lydall 2004; 
Sweeney et al. 2005). Rad9 activation/phosphorylation can be performed by Mec1 
and Tel1, promoting Rad9 oligomerization (Longhese et al. 1998; Vialard et al. 1998; 
Usui et al. 2009). Rad53 then binds to the phosphorylated/oligomerized Rad9, gets 
oligomerized and finally promotes its own phosphorylation/activation (Schwartz et al. 
2002; Sweeney et al. 2005). Also, Rad9 inhibits ssDNA generation both dependent 
and independently of Mec1/Rad53 (Jia et al. 2004). 
Finally, Rad53 and Chk1 are effector kinases whose activation is dependent on Rad9 
and Mec1 (Blankley and Lydall 2004; Sweeney et al. 2005). Chk1 and Rad53 
promote cell cycle arrest upon DNA damage by inducing Pds1 phosphorylation 
(Chk1-dependent) and repressing Pds1 degradation (Rad53-dependent) (Cohen-Fix 
and Koshland 1997; Sanchez et al. 1999; Agarwal et al. 2003). Pds1 is required for 
yeast cell cycle arrest in response to DNA damage (Cohen-Fix and Koshland 1997). 
Interestingly, Chk1 (and Rad9), but not Rad53, plays an important role in the cell 
cycle arrest of yku70Δ cells (Maringele and Lydall 2002). Rad53 also has the 
important function to inhibit Exo1 in order to avoid extensive DNA resection, which 
constitutes damage (Jia et al. 2004).  
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1.3. Telomeres, senescence and cancer 
In 1961, Hayflick noticed that human fibroblasts cultivated for long periods of time 
(more than 50 passages) start to degenerate, i.e. they enter senescence (Hayflick 
and Moorhead 1961). Cellular senescence is related to telomere shortening (Lopez-
Otin et al. 2013), however there are other factors involved as suggested by the 
senescence entry of some cells that are telomerase positive (Kiyono et al. 1998; 
Dickson et al. 2000). Importantly, the presence of only one (or few) short telomeres is 
able to trigger senescence (Hemann et al. 2001). Cells that become senescent 
cannot replicate and therefore senescence is believed to be an anti-cancer 
process (Lopez-Otin et al. 2013).  
In 2007, Ruddon came up with the following definition: “Cancer is an abnormal 
growth of cells caused by multiple changes in gene expression leading to 
dysregulated balance of cell proliferation and cell death and ultimately evolving into a 
population of cells that can invade tissues and metastasize to distant sites, causing 
significant morbidity and, if untreated, death of the host” (Ruddon 2007). Thus, the 
ability to resist cell death, to evade growth suppressors, to sustain the proliferative 
signalling and induce angiogenesis, to enable replicative immortality and to activate 
invasion are all hallmarks of cancer (Hanahan and Weinberg 2011). Cancers present 
dysregulated cellular energetics (mitochondrial dysfunction) as well as a capacity to 
avoid immune destruction (Hanahan and Weinberg 2011). The causes for all of this 
to happen are vast, varied (each tumour is different) and not fully understood. 
However, genetic and epigenetic modifications are thought to be responsible for the 
development of the majority of these hallmarks (Hanahan and Weinberg 2011). 
Genomic instability is an extremely common characteristic in most cancers, however, 
whether it is the cause or the consequence of cancer is not yet defined (Negrini et al. 
2010). One of the most common genes mutated in cancers is the tumour suppressor 
gene and DNA damage checkpoint TP53 (Negrini et al. 2010). Many other genes 
responsible for the DNA damage checkpoint/repair are often found to be mutated in 
cancers: ATM (which, like TP53, is inactivated during cancer), BRCA1, BRCA2, 
MRE11, RAD52, RAD51L3, etc. (Negrini et al. 2010; Salk et al. 2010). Epigenetic 
alterations are also an important way of repressing or stimulating gene expression 
(Esteller 2007; Jones and Baylin 2007; Berdasco and Esteller 2010). Consequently, 
DNA methylation patterns suffer great changes during cancer, with hypermethylation 
of some promoters and decreased methylation in some genes (Esteller 2007). At the 
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same time, histones also suffer modifications: deacetylation in some promoter-
associated histones, and change in the methylation pattern (Esteller 2007; Jones and 
Baylin 2007).  
Cancer is a serious threat to human health, with 8.2 million worldwide deaths related 
to cancer in 2012 (World Health Organization). Since telomere maintenance is a key 
feature of cancer cells, with telomerase being expressed in most cancer cells, the 
understanding of telomere regulation is extremely important (Shay and Wright 2011). 
1.4. Yeast as a cellular model 
S. cerevisiae, budding yeast or simply, yeast, has proven to be a very helpful 
organism regarding the study of many basic cellular functions (Botstein et al. 1997). 
S. cerevisiae belongs to the Fungi phylum and it was the first eukaryote to have its 
genome completely sequenced in 1996 (Goffeau et al. 1996; Hedges 2002). The 
main characteristics of this organism are its fast growth and ease of maintenance, 
the fact that it can be both cultivated as a diploid or haploid, the facility to perform 
genetic modifications and the possibility to cross strains with opposing mating types 
(Gomez et al. 2005). Yeast can enter the stationary phase when faced with lack of 
nutrients and it is able to go through meiosis (when in its diploid state). And perhaps 
the most important of all: it shows a high rate of conservation with human genes and 
cellular functions, which makes it very suitable to study new gene functions and 
interactions (Gomez et al. 2005). Thus, because of all these characteristics S. 
cerevisiae is often used in a first line of studies before the slower studies in 
human/mammalian cells or multicellular organisms like worms, rats and mice. 
1.4.1. yku70Δ mutants 
yku70Δ cells are both defective in their capacity to cap the telomere and in their 
capacity to repair double stranded breaks. yku70Δ cells are temperature sensitive 
presenting extensive fitness defects at 37°C, but not at 30°C (Feldmann and 
Winnacker 1993). Telomere defects are thought to be the main cause of the fitness 
defects in yku70Δ cells, since overexpression of telomerase subunits can partially 
suppress the fitness defects at higher temperatures (Nugent et al. 1998; Teo and 
Jackson 2001; Lewis et al. 2002). Additionally yku70Δ cells accumulate telomeric 
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ssDNA and deletion of EXO1, both decreases telomeric ssDNA and increases 
yku70Δ cell fitness (Maringele and Lydall 2002). 
1.4.2. cdc13-1 mutants 
Cdc13 is an essential telomeric capping protein and the cdc13-1 allele is a 
temperature sensitive version of the gene (the highest permissive temperature is 
26°C) (Nugent et al. 1996). cdc13-1 mutants, as well as yku70Δ mutants (which are 
also temperature sensitive), are very important to study genes that affect telomere 
maintenance (by affecting the temperature sensitivity of these strains) (Addinall et al. 
2011). 
1.4.3. Genome-wide screens 
One of the advantages of yeast studies is the possibility of performing genome-wide 
screens, where one can evaluate the effect of a parameter in a considerable amount 
of genes and strains (Carpenter and Sabatini 2004). Synthetic genetic array (SGA), 
first described in 2001, is an example of a high-throughput study that can be 
performed in S. cerevisiae, which involves the cross of a mutated strain with a library 
of thousands of strains, each of them carrying one single mutation (Tong et al. 2001). 
Diploids are then sporulated and double mutants selected using antibiotic resistance. 
SGA relies on the use of an automated robotic system and allows the creation of a 
large number of double (or multiple) mutants in one single experiment (Tong et al. 
2001). Importantly, this approach not only generates a large number of double 
mutants simultaneously but also allows the detection of synthetic lethality or synthetic 
sick interactions between the genes analysed.  
In 2011, Addinall et al. used SGA followed by QFA (quantitative fitness analysis) in 
order to find a vast number of genetic interactions that affected cell fitness (Addinall 
et al. 2011). In this case the objective was to find genes that could affect telomere 
maintenance by crossing cdc13-1 or yku70Δ strains against a mutant library (single 
deletions). QFA is an experimental and computational workflow that involves the 
analysis of a growth curve obtained from time course photography of cell cultures 
grown in solid agar plates (Addinall et al. 2011). The use of QFA allowed the authors 
to evaluate the differences between the growth of double mutants and single mutants 
to infer the existence of genetic interactions (Addinall et al. 2011). Genome-wide 
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screens are therefore an important tool to provide a large amount of genetic 
information that can be further studied in more detail in yeast or other organisms. 
1.5. Aims 
The aim of this thesis is to identify a small number of genetic interactions that occur 
in yeast and that can be relevant to both telomeres and cancer. This will be achieved 
by the analysis of previously published high-throughput screens. After the 
identification of candidate genes, I intend to confirm and understand their role at 
telomeres. If possible I will extrapolate my results to a human context and gain new 
insights about the role of the candidate genes in cancer development. 
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2. Materials and Methods 
2.1. Yeast strains 
S. cerevisiae strains used in this study are listed in Appendix A. Strains are in the 
W303 genetic background and are RAD5+. 
2.2. Media composition 
2.2.1. Yeast Extract, Peptone, Dextrose (YEPD) 
1% (w/v) yeast extract, 2% Bactopeptone, 2% (w/v) dextrose, 0.0075% (w/v) 
adenine. For plates 2% (w/v) agar was added. For antibiotic selection either 0.2 
mg/mL of G418 or 0.1 mg/mL of clonNAT or 0.3 mg/mL of hygromycin was added. 
The media was autoclaved for 12 min at 121°C and cooled to 60°C. Antibiotics and 
sensitive chemical compounds were not autoclaved. Instead, antibiotic stock 
solutions were filtrated and added to the media after autoclaving. 
2.2.2. 5-Fluoroorotic Acid Media (5-FOA) 
0.13% (w/v) amino acid powder (lacking uracil), 0.67% (w/v) yeast nitrogen base, 
0.005% (w/v) uracil, 0.1% (w/v) 5-FOA, 2% (w/v) dextrose. 
2.2.3. Complete Synthetic Media (CSM) 
Amino Acid Powder Recipe 
Adenine  2.5 g 
L-arginine (HCl)  1.2 g 
L-aspartic acid  6.0 g 
L-glutamic acid (monosodium salt)  6.0 g 
L-histidine  1.2 g 
L-leucine  3.6 g 
L-lysine (mono-HCl)  1.8 g 
L-methionine  1.2 g 
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L-phenylalanine  3.0 g 
L-serine  22.5 g 
L-threonine  12.0 g 
L-tryptophan 2.4 g 
L-tyrosine  1.8 g 
L-valine  9.0 g 
Uracil  1.2 g 
  
The amino acids above were thoroughly mixed together and stored in a dry place. 
For the media: 0.13% (w/v) of amino acid powder, 0.17% (w/v) yeast nitrogen base, 
0.5% (w/v) ammonium sulphate, 2% (w/v) dextrose.  
2.2.4. Selective media 
0.13% (w/v) of amino acid powder (lacking the appropriate amino acid), 0.17% (w/v) 
yeast nitrogen base, 0.5% (w/v) ammonium sulphate, 2% (w/v) dextrose. 
2.2.5. Sporulation media 
0.1% (w/v) yeast extract, 0.05% (w/v) dextrose, 1% (w/v) potassium acetate, pH 7.6. 
2.2.6. Lysogeny Broth (LB) 
0.5% (w/v) yeast extract, 1% (w/v) peptone, 1% (w/v) NaCl. For solid media 2% of 
agar added prior to autoclaving. When necessary, after autoclaving, ampicillin was 
added to a final concentration of 50 µg/mL. 
2.2.7. Super Optimal broth with Catabolite repression (SOC) 
0.5% (w/v) yeast extract, 2% (w/v) bactotryptone, 9.7 mM NaCl, 2.2 mM KCl, 0.36% 
(w/v) glucose, 10 mM MgCl2, 10 mM MgSO4. 
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2.3. Methods 
2.3.1. Yeast cell maintenance and culture 
Yeast strains were cultivated at 30°C or 23°C. Cultivation at 23°C was used for 
strains carrying the cdc13-1 allele and experiments involving paf1Δ or ctr9Δ strains. 
Standard procedures for culture, mating and tetrad dissection were followed (Adams 
et al. 1997).  
2.3.2. Sporulation of diploids 
A single colony of diploid cells was inoculated in 2 mL of YEPD and grown overnight 
at 30°C. 500 µL of the saturated culture were washed twice with 4 mL of sterile water 
(1000 rpm for 3 min). The cell pellet was resuspended in 2 mL of sporulation media 
and incubated at 23°C for 2-5 days. In cases where the diploids carried a plasmid, 
cells were scraped from a fresh selective plate and resuspended directly in the 
sporulation media. 
2.3.3. Primer design  
Primer design was performed using the software ApE – A plasmid Editor by M. 
Wayne Davis (http://biologylabs.utah.edu/jorgensen/wayned/ape/). For gene 
deletions primers consisted of 40 bp of homology to the region immediately upstream 
(forward) or downstream (reverse) of the start or stop codons, followed by 20 bp with 
homology to a plasmid containing an antibiotic resistance or auxotrophy marker. For 
deletion confirmation, ~20 bp primers were designed to anneal roughly 500 bp 
upstream and downstream of the start and stop codons. A reverse primer 
recognising inside the deletion cassette was used together with a forward primer 
upstream of the coding region of the deleted gene. qPCR primers were designed 
using the Invitrogen Perfect Primer Design application (PCR detecting application)  
(Kim et al., 2010). Primer specificity of all qPCR primers was verified (Kent). Primer 
efficiency was tested for all pairs of primers used in qPCR (and RT-qPCR). To 
calculate primer efficiency 16, 1.6, 0.16 and 0.016 ng of genomic DNA were used as 
template for the primers. A standard curve (y=mx+b) was obtained by plotting the 
Log2 (DNA concentration) against the CTs. Primer efficiency was calculated using 
39 
the following equation: Efficiency=(10^(-1/m)-1)×100. All primers used in this study 
had efficiencies between 85 and 115. 
2.3.4. Gene deletion 
All the genetic modifications were made according to Longtine et al. (Longtine et al. 
1998). Shortly, specific plasmids carrying an antibiotic resistance cassette or a 
nutrient gene were amplified by PCR and then transformed into the appropriate 
strains by high efficiency lithium acetate (LiAc) transformation. The primers were 
designed as described in section 2.3.3. 
2.3.5. Lithium acetate (LiAC) transformation 
50 mL of exponentially-dividing cells (OD600=0.5-1) were harvested at 1500 rpm for 3 
min, the medium was poured off, washed once in 25 mL sterile water and the cells 
were resuspended in 1 mL 0.1 M (1X) LiAc. Cells were transferred to an Eppendorf 
tube and spun down at 13000 rpm for 15 sec. LiAc was removed by aspiration. Cells 
were resuspended in a final volume of 500 µL by adding 400 µL of 0.1 M LiAc. 50 μL 
of the cell suspension were pelleted at 13 000 rpm for 15 sec and used for one 
transformation. The following reagents were then added to the pellet in the following 
order: 240 μL of PEG 4000 (50% w/v); 36 μL of 1 M (10X) LiAc; 50 μL of Salmon 
Sperm DNA (2 mg/mL, previously boiled and rapidly cooled in ice); and 50 μL of 
Transforming DNA in Water (0.1 – 10 μg). Samples were vortexed vigorously and 
incubated at 23°C for 30 min before being heat shocked at 42°C for 20 min. Cells 
were pelleted at 6000 rpm for 15 sec and transformation mix removed by aspiration. 
Cells were carefully resuspended in 200 μL sterile water then either plated onto 
selection plate to select for auxotrophy markers, or plated onto YEPD, incubated at 
23°C (for ts strains) or 30°C overnight and then replica plated the next day onto 
plates containing antibiotics. Transformants were allowed to grow at 23°C for 4-5 
days or at 30°C for 3-4 days. Single colonies were then picked and streaked for 
single colonies onto selective media. Transformants were verified by colony PCR. 
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2.3.6. Transformation of plasmids into yeast 
Fresh cells were scraped from an agar plate using a yellow tip and resuspended in 
100 µL of freshly prepared One-Step buffer (0.2 M LiAc, 40% (w/v) PEG, 100 mM 
DTT). 1 µL of plasmid (100-400 ng) and 5.3 μL salmon sperm DNA (10 mg/mL; 
boiled for 5 min then cooled rapidly in iced water) were added. Samples were 
vortexed and incubated at 45°C for 30 min. Cells were then plated onto the 
appropriate selective media and the grown colonies were streaked for single colonies 
and a single colony was picked for further experiments. 
2.3.7. E.coli transformation 
1-15 μL of plasmid DNA were added to 50 μL E.coli DH5α competent cells. Cells and 
DNA were incubated on ice for 30 min and heat-shocked in a 42°C water bath for 90 
sec. Cells were then incubated on ice for 2 min and 450 µL of pre-warmed (37°C) 
SOC medium was added to the cells. Cells were incubated in a rotating wheel for 1 
hour at 37°C. 200 μL of the cell suspension were spread onto LB plates with 0.1 
mg/mL of ampicillin and incubated overnight at 37°C. Single colonies were inoculated 
into 2 mL of LB with 0.1 mg/mL of ampicillin and incubated overnight at 37°C. 
Plasmid DNA was recovered using a QIAprep Spin Miniprep Kit (Qiagen). 
2.3.8. Plasmid recovery from S. cerevisiae 
Plasmid recovery from S. cerevisiae was made using QIAprep Spin Miniprep Kit 
(Qiagen). All buffers are provided by the kit and the compositions are confidential. 
Shortly, overnight cell cultures (grown at 36°C) were harvested by centrifugation for 5 
min at 6500 rpm and the cell pellets were resuspended in 250 µL of Buffer P1 
containing 0.1 mg/mL RNase A. 100 µL of acid-washed glass beads were added and 
samples were vortexed for 5 min. Supernatants were transferred to a new Eppendorf, 
250 µL of buffer P2 were added and mixed by inversion. Samples were incubated at 
room temperature for 5 min and 350 µL of buffer N3 were added. After mixing by 
inversion, samples were spun for 10 min at 13000 rpm. Supernatant was transferred 
to a QIAprep Spin Column and spun for 30 sec at 13000 rpm. 750 µL of buffer PE 
were added and samples were centrifuged for 30 sec at 13000 rpm. An additional 
centrifugation at 13000 rpm for 1 min was performed. Finally, DNA was eluted in 25 
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µL of water. 10 µL were used to transform E.coli DH5α competent cells (as described 
in section 2.3.7). 
2.3.9. DNA isolation from yeast (Yale quick method) 
Yeast strains were grown overnight to saturation on a wheel and spun at 13000 rpm. 
Pellet was resuspended in 0.1 M EDTA (pH 7.5), 1:1000 β-mercaptoethanol and 2.5 
mg/ml zymolyase and incubated at 37°C until spheroplasted. A solution of 0.25 M 
EDTA pH 8.5, 0.5 M Tris Base, 2.5% (w/v) SDS was added to each tube and the 
mixture incubated at 65°C. After that, 5 M of KAc was added to the mixture followed 
by incubation on ice. Samples were spun again and the supernatants transferred to a 
new tube that was filled with 100% ethanol. Samples were spun again. The pellets 
were dried briefly before adding 100 µL of a solution of 10 mM Tris, 1 mM EDTA (pH 
8) and RNAse A. The mixture was incubated at 37°C, followed by precipitation with 
isopropanol. Samples were spun again, washed with 70% ethanol and the pellets 
resuspended in 40 µL of 10 mM Tris, 1 mM EDTA (pH 8) after a period of air drying. 
Isolation of DNA to amplify genes by PCR was performed using the YeaStar 
Genomic DNA Kit (Zymo Research). 
2.3.10. DNA isolation (using phenol) 
Between 7×107 to 1.5×109 (exponentially growing) yeast cells were spun at 1500 rpm 
for 5 min (4°C). Pellets were washed twice in ice-cold mQ H2O, supernatants were 
completely removed and pellets were frozen at -80°C for at least 2 hours. Cell pellets 
were thawed on ice, resuspended in 400 μL of lysis buffer (2 % (v/v) Triton X-100, 1 
% (w/v) SDS, 100 mM NaCl, 10 mM Tris–HCl, pH 8.0, 100 mM EDTA, pH 8.0) and 
added to screw-cap tubes (Sarstedt) containing 0.6 g glass beads. 400 μL of 
phenol:chloroform:isoamyl alcohol (25:24:1, v/v/v) were added and lysis was 
performed using a Precellys 24 ribolyser at 5.5 power setting for 20 sec (3 times, 
placing the samples on ice between cycles). 400 μL of TE (10 mM Tris-Cl, 1 mM 
EDTA, pH 8.0) were added and samples were spun at 13000 rpm for 5 min (4°C). 
The aqueous phase (top) was transferred to previously spun 2 mL tubes of phase 
lock gel, light. 750 μL of phenol:chloroform: isoamyl alcohol (25:24:1) were added 
and mixed by inversion. Samples were spun at 13000 rpm for 5 min. Aqueous phase 
was transferred to a 2 mL Eppendorf and 100% ethanol was added to fill the tube. 
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Tubes were incubated at room temperature for 5 min and then centrifuged at 13000 
rpm for 3 min. Supernatant was completely removed and pellet was air dried for 5 
min. Pellet was resuspended in 806 µL of TE/RNA (7.5 µg/mL RNAse) by incubation 
at 37°C for 30 min. 50 µL of 3 M NaAc, pH 5.2 were added together with 100% 
ethanol to fill the tube. After 15 min incubation at room temperature, samples were 
centrifuged at 13000 rpm for 5 min. Pellet was air-dried and resuspended in 40 μL of 
TE by incubation in a 37°C water bath. DNA yield and purity was determined using a 
Nanodrop 2000 (Thermo Scientific). 
2.3.11. RNA isolation (using phenol) 
25 mL of overnight exponentially growing yeast culture (e.g. 2×107 cells/mL) was 
spun for 2 min at 3,000 rpm at 4°C (culture was set by 2:10000 dilution of a saturated 
culture). Pellet was resuspended in 1 mL ice-cold DEPC-treated water (Sigma 
Aldrich) and transferred to two 1.5 mL Eppendorf tubes. Samples were spun for 30 
sec at 13,000 rpm, and pellet washed again in 0.5 mL ice-cold DEPC water. Pellets 
were frozen at -80°C for at least 2 hours. Pellets were resuspended in 300 μL of ice-
cold RNA buffer (0.5 M NaCl, 0.2 M Tris- HCl pH 7.5, 10 mM EDTA pH 8.0) and 
transferred to a 2 mL screw cap tube (Sarstedt) containing 200 μg of glass beads (ice 
cold). 300 μL of chilled phenol:chloroform:isoamyl alcohol (25:24:1 (v/v/v)) saturated 
with RNA buffer were added and lysis was performed in a Precellys 24 ribolyser 
(Bertin Technologies) using two cycles of 30 sec at 6500 rpm with a 15 sec pause 
between cycles. Samples were spun at 13,000 rpm for 1 min at 4°C. The upper 
phase was transferred to a new Eppendorf and 300 μL of chilled 
phenol:chloroform:isoamyl alcohol (25:24:1 (v/v/v)) saturated with RNA buffer were 
added. After brief vortexing samples were centrifuged for 1 min at 13,000 rpm at 4°C. 
Upper phase was transferred to a new Eppendorf and 900 μL of ice-cold 100% 
ethanol were added. Samples were incubated at -80°C for 2 hours and then 
centrifuged 2 min at 13,000 rpm at 4°C. Supernatant was completely removed and 
pellets were air-dried for 15 min. Finally, RNA was dissolved in 50 μL of RNAse-free 
water. Samples were stored at -80°C. 100 µL of 1 µg/µL RNA were purified using the 
RNA Cleanup in the RNeasy Mini Kit (Qiagen) and eluting the RNA in 30 µL of 
RNAse free water. 5 µL of 1 µg/µL RNA were then digested with 2 µL (2 units) of 
DNAse I (Amplification grade, Invitrogen) and 1X DNAse I buffer (Invitrogen) in a final 
volume of 19 µL. Reaction was stopped with 2 µL of 25 mM EDTA (Invitrogen) and 
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incubation at 65°C for 10 min. 40 µL of DEPC-treated water were added to each 
sample to get a concentration of 82 ng/µL. 2 µL of this RNA were used in One-Step 
RT-qPCR.  
2.3.12. RNA isolation (using RNeasy Mini Kit) 
All TERRA measurements were made using this protocol. RNA was extracted using 
the RNeasy Mini Kit (Qiagen) with 3 DNAse treatments (RNase-Free DNase Set, 
Qiagen). All buffers are provided by the kit and the compositions are confidential. 
Pellets (5×107 to 20×107 cells) were collected, washed and frozen as described in 
section 2.3.11. Frozen pellets were resuspended in 600 µL of buffer RLT 
supplemented with ß-mercaptoethanol (10 µL ß-mercaptoethanol/1 mL RLT buffer) 
and lysed as described in section 2.3.11. 350 µL of the lysate were transferred to a 
new Eppendorf, centrifuged at full speed and the supernatant transferred to a new 
Eppendorf. 350 µL of 70% ethanol were added and the sample was transferred to an 
RNeasy mini column. Samples were centrifuged for 15 sec at 12,000 rpm and 350 µL 
of buffer RW1 were added. Samples were centrifuged for 15 sec at 12,000 rpm and 
80 µL of DNase I incubation mix (10 µL DNase I stock solution to 70 µL Buffer RDD) 
was added. Samples were incubated for 15 min at 23°C, 350 µL of Buffer RW1 were 
added and samples were centrifuged for 15 sec at 12,000 rpm. Samples were 
washed twice with 500 µL of RPE buffer (first by centrifugation for 15 sec at 12,000 
rpm and then for 2 min at 12,000 rpm). An extra centrifugation (1 min at max speed) 
was performed to get rid of residual buffer. RNA was eluted with RNase-free water in 
two centrifugation steps: first with 40 µL and then with 47.5 µL (1 min at 12,000 rpm). 
10 µL of Buffer RDD and 2.5 µL of DNase I stock were added to each sample and 
incubated at 23°C for 10 min. 350 µL of Buffer RLT were added to each sample 
followed by 250 µL of 100% ethanol. Each sample was applied to the corresponding 
previously used RNeasy mini column. Samples were centrifuged for 15 sec at 12,000 
rpm and 350 µL of buffer RW1 were added. A new on-column DNAse I digestion and 
subsequent washing steps was performed as described above. RNA was eluted with 
RNase-free water in two centrifugation steps: first with 30 µL and then by reapplying 
the eluted sample to the column. 
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2.3.13. In vivo cloning 
In vivo cloning was performed using the Lithium acetate transformation method 
(Section 2.3.5).The DNA to transform was created the following way: 0.6-1.5 µg of 
plasmid (vector) was cut with 15 units of the appropriate restriction enzyme (New 
England Biolabs) and the appropriate restriction enzyme buffer (New England 
Biolabs) in a 20 μL volume digest for 2 hours at the appropriate temperature. Insert 
DNA was created by PCR. Both vector and insert were purified using a Biomiga Gel 
Purification kit. The transformation was carried out with 15 µL of the vector and 20 µL 
of the insert. Transformations with the following controls were also performed: vector; 
insert; undigested vector; and TE. Plasmids were then removed from yeast using the 
method described in section 2.3.8. 
2.3.14. In vitro cloning 
2 μg plasmid vector DNA and plasmid DNA containing the required insert were cut 
with 15 units of the appropriate restriction enzyme (New England Biolabs) and the 
appropriate restriction enzyme buffer (New England Biolabs) in a 20 μL volume 
digest for 90 min at 37°C. Then, to the vector, 1 µL of 5X New England Biolabs Buffer 
4 (CutSmart) and 1 µL of 2X CIP phosphatase (New England Biolabs) were added. 
After 30 min of incubation both vector and insert DNA were ran on a gel and purified 
using a Biomiga Gel Purification kit. Vector (2 µL) and insert (6 µL) were ligated 
together using T4 DNA ligase in 1X T4 DNA ligase buffer by overnight incubation at 
16°C. 5 μL of the ligated DNA were transformed into 100 μL E.coli DH5α competent 
cells as described in section 2.3.7. 
2.3.15. Spot test 
A pool of colonies were grown until saturation overnight at 23°C in liquid YEPD (for 
spot tests containing sick strains saturation was only achieved after 2 days). 5, 10 or 
20-fold serial dilutions in water were spotted onto the appropriate plates using a 
replica plating device. Plates were incubated for 2 (or 5) days at the appropriate 
temperatures. Pictures were taken using a SPimager. 
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2.3.16. Southern blot 
Southern blot analysis was used to assess telomere length and performed as 
previously described (Dewar and Lydall 2010). Genomic DNA was extracted from 2 
different strains for each genotype. 2.5 µL of equally concentrated DNA preparations 
were digested with 0.5 µL XhoI or Hind III (20 units/µL), 2 µL 5x NEBuffer 4, 1 µL 10x 
BSA, 4 µL water for 3 hours at 37°C. Samples were run on a 1% agarose gel (0.5X 
TBE, SybrSafe) at 20 volts for ~17 hours. The gel was photographed using a Fuji 
LAS 4000 imager to determine loading. The gel was depurinated in 0.25 M HCl for 15 
min, rinsed twice in sterile water then denatured in 0.5 M NaOH for 30 min. The gel 
was blotted to positively-charged nylon membrane (Roche) using a vacuum blotter 
(Model 785, BioRad) at 5 inches Hg in 10X SSC (87.6 g of NaCl, 44.1 g of sodium 
citrate, pH 7.0, in 1 litre) for 90 min. DNA was cross-linked to the wet membrane 
using auto UV cross-linking (Stratalinker). The membrane was rinsed briefly in sterile 
water and allowed to air-dry. The probe was hybridized to the membrane using the 
labelled probe and the DIG High Prime Labelling and Detection Starter Kit II (Roche). 
The probe was detected using the same kit and the membrane was imaged using a 
Fuji LAS 4000 imager for chemiluminescence, for 20-30 min.  
2.3.17. Passage test 
Single colonies (from the germination plates) were streaked on to a YEPD plate and 
let grow for 2 (30°C) or 4 (23°C) days. Pictures were taken using a SPimager and 
pooled colonies from this plate were used to streak on a new YEPD plate. Pictures 
were taken again and this procedure was repeated until no differences were 
observed between two subsequent passages. 
2.3.18. Genomic/Plasmid PCR 
PCR was used to amplify DNA fragments from genomic DNA or plasmids. 
Oligonucleotides used in this study are listed in Appendix B and a list of plasmids can 
be found in Appendix C. PCR was performed in a final volume of 20 µL containing: 
0.3 µM of each primer, 0.5 units of ExTaq polymerase (TaKaRa Bio Inc.), 0.2 mM of 
dNTPs, 1X ExTaq buffer and 5-15 ng of genomic or plasmid DNA. PCR conditions 
used were: 1 cycle of 1 min at 95°C; 35 cycles of 30 sec at 94°C, 30 sec at 55°C and 
1 min per kb DNA amplified at 68°C; 1 cycle of 10 min at 68°C. PCR product sizes 
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were verified by running samples on agarose gels made with 0.5X TBE and 1X 
SyBrSafe (1/10,000 dilution; Invitrogen). Gels were imaged using a FujiFilm LAS 
Image 4000.  
2.3.19. Colony PCR 
Colony PCR was used to confirm correct deletion of genes. PCR was performed in a 
final volume of 20 µL containing: 0.3 µM of each primer, 0.5 units of GoTaq HotStart 
polymerase (Promega), 0.2 mM of dNTPs, 2.5 mM of MgCl2, 1x green GoTaq buffer 
and 2 µL cell suspension in water. PCR product sizes were verified as described in 
section 2.3.18.  
2.3.20. qPCR 
Quantitative PCR was performed with 2 µL of 0.08-80 ng/µL of DNA in 1X Platinum 
SYBR Green qPCR SuperMix-UDG with ROX (Invitrogen), 200 nM forward primer 
and 200 nM reverse primer. For each sample three replicates were measured and a 
no-template control was also analysed (with water instead of DNA). The qPCR 
program was 50°C for 2 min, 95°C for 2 min, followed by 40 cycles of 95°C for 15 sec 
and 60°C for 30 sec using an ABI Systems StepOnePlus thermal cycler. A melting 
curve was also analysed. BUD6, ACT1 or 7S RNA were used as internal controls to 
normalize the DNA loaded. Fold changes were calculated using the formula: 2^-
(SampleCT-ControlCT). Data was then analysed relative to WT values (considering 
WT fold change to be 1). 
2.3.21. RT-qPCR 
Reverse transcriptase PCR was performed either by a One-Step or a Two-Step 
method. The One-Step method was made using the SuperScript® III Platinum® 
SYBR® Green One-Step qPCR Kit w/ROX (Invitrogen). The RT-qPCR was 
performed using 2 µL of 80-82 ng/µL RNA in 1X SYBR® Green Reaction Mix, 200 
nM of forward and reverse primers, 0.2 µL of SuperScript® III Reverse Transcriptase 
and 0.2 µL of Rox Reference Dye. The qPCR program was 50°C for 3 min, 95°C for 
5 min, followed by 40 cycles of 95°C for 15 sec and 60°C for 30 sec and a final cycle 
of 1 min at 40°C using an ABI Systems StepOnePlus thermal cycler. Data was 
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analysed as described in section 2.3.20. In the Two-Step method cDNA was 
produced using SuperScript™ II Reverse Transcriptase (Invitrogen). 3.8 µL of 0.8 
µg/µL RNA with 0.769 µM of dNTP mix, 2 µM of reverse primers (10 µM for CA-rich 
primer, m4104) in a final volume of 13 µL were incubated at 90 °C for 1 min followed 
by 1 min at 55°C. With the mix still at 55°C, 7 µL of the following mix were added to 
each sample: 4 µL of 5X First-Strand Buffer, 1 µL of DTT (0.1M), 1 µL SuperScript™ 
II RT and 1 µL of RNasin plus inhibitor (Promega). Samples were incubated for a 
further 60 min at 55°C followed by 15 min at 70°C. Samples were diluted 2.5 times in 
water and 2 µL of the cDNA was quantified by qPCR using the method described in 
section 2.3.20. 
2.3.22. In-gel assay  
In-gel assay was used to assess the amount of telomeric ssDNA. Telomeric DNA 
damage was induced by shifting the temperature of exponentially growing cultures 
(containing cdc13-1 or yku70Δ cells) from 23°C to 36°C. Cells were collected after 4 
hours and DNA extracted as described in section 2.3.10. 5-10 µg of DNA were 
digested overnight at 37°C in a 20 µL reaction containing: 2 units of XhoI, 1X NEB 
Buffer 4 and 0.1 µg/µL of BSA. Enzyme was inactivated by 20 min incubation at 65 
°C. Samples were placed on ice and 1 µL of an AC-rich oligo labelled on the 5’ end 
with IRDye800 (m3157, 500 nM) was added. Samples were incubated first 10 min at 
37°C and then 30 min on ice. 4 μL of Orange G Loading Buffer (0.125 g Orange G, 
0.75 g Ficoll Type 400, 12 mL 0.5 M EDTA, pH 8.0 water to 50 mL) was added to 
each sample, to blank samples (1X NEB Buffer 4, 0.1 µg/µL of BSA, 25 nM of IRDye 
800 AC Oligo) and to DNA ladder (4 ng of DNA ladder, 1X NEB Buffer 4, 0.1 µg/µL of 
BSA, 25 nM of IRDye 800 AC Oligo). Samples, ladder and blanks were loaded onto a 
1% (w/v) agarose gel (in 0.5X TBE) and ran at 5 V/cm for 90–120 min. Gel was 
imaged in a LI-COR Odyssey® Infrared Imaging System (channel 800 nm). The gel 
was then incubated in 200 mL of 0.5X TBE with SYBR Safe (1:10000) for 30 min. 
Gels were imaged using a FujiFilm LAS Image 4000 to get the loading control image. 
2.3.23. Yeast cell imaging 
Yeast live imaging was performed with filter-sterilized liquid YEPD. Saturated cultures 
were diluted (1:125) and grown overnight at 23°C, in a water bath with agitation (190 
48 
rpm). When the OD600 was between 0.4-0.5, the temperature was shifted to 36°C, 
cultures were subdivided and MMS (0.1% w/v) and HU (200 mM) were added. 
Addition of water was used as a control. Pictures were taken either before 
temperature change (and addition of the drugs) and after 180 min of exposure to 
temperature and the drugs. For microscopy, YEPD media was removed and cells 
were resuspended in CSM media. Cells were photographed under a fluorescence 
microscope (Nikon eclipse 50i), 500 ms exposure with the GFP filter (phase contrast 
pictures were taken for each field). For each culture/condition at least 8 different and 
randomly chosen fields were analysed. Images were analysed with the ImageJ 
software (Schneider et al. 2012). To all images (fluorescent and phase contrast) the 
following sequence of actions was performed in ImageJ: 1) Cut pictures in order to 
reproduce the size and position of a selection (Ctrl+Alt+E, in Windows); 2) subtract 
background (75 px); 3) LUT (green); 4) Split channels (Keep green).  
2.3.24. RNA half-life 
Anchors-Away strain background (tor1-1 fpr1::NAT RPL13A-2*FKBP12::TRP1 Rpb1-
FRB-KANMX6) was used to stop RNA pol II-mediated transcription upon rapamycin 
addition. Cell cultures were grown overnight at 30°C until early exponential (OD600 ~ 
0.5). A fraction of the culture was harvested (0 min time-point) and rapamycin was 
added (1 µg/mL final). Total RNA was isolated from cells harvested at 0, 10, 20, 40 
and 60 min after rapamycin addition. RNA levels were measured for each time-point 
and normalized for the amount of 7S RNA. The fold change from the 0 min time point 
was obtained and the logged (LOG2) data was plotted as a function of time starting 
from the 10 min time-point. The slope (m) of a line that best represents the data was 
finally used to calculate RNA half-life: 0.693/m. 
2.3.25. ImageJ quantification of images 
Image quantifications were performed using the ImageJ software 
(https://imagej.nih.gov/ij/) as described in the website: 
https://imagej.nih.gov/ij/docs/menus/analyze.html#gels. Rectangular selection tool 
was used to surround the areas to quantify (pressing “1” to define the first lane and 
“2” to define any other lanes). By pressing “3” profile plots were generated. The 
straight line selection tool was used to draw a line in the base of each peak of 
49 
interest and the wand tool was used to quantify the area of each peak, by clicking 
inside the peak. 
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3. Yeast telomere screens and cancer 
3.1. Introduction 
A report by Kachroo and colleagues showed that close to half of the yeast essential 
genes can be replaced by their human orthologues (Kachroo et al. 2015). This high 
degree of conservation of function between basic processes in yeast and humans 
allows us to gain important insights into human biology by studying a simple 
unicellular organism like yeast. Hence, yeast genome-wide screens are a powerful 
tool to identify genetic interactions that might be relevant to human biology. For 
example, there are thousands of genes that are affected/mutated in cancer, but how 
those mutations influence cancer onset and progression is still not fully understood 
(Pon and Marra 2015). This is where the use of yeast genome-wide screens might 
help to speed up the process of further understanding cancer biology. For instance, 
the study of the orthologues of cancer-related genes in yeast might reveal which 
processes are affected by certain mutations in cancer.  
Telomere maintenance is a priority for highly dividing cells, like cancer cells, or yeast 
(Dilley and Greenberg 2015). Therefore, the better understanding of telomere biology 
in yeast might help to understand the mechanisms involved in the maintenance of 
telomeres in cancer cells. 
Published yeast genome wide-screens reported how the lack of a given gene 
affected the fitness of cells with telomere capping defects caused by yku70Δ or 
cdc13-1 (Addinall et al. 2011). From these screens they identified various gene 
deletions that suppressed or enhanced yku70Δ or cdc13-1 fitness defects (i. e, gene 
deletions that genetically interacted with yku70Δ and/or cdc13-1).  
High-throughput screens generate an immense amount of data and consequently 
often contain errors. Therefore, it is essential to validate genetic interactions 
identified in those screens. Validation consists of repeating the result/genetic 
interaction in a small-scale experiment, preferentially in a different yeast genetic 
background. After the validation, small and focused experiments can be performed to 
understand the biological processes underneath the genetic interaction observed. 
Ultimately, the objective is to understand how genes interact in yeast and, if possible, 
51 
extrapolate from the results obtained to understand how similar genes interact in 
humans. 
In this chapter I used the Addinall et al. screens to identify genes that are potentially 
relevant to both cancer and telomere biology. Some of the genes validated in this 
Chapter will be further studied in Chapters 4, 5 and 6. 
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3.2. Results 
Around 700 strong enhancers or suppressors of cdc13-1 fitness (Addinall et al. 2011) 
were analysed for cancer relevance by: orthology to human genes (only genes with 
human orthologues were considered); gene function; presence in cancer gene 
databases and frequency of gene mutations reported in cancers. Gene deletions 
affecting yku70Δ fitness and genes whose overexpression affected cdc13-1 fitness 
were also analysed by the same criteria. Table 3-1 shows the top 91 genes identified, 
ranked by percentage of mutations that affect protein function, present in cancer 
samples (mutational score). Additionally, I added to the table the mutational score of 
well known tumour suppressor genes: TP53 (transcriptional activator) and BRCA1 
(involved in homologous recombination). Importantly, BRCA1 is found mutated in 
1.4% of the cancer samples, a value much lower than TP53 (32.2%), but similar to 
the genes on the top of Table 3-1. 
From the 91 genes identified in Table 3-1, 12 (DYN1, UFD2, SKI2, INP52, CDC73, 
BAS1, SLA2, MON1, DOA1, VPS74, FYV10 and SUB1) were further investigated. 
The 12 candidates were chosen not only by their mutational score (Table 3-1) but 
also by the relevance of the processes they are known to be involved in and the 
relevance of the most recent literature on those genes. For instance, genes involved 
in proteasome degradation, transcription, replication, DNA damage, etc. were 
preferred over genes involved in cell wall maintenance, nutrient/energy metabolism, 
etc. Additionally, genes that have been previously deleted and were already present 
in David Lydall’s yeast library were not taken into account for further studies 
(highlighted in blue in Table 3-1). 
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3.2.1. Small scale experiments validated the majority of the high-throughput 
data  
In order to validate high-throughput data, 12 genes of interest highlighted in red in 
Table 3-1 were deleted in a cdc13-1 rad9Δ heterozygous diploid in the W303 genetic 
background (versus the S288C background used in the screens) (Addinall et al. 
2011). RAD9, a checkpoint gene that responds to DNA damage, was used as a 
control for strong cdc13-1 fitness defects suppression (Siede et al. 1993). yfgΔ rad9Δ 
cdc13-1 heterozygous diploids were sporulated and tetrad dissection was carried out 
to obtain haploid cells with the relevant genotypes. Fitness of haploid cells was 
tested by spot test to detect genetic interactions between yfgΔ, cdc13-1 and rad9Δ 
(Figure 3-1, Figure 3-2, Figure 3-3 and in sections 3.2.2 and 3.2.3). Additionally, 
some of the strains carrying a single deletion of the candidate genes were crossed to 
yku70Δ (and yku80Δ) cells (Figure 3-1 and Figure 3-4 in sections 3.2.2 and 3.2.4). 
Table 3-2 summarises the effects that the deletion of the candidate genes had in low-
throughput experiments versus high-throughput experiments. From the candidates 
deleted in the cdc13-1 background, nine out of eleven, behaved as predicted by high-
throughput data. Five, out of eight, genes deleted in the yku70Δ background behaved 
as predicted by high-throughput data. Importantly, many of the genetic interactions 
confirmed in low-throughput experiments appeared not to be as strong as suggested 
by the high-throughput screens (Table 3-2 and sections 3.2.2 and 3.2.4). 
I conclude that the majority of the interactions described in Addinall et al. dataset 
could be confirmed by low-throughput experiments in W303. Nonetheless, the 
phenotypic changes representing those interactions were much milder in the low-
throughput experiments here performed. 
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Table 3-2 Genetic interactions between the candidate genes and cdc13-1 or 
yku70Δ in high-throughput versus low-throughput screens. High-throughput 
(HT) data was obtained from the Addinall et al. screen (Addinall et al. 2011), and 
low-throughput (LT) data was obtained from Figures 3-1 to 3-4 and Figure 3-6. 
Enhancers increase the fitness defects of cdc13-1 or yku70Δ. Suppressors decrease 
the fitness defects of cdc13-1 or yku70Δ. N.d., not determined. 
Mutation 
cdc13-1 yku70Δ 
HT LT HT LT 
dyn1Δ Enhancer Enhancer No effect Enhancer (very weak) 
ufd2Δ Suppressor Suppressor Enhancer (very weak) Enhancer (very weak) 
ski2Δ Suppressor Suppressor No effect Enhancer 
inp52Δ Enhancer No effect Enhancer (very weak) No effect 
cdc73Δ Enhancer Suppressor Enhancer (23°C) Enhancer 
bas1Δ Suppressor Suppressor (very weak) No effect No effect 
sla2Δ N.d. No effect N.d. N.d. 
mon1Δ Suppressor Suppressor (very weak) No effect N.d. 
doa1Δ Suppressor Suppressor (very weak) No effect N.d. 
vps74Δ Suppressor (very weak) Suppressor (very weak) Enhancer Enhancer 
fyv10Δ Suppressor Suppressor (very weak) No effect No effect 
sub1Δ Suppressor Suppressor (very weak) Enhancer (very weak) N.d. 
3.2.2. Cdc73 and Vps74 have a strong role in telomere biology 
From the gene list in Table 3-1, a telomere role of two very distinct genes was 
particularly exciting: CDC73 and VPS74. First, human orthologues of both genes 
have been implicated in cancer onset, increasing the relevance of the study of these 
genes (Carpten et al. 2002; Ma et al. 2014; Zhang et al. 2014; Zhang et al. 2015). 
Additionally, the yeast CDC73 was shown to regulate telomerase function (Mozdy et 
al. 2008), while the mammalian VPS74 (GOLPH3) was shown to sense DNA damage 
(Farber-Katz et al. 2014).  
In the Addinall et al. dataset, CDC73 appears as an enhancer of cdc13-1 fitness 
defects (Figure 3-1A) and due to its own fitness defects at 36°C an interaction with 
YKU70 could not be measured in the screens (Figure 3-1A, B) (Addinall et al. 2011). 
vps74Δ weakly suppresses cdc13-1 fitness defects (Figure 3-1A) and enhances 
yku70Δ fitness defects (Figure 3-1B) in high-throughput studies. Surprisingly and 
opposite to that observed in high-throughput studies, cdc73Δ cdc13-1 cells grew 
better than cdc13-1 at 27°C and 28°C (Figure 3-1A, C). Interestingly, cdc73Δ rad9Δ 
cdc13-1 cells grow worse than cdc73Δ cdc13-1 and rad9Δ cdc13-1 at any 
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Figure 3-1 cdc73Δ and vps74Δ suppress cdc13-1 and enhance yku70Δ fitness 
defects. A and B) The yeast genome knock out collection (~4200 strains) was 
crossed with cdc13-1 (A), yku70Δ (B) or ura3Δ (A and B). Double mutants were then 
grown on solid agar plates and the fitness was measured at 27°C (A) or 37°C (B) 
(Addinall et al. 2011). Each dot indicates the effect of a gene deletion (yfgΔ) on the 
fitness of cdc13-1 (A), yku70Δ (B) or ura3Δ. Represented by grey dots are all the 
deletions that did not significantly alter the fitness of cdc13-1 (A) or yku70Δ (B). 
Green dots represent gene deletions that are enhancers of the cdc13-1 (A) or 
yku70Δ (B), red dots are suppressors and the purple dots represent the fitness of 
CDC73 and VPS74 deletions. C-F) Saturated cultures of the genotypes indicated 
were serially diluted across YEPD agar plates and grown for 3 days at the 
temperatures indicated. One single rectangular plate was used for each temperature 
but have been cut and pasted to allow better comparisons. 
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temperature tested. This suggests that Rad9 increases the fitness of cdc73Δ cdc13-1 
cells, which is the opposite to the described checkpoint role of Rad9 in cdc13-1 cells. 
cdc73Δ cells have no fitness defects at these temperatures. As expected, cdc73Δ 
yku70Δ grow very poorly, even at 23°C, showing cdc73Δ as an enhancer of yku70Δ 
fitness defects (Figure 3-1D). Also, as previously reported cdc73Δ is temperature 
sensitive at 36°C (Betz et al. 2002). These data suggests that Cdc73 has an 
important role in telomere biology and this role will be studied in more detail in 
Chapters 5 and 6. 
Figure 3-1E shows that vps74Δ is, as suggested by high-throughput data, a weak 
suppressor of cdc13-1 fitness defects at 27°C (Addinall et al. 2011). Deletion of 
VPS74 also causes fitness defects observable at both 23°C and 27°C. It was also 
confirmed that vps74Δ strongly enhances yku70Δ fitness defects at 36°C (Figure 
3-1F). The high-throughput data was confirmed and the role of Vps74 in telomere 
biology will be addressed in Chapter 4 (Addinall et al. 2011). 
3.2.3. DYN1 and UFD2, but not BAS1, DOA1, FYV10, SKI2, MON1, SUB1 or 
INP52, strongly interact with CDC13 
According to the high-throughput data, deletion of UFD2, BAS1, DOA1, FYV10, 
SKI2, MON1 or SUB1 suppresses cdc13-1 fitness defects while DYN1 and INP52 
deletions enhance cdc13-1 fitness defects (Figure 3-2A) (Addinall et al. 2011). 
However, spot test assays in a different genetic background only confirmed UFD2 
and DYN1 to (strongly) genetically interact with CDC13 (Figure 3-2 and Figure 3-3). 
Figure 3-2B shows that ufd2Δ strongly suppresses cdc13-1 fitness defects at 26°C, 
while ski2Δ, bas1Δ and fyv10Δ have a very mild suppressing effect. inp52Δ does not 
affect cdc13-1 cell growth at any temperature while dyn1Δ was confirmed to enhance 
cdc13-1 fitness defects at 26°C and 27°C. Interestingly, at 27°C and 28°C, ufd2Δ 
improves the fitness of rad9Δ cdc13-1 cells, suggesting that Ufd2 might play a small 
role in the DNA damage response to telomere uncapping when Rad9 is missing. 
Deletion of DYN1 enhances cdc13-1 fitness defects at 26°C and 27°C, as suggested 
by the high-throughput data (Figure 3-2A). Single deletions of BAS1, UFD2, SKI2, 
DYN1, INP52 or FYV10 do not cause any visible fitness defect or temperature 
sensitivity.  
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Figure 3-2 ufd2Δ, bas1Δ, doa1Δ, fyv10Δ, ski2Δ, mon1Δ, sub1Δ and dyn1Δ 
genetically interact with cdc13-1, while inp52Δ does not. A) Purple dots 
represent the fitness of UFD2, BAS1, DOA1, FYV10, SKI2, MON1, SUB1, DYN1 and 
INP52 deletions. High-throughput data was obtained as described in Figure 3-2A. B-
D) Saturated cultures of the genotypes indicated were serially diluted across YEPD 
agar plates and grown for 3 days at the temperatures indicated. 3 independent spot 
tests are represented. One single rectangular plate was used for each temperature 
(images were cut and pasted for clarity). For each genotype 2 or 3 strains were 
tested by independent spot test assays and one representative strain is shown. 
When the strain number is not shown, the number of the spore and the cross is 
shown. These strains were not frozen, but the phenotype is representative of the 
genotype. 
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An unpublished screen by David Lydall’s laboratory suggested that SLA2 
overexpression (under a GAL promoter) suppressed cdc13-1 fitness defects. 
However, there was no data for this gene in the cdc13-1 or yku70Δ deletion screens 
(Addinall et al. 2011). Deletion of SLA2 did not affect the fitness of cdc13-1 strains: 
sla2Δ cdc13-1 cells are as sick as sla2Δ cells, therefore no genetic interaction is 
observed (Figure 3-2C). The poor growth of sla2Δ cells at any temperature is likely 
related to the role of Sla2 in cytoskeleton assembly (Holtzman et al. 1993).  
Figure 3-3 shows that deletions of MON1, SUB1 and DOA1 just very weakly 
suppressed cdc13-1 fitness defects at 26°C, with no effect at 27°C. mon1Δ also 
slightly suppresses rad9Δ cdc13-1 fitness defects. Interestingly, sub1Δ rad9Δ cdc13-
1 cells barely grow at 20°C but are able to grow at 23°C. This fitness defect only 
happens when all the 3 genes are affected simultaneously and suggest that 
somehow MON1, RAD9 and CDC13 work in parallel to maintain the capacity of yeast 
to divide at low temperatures. 
3.2.4. SKI2, but not BAS1, FYV10, DYN1, UFD2 or INP52, strongly interacts with 
YKU70 
The yKu complex is composed of Yku70 and Yku80 and forms a ring-like structure 
that binds to double stranded DNA close to telomere ends (Walker et al. 2001). 
Although a major function of the yKu complex is at telomeres, maintaining telomere 
stability and length, the complex is also known to re-localise to double-stranded 
break sites to promote repair through NHEJ (Bertuch and Lundblad 2003). To better 
understand the role of the selected genes (Table 3-1) in telomere protection, bas1Δ, 
fyv10Δ, dyn1Δ, ski2Δ, ufd2Δ and inp52Δ strains were crossed with a yku70Δ strain. 
The Addinall et al. screen showed inp52Δ and ufd2Δ as weak enhancers of yku70Δ 
fitness defects while bas1Δ, fyv10Δ, dyn1Δ and ski2Δ showed no effect on yku70Δ 
fitness (Figure 3-4A) (Addinall et al. 2011). The spot test assay in Figure 3-4B-D 
confirms that BAS1, FYV10 and DYN1 do not interact with YKU70 while deletion of 
UFD2 slightly enhances yku70Δ fitness defects at 36°C. Also, opposite to that 
expected for inp52Δ, it did not affect yku70Δ cell fitness at 36°C (Figure 3-4C). 
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Figure 3-3 MON1, SUB1 and DOA1 deletions do not significantly affect fitness 
of cdc13-1 cells. A and B) Saturated cultures of the genotypes indicated were 
serially diluted across YEPD agar plates and grown for 3 days at the temperatures 
indicated. One single rectangular plate was used for each temperature. Images were 
cut and pasted for clarity. When the strain number is not shown, the number of the 
spore and the cross is shown. These strains were not frozen, but the phenotype is 
representative of the genotype. 
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Figure 3-4 ski2Δ enhances yku70Δ fitness defects. A) The yeast genome knock 
out collection (~4200 strains) was crossed with yku70Δ or ura3Δ. Double mutants 
were then grown on solid agar plates and the fitness was measured at 37°C 
(Addinall et al. 2011). Each dot indicates the effect of a gene deletion (yfgΔ) on the 
fitness of yku70Δ or ura3Δ. Represented by grey dots are all the deletions that did 
not significantly alter the fitness of yku70Δ. Green dots represent gene deletions 
that are enhancers of the yku70Δ, red dots are suppressors and the purple dots 
represent the fitness of UFD2, BAS1, FYV10, SKI2, DYN1 and INP52 deletions. B-
D) Saturated cultures of the genotypes indicated were serially diluted across YEPD 
agar plates and grown for 3 days at the temperatures indicated. One single 
rectangular plate was used for each temperature. When the strain number is not 
shown, the number of the spore and the cross is shown. These strains were not 
frozen, but the phenotype is representative of the genotype. 
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Different from what was suggested by high-throughput screens (Figure 3-4A), ski2Δ 
enhanced yku70Δ fitness defects at 35°C and 36°C (Figure 3-4D). Furthermore, the 
fitness of different ski2Δ yku70Δ strains showed some variability. This variability will 
be addressed in section 3.2.10. 
I conclude that, although the majority of the gene deletions confirmed the high-
throughput data (Table 3-2), the interactions are milder in W303 low-throughput 
experiments. This difference between high and low-throughput might be related to 
the fact that in high-throughput experiments colony growth is followed 
(photographed) very early after inoculation, making it easier to catch growth 
differences. In low-throughput experiments usually only one time-point is captured. 
Nevertheless, SKI2 seems to clearly affect the fitness of telomere defective cells and 
a more careful study of this gene will be presented next. 
3.2.5. Ski2 represses telomeric ssDNA formation in cdc13-1 cells 
The cdc13-1 allele causes telomere uncapping at non-permissive temperatures 
(higher than 26°C) (Garvik et al. 1995). Uncapped telomeres are resected by 
nucleases such as Exo1. EXO1 deletion improves the growth of cdc13-1 cells at non-
permissive temperatures by decreasing telomere resection (Zubko et al. 2004). To 
test if the deletion of BAS1, SKI2, UFD2 and VPS74 suppressed cdc13-1 fitness 
defects by decreasing the levels of telomeric ssDNA in cdc13-1 cells, single-stranded 
telomeric DNA was analysed by In-gel assay (a cartoon to aid the interpretation of a 
telomeric In-gel assay can be found in Appendix D).  
Figure 3-5 shows that cdc13-1 cells have, as expected, high levels of single-stranded 
DNA in TG repeats (arrows). Also, as previously reported, yku70Δ cells have short 
telomeres and high levels of telomeric ssDNA (last lane, bottom band) (Maringele 
and Lydall 2002). bas1Δ, ski2Δ and ufd2Δ single deletion do not cause any increase 
in telomeric ssDNA, while vps74Δ seems to cause an increase on telomeric ssDNA. 
From the analysis of double mutants, only ski2Δ cdc13-1 have a decrease in 
telomeric ssDNA (with same length of that observed in cdc13-1 cells). These data 
suggest that Ski2 facilitates telomere resection in cdc13-1 cells.  
 
72 
 
Figure 3-5 Ski2 helps telomere resection in cdc13-1 cells. Cell cultures of the 
indicated genotypes were grown to saturation at 23°C. DNA was extracted and 
ssDNA in the TG repeats was measured by In-gel assay (Appendix D). The arrow 
indicates the signal corresponding to the telomeric ssDNA that is found to be 
increased in cdc13-1 cells at 23°C. SYBR Safe staining was used as loading control. 
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3.2.6. The Ski complex suppress cdc13-1 fitness defects 
SKI2 deletion caused a strong enhancement of yku70Δ fitness defects (Figure 3-4D) 
and ski2Δ weakly suppressed of cdc13-1 fitness defects (Figure 3-2). In both cases, 
strains with the same genotype showed slightly variable growth phenotypes. To 
understand the true effect of ski2Δ deletion on cdc13-1 fitness defects, the fitness of 
4 different ski2Δ cdc13-1 strains was assessed by spot test. 
Figure 3-6 shows that 3, out of 4, ski2Δ cdc13-1 strains grow noticeable better than 
the cdc13-1 strain (DLY1108) at both 26°C and 27°C. I conclude that overall Ski2 
decreases the fitness of telomere uncapped cells. 
Ski2, part of the Ski complex together with Ski3 and Ski8, is involved in 3’-5’ RNA 
degradation (Brown et al. 2000; Araki et al. 2001). Together with Ski7 and the 
exosome, the Ski complex is responsible for the degradation of normal and 
dysfunctional RNAs in the cytoplasm (Anderson and Parker 1998; van Hoof et al. 
2002; Mitchell and Tollervey 2003). A role in the degradation of viral dsRNAs is also 
well characterized and gave the name to the complex: Superkiller complex (Toh et al. 
1978). To validate the role of the Ski complex at telomeres, SKI8 was deleted in 
telomere defective cells (carrying the cdc13-1 mutation) (Figure 3-7). SKI7, 
responsible for the link of the Ski complex to the exosome was also deleted to 
understand if the lack of interaction of the Ski complex to the exosome is responsible 
for the better fitness of ski2Δ cdc13-1 when compared to cdc13-1 cells (Figure 3-6). 
Figure 3-7A shows that ski8Δ weakly suppresses cdc13-1 fitness defects at 27°C. It 
is interesting to note that ski2Δ is a slightly stronger suppressor of cdc13-1 fitness 
defects than ski8Δ (27°C, third dilution), even though Ski2 and Ski8 are part of the 
same complex. This difference suggests that Ski2 and Ski8 must play slightly 
different roles in the context of telomere biology (they have, perhaps, distinct 
interaction partners). This division of labour is not new, since Ski8 was found to play 
a distinct role in double-strand break formation during meiotic recombination, where it 
localises to the nucleus and promotes DSB by interacting with Spo11 (Arora et al. 
2004). ski2Δ ski8Δ cdc13-1 triple mutant cells have a variable phenotype, making it 
difficult to tell whether they grow better or worse than cdc13-1 cells. Figure 3-7B 
shows that ski7Δ behaves very similarly to ski8Δ in a cdc13-1 or ski2Δ cdc13-1 
background. Again, I observe high variability between strains with the same 
genotype.  
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Figure 3-6 ski2Δ suppresses cdc13-1. Saturated cultures of the genotypes 
indicated were serially diluted across YEPD agar plates and grown for 3 days at the 
temperatures indicated. One single rectangular plate was used for each 
temperature. When the strain number is not shown, the number of the spore and the 
cross is shown. These strains were not frozen, but the phenotype is representative 
of the genotype. 
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Figure 3-7 ski7Δ and ski8Δ are weaker cdc13-1 suppressors than ski2Δ. A and 
B) Saturated cultures of the genotypes indicated were serially diluted across YEPD 
agar plates and grown for 3 days at the temperatures indicated. One single 
rectangular plate was used for each temperature. When the strain number is not 
shown, the number of the spore and the cross is shown. These strains were not 
frozen, but the phenotype is representative of the genotype. 
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I conclude that ski2Δ is a stronger suppressor of cdc13-1 fitness defects than ski7Δ 
or ski8Δ. This suggests that Ski2 plays a role at telomeres independent of the 
exosome RNA degradation functions. 
3.2.7. Ski2 does not affect CST mRNA levels 
The cytoplasmic Ski complex is involved in mRNA decay (Anderson and Parker 
1998; van Hoof et al. 2002; Mitchell and Tollervey 2003). A role for another RNA 
decay pathway in telomere biology was previously shown for the NMD (Nonsense-
mediated mRNA Decay) complex (Holstein et al. 2014). It was shown that the 
deletion of members of the NMD complex strongly suppresses cdc13-1 fitness 
defects (Holstein et al. 2014). NMD2 deletion (a member of NMD complex) leads to 
the increase of STN1 mRNA by around 8-fold and TEN1 mRNA by 3-fold, which 
might compensate for the less functional Cdc13-1 (Holstein et al. 2014). To test 
whether Ski2 has a similar role to Nmd2, reducing the levels of Ten1 and Stn1, 
CDC13, TEN1 and STN1 mRNA levels were measured in ski2Δ cells. 
It is shown in Figure 3-8 that deletion of SKI2 does not strongly affect the CST mRNA 
levels. As expected, nmd2Δ leads to high levels of both TEN1 and STN1 mRNA, 
while CDC13 mRNA is unaffected (Holstein et al. 2014). Therefore, unlike the NMD 
complex, the Ski complex does not directly affect the levels of CST complex 
components. 
3.2.8. ski2Δ exo1Δ rad24Δ cdc13-1 cells are viable at non-permissive 
temperatures 
It was previously shown that if EXO1 and RAD24 (both affecting the DNA damage 
response) were deleted with NMD2, cdc13-1 cells could grow at 36°C (Holstein et al. 
2014). Even more strikingly, simultaneous deletion of EXO1, RAD24 and NMD2 
allows the deletion of CDC13 (Holstein et al. 2014). To understand if the Ski complex 
inhibits the growth of cdc13-1 cells similarly to the NMD complex, I assessed the 
growth of ski2Δ rad24Δ exo1Δ cdc13-1 cells (Figure 3-9). To obtain these, ski2Δ was 
crossed to rad24Δ exo1Δ cdc13-1, the diploid was sporulated, and the haploid 
progeny tested by spot test. Figure 3-9A shows that ski2Δ rad24Δ exo1Δ cdc13-1 
cells are able to normally grow at 36°C, and are much fitter than rad24Δ exo1Δ 
cdc13-1 cells, which do not grow at 36°C. ski2Δ exo1Δ cdc13-1 strains were also  
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Figure 3-8 Ski2 does not affect mRNA levels of CST complex components. RT-
qPCR analysis of TEN1, STN1 and CDC13 RNA expression levels in the strains 
indicated. Two independent strains of each genotype were analysed and each value 
was normalized to BUD6 mRNA. The mean of the wild-types (WT) was set to 1. The 
other genotypes were expressed relative to the WT. WT strain numbers were 3001 
and 8460; ski2Δ were 8844 and 8845; and nmd2Δ were 4528 and 4765. Error bars 
indicate the value of each individual strain. 
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Figure 3-9 Evidence that ski2Δ strongly suppresses rad24Δ exo1Δ cdc13-1 
fitness defects. A) Saturated cultures of the genotypes indicated were serially 
diluted across YEPD agar plates and grown for 3 days at the temperatures 
indicated. One single rectangular plate was used for each temperature. When the 
strain number is not shown, the number of the spore and the cross is shown. These 
strains were not frozen, but the phenotype is representative of the genotype. B) 
Telomeric Southern blot was performed using a probe against the Y’+TG fragments. 
SYBR Safe staining was used as loading control. 
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fitter than exo1Δ cdc13-1 (29°C). Intriguingly, no ski2Δ rad24Δ cdc13-1 strains were 
obtained from this ski2Δ rad24Δ exo1Δ cdc13-1 heterozygous diploid (for 56 tetrads 
dissected and 149 viable spores analysed). 
At low rates, yeast telomere defective cells can escape senescence and generate 
“survivors” using recombination dependent mechanisms to rearrange their telomeres 
(Lundblad and Blackburn 1993). Since ski2Δ rad24Δ exo1Δ cdc13-1 strains showed 
elevated fitness, I hypothesised that these strains had rearranged their telomeres to 
become survivors. To test this hypothesis I analysed the telomere length (and 
structure) of ski2Δ rad24Δ exo1Δ cdc13-1 cells by Southern Blot using a probe to the 
Y’ and TG repeats (Figure 3-9B). It was surprising to note that the ski2Δ rad24Δ 
exo1Δ cdc13-1 cells that are able to grow at the non-permissive temperature of 36°C 
have telomere length similar to those of the wild-type cells. ski2Δ and ski2Δ cdc13-1 
also have normal telomere structure. These results suggested that Ski2, like NMD 
proteins, inhibits the growth of cdc13-1 cells by a DDR-independent pathway. 
The capacity of ski2Δ rad24Δ exo1Δ cdc13-1 cells to growth at 36°C is a very strong 
and exciting result even more when those cells have normal telomere structure 
(Figure 3-9). ski2Δ cdc13-1 cells showed some phenotypic variability (Figure 3-6), 
suggesting that those cells might be subject to genetic instability. It was therefore 
tested whether ski2Δ rad24Δ exo1Δ cdc13-1 had acquired the wild-type CDC13. The 
distinction between cdc13-1 and CDC13 can be easily made by PCR followed by the 
use of an RFLP (Figure 3-10) (Zubko and Lydall 2006). Interestingly the ski2Δ 
rad24Δ exo1Δ cdc13-1 strains tested had both cdc13-1 and CDC13 alleles. The 
presence of both CDC13 and cdc13-1 alleles might be because the cells are diploid 
or aneuploid. The possibility of those ski2Δ rad24Δ exo1Δ cdc13-1 cells to be 
diploids is unlikely: 1) cells cannot grow at 38°C as it would be expected for diploid 
cells; 2) cells do not sporulate; 3) cells have respiration defects, unlike, their diploid 
parent (see next Section); 4) 2 out of the 4 ski2Δ rad24Δ exo1Δ cdc13-1 strains were 
from a tetrad where all spores were viable and a 2:2 genetic segregation was 
observed to all genes scored. On the other hand, ski2Δ rad24Δ exo1Δ cdc13-1 cells 
did not mate (two of the four strains were “crossed” to many haploid strains, and a 
diploid carrying markers from both parents was never obtained). I conclude that 
ski2Δ rad24Δ exo1Δ cdc13-1 cells can grow at 36°C because they have the wild-type 
CDC13. 
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Figure 3-10 ski2Δ rad24Δ exo1Δ cdc13-1 cells that can grow at 36˚C have the 
wild-type CDC13. A) cdc13-1, but not CDC13, has an EcoRI cutting site introduced 
by the point mutation (Zubko and Lydall 2006). After PCR and EcoRI digestion, 
CDC13 produces a single band of 358 bp (position 953 to 1311 of ORF), while 
cdc13-1 produces two bands of 198 and 160 bp (cdc13-1/EcoRI site at position 1113 
of ORF). B) Colony PCR (using primers m550 and m551) followed by EcoRI 
digestion was performed in colonies of the genotypes indicated. DNA products were 
then ran on an agarose gel. The presence of cdc13-1 is detected as two bands in 
the gel while the wild-type CDC13 DNA runs as a single band. 
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3.2.9. ski2Δ rad24Δ exo1Δ cdc13-1 strains are respiration defective 
During the manipulation of ski2Δ rad24Δ exo1Δ cdc13-1 cells it was noticed that, 
when left on YEPD solid media, upon nutrient exhaustion, colonies never acquired a 
red colour, characteristic of old yeast colonies that carry the ade2-1 mutation (Figure 
3-11A). Yeast lab strains (W303) carry a mutation in the ADE2 gene (ade2-1), which 
catalyses the sixth step of the purine biosynthetic pathway (Saffran et al. 1994). In 
the absence of adenine, ADE2 mutants accumulate purine precursors that, upon 
oxidation, cause red pigmentation, observable in the colony colour (Aronson and 
Silveira 2009). The ade2-1 allele introduces a premature stop codon, leading to a 
truncated, non-functional enzyme (Wilson et al. 2005). The presence of the prion-like 
structure [PSI+] was known to be able to bypass the ade2-1 premature stop codon 
causing white colonies (True et al. 2004). The [PSI+] prion is a less functional version 
of the eRF3 protein, encoded by the SUP35 gene (Uptain and Lindquist 2002). eRF3 
is needed for efficient translation termination, hence, the prion version, leads to read-
through of the ade2-1 nonsense mutation, and to expression of ADE2. Therefore, the 
white colour of ski2Δ rad24Δ exo1Δ cdc13-1 colonies in medium lacking adenine 
could be due to: 1) cells are able to bypass ade2-1 mutation due to the presence of 
prions; 2) cells reverted the ade2-1 mutation to the wild-type ADE2 allele; 3) cells 
lack oxidative capacity to cause the red pigment.  
First I tested if ski2Δ rad24Δ exo1Δ cdc13-1 had acquired the [PSI+] prion. [PSI+] is 
“cured” by the overexpression of the Hsp104 chaperone which can be achieved by 
growth on medium containing guanidine hydrochloride (GdnHCl) (Liebman and 
Derkatch 1999; Ferreira et al. 2001). Therefore, a ski2Δ rad24Δ exo1Δ cdc13-1 strain 
and its parental diploid were grown on YEPD media lacking adenine and 
supplemented with 3 mM of GdnHCl (Figure 3-11B). [PSI+] and [PSI-] strains were 
used as controls. The growth in the presence of GdnHCl totally reverted the white 
phenotype of the [PSI+] control colonies, while no change was observed in ski2Δ 
rad24Δ exo1Δ cdc13-1 (Figure 3-11B). ski2Δ, ski2Δ cdc13-1 and the parental ski2Δ 
rad24Δ exo1Δ cdc13-1 heterozygous diploid did not show the white phenotype. This 
suggests that the ski2Δ rad24Δ exo1Δ cdc13-1 cells tested do not carry the [PSI+] 
prion, or at least this is not the only reason why those cells cannot form red colonies. 
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Figure 3-11 Evidence that prions are not responsible for ski2Δ rad24Δ exo1Δ 
cdc13-1 colony red colour. A) A ski2Δ rad24Δ exo1Δ cdc13-1 heterozygous diploid 
strain was sporulated and tetrad spores were dissected using standard techniques. 
Spores were germinated at 23°C for 8 days before photographing. Arrows indicate 
the strains with the ski2Δ rad24Δ exo1Δ cdc13-1 genotype. B) Cells of the indicated 
genotypes were streaked onto a YEPD agar plate with no adenine supplementation 
(-ade) and allowed to grow for 5 days at 23°C. A pool of colonies was then 
transferred to a new YEPD (-ade) supplemented with 3mM of guanidine 
hydrochloride and allowed to grow for 6 days at 23°C. 
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As previously mentioned, the incapacity of yeast colonies to turn red over time, might 
be due to: 1) prions; 2) ADE2 presence; 3) lack oxidative of capacity. Therefore, after 
the suggestion that the [PSI+] prion is not causing the white colony phenotype 
observed in Figure 3-11, the capacity of ski2Δ rad24Δ exo1Δ cdc13-1 cells to grow 
on synthetic complete media lacking adenine and in media with glycerol as carbon 
source was tested (Figure 3-12). The ability of cells to growth without any adenine 
supplementation would mean that cells have a functional ADE2 gene. Because 
glycerol is a non-fermentable carbon source, yeast rely on mitochondria and 
respiration to obtain energy from glycerol. Therefore, growth on glycerol indicates 
healthy mitochondria and the capacity to generate reactive oxygen species able to 
oxidize cellular metabolites. 
Figure 3-12 shows that ski2Δ rad24Δ exo1Δ cdc13-1 cells (and all the strains 
obtained from the same parental diploid) are unable to grow on synthetic complete 
media lacking adenine (SC-ade). This indicates that ski2Δ rad24Δ exo1Δ cdc13-1 
cells did not bypass the ade2-1 mutation. Interestingly, ski2Δ rad24Δ exo1Δ cdc13-1 
cells were also unable to use glycerol as carbon source. Since glycerol can only be 
used as a precursor for oxidative respiration, I conclude that ski2Δ rad24Δ exo1Δ 
cdc13-1 cells are respiration-defective (petite) and that this might be the reason for 
their whitish colony phenotype.  
It was curious to notice that all ski2Δ rad24Δ exo1Δ cdc13-1 cells tested were petite. 
It is not reported that a petite phenotype suppress the cdc13-1 fitness defects, 
however, mitochondria have an important role in DDR. For example, iron-sulphur 
(Fe/S) clusters are important co-factors for DNA helicases and proteins involved in 
DNA replication and repair, such as Rad3 and Dna2 (Zhang 2014). Fe/S clusters 
biosynthesis is dependent on the mitochondria and defective synthesis of Fe/S 
clusters affects proteins of the respiratory chain (Lill and Muhlenhoff 2008; Stehling et 
al. 2009). To understand if the genotype of ski2Δ rad24Δ exo1Δ cdc13-1 was 
associated with loss of respiratory chain function (petite phenotype), random spore 
analysis was performed to score the petite genotype (by incapacity to grow in 
glycerol containing media). It was observed that from the sporulation of a ski2Δ 
rad24Δ exo1Δ cdc13-1 heterozygous diploid, 10% of the progeny was respiration 
deficient (Table 3-3). However, loss of respiration capacity seems to happen 
randomly, and is not associated with a particular genotype.  
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Figure 3-12 ski2Δ rad24Δ exo1Δ cdc13-1 cells cannot use glycerol as a carbon 
source. Saturated cultures of the genotypes indicated were serially diluted across 
YEPD, YEPG (with glycerol instead of dextrose), synthetic complete (SC) and SC 
depleted of adenine (SC-ade) agar plates and grown for 3 days at 23°C. ρ0, or 
petite, are mitochondria defective cells (by loss of HMI1). One single rectangular 
plate was used for each temperature. When the strain number is not shown, the 
number of the spore and the cross is shown. These strains were not frozen, but the 
phenotype is representative of the genotype. 
 
  
87 
I conclude that some of the progeny of a ski2Δ rad24Δ exo1Δ cdc13-1 heterozygous 
diploid loses respiration capacity in a manner that is independent of the genotype.  
 
Table 3-3 Progeny of a ski2Δ rad24Δ exo1Δ cdc13-1 heterozygous diploid 
randomly loses mitochondria integrity. Random spore analysis of ski2Δ rad24Δ 
exo1Δ cdc13-1 heterozygous diploid. Numbers obtained per genotype are shown 
(number) as well as number of petite colonies per genotype (petite). Petite cells 
were defined by the incapacity to grow in glycerol containing plates. 
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3.2.10. Deletion of SKI2 causes a high fitness variability in a cdc13-1 
background 
The high phenotypic variability that was observed in strains with SKI2 (and SKI8) 
deleted made it questionable if Ski2 (and Ski8) was directly involved in decreasing 
the fitness of cdc13-1 cells. When ski2Δ cdc13-1 cells grow well at non-permissive 
temperatures it might be the result of defects in pathways that have nothing to do 
with Ski2 directly, but are affected when mRNA surveillance pathways are affected. 
For example, a defective mRNA might be translated originating a defective 
checkpoint protein that can act as a dominant negative and suppress cdc13-1 fitness 
defects. It could also happen that defective chromatin modifiers alter gene 
expression (maybe even giving raise to epigenetic changes), or defective chaperone 
proteins allow the accumulation of unfolded proteins. In all those cases, the degree of 
variability makes the process of understanding the connection of Ski2 to telomeres 
much harder. To understand the degree of variability caused by deletion of SKI2 in 
cdc13-1 cells, we assessed the fitness of ski2Δ cdc13-1 progeny from 3 different 
crosses. Simultaneously, I tested if the petite phenotype had any effect on cdc13-1 
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cells fitness, since the ski2Δ rad24Δ exo1Δ cdc13-1 cells tested in Figure 3-9, able to 
grow at 36°C without rearranging their telomeres, are petite. 
Figure 3-13 shows that there is indeed a significant variability between the ski2Δ 
cdc13-1 cells. Interestingly, the fittest strains are petite (although not all petite strains 
are very fit) suggesting that dysfunction in mitochondrial respiration might facilitate 
the bypass of cdc13-1 telomere defects. cdc13-1 petite cells might be fitter due to 
effects on the DDR proteins (that can happen if Fe/S cluster synthesis is affected in 
the petite cells). I conclude that deletion of SKI2 causes high phenotypic instability in 
cdc13-1 cells, making the study of a telomeric role for Ski2 difficult. It was therefore 
decided, at this stage, not to proceed further with the study of SKI2 and to focus on 
VPS74 and CDC73. 
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Figure 3-13 ski2Δ cdc13-1 strain fitness is highly variable and independent of 
the respiration capacity. Saturated cultures of the genotypes indicated were 
serially diluted across YEPD agar plates and grown for 3 days at the temperatures 
indicated. Strains were obtained from the random spore analysis of 3 different 
crosses: Cross 57 (c57), originated from the mating of DLY8845 (ski2Δ) to DLY1697 
(exo1Δ rad24Δ cdc13-1); Cross 101 (c101), originated from SKI2 deletion in a 
diploid obtained by the backcross of DLY7752 (nmd2Δ exo1Δ rad24Δ cdc13-1); and 
Cross 124 (c124), originated from the mating of DLY10540 (ski2Δ nmd2Δ) to 
DLY1696 (exo1Δ rad24Δ cdc13-1). ρ0 means that cells are respiration deficient, or 
petite, as tested by growth in glycerol containing plates. One single rectangular 
plate was used for each temperature. When the strain number is not shown, the 
number of the spore and the cross is shown. These strains were not frozen, but the 
phenotype is representative of the genotype. 
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3.3. Discussion/Conclusion 
Yeast genome-wide screens have been used in the analysis and discovery of new 
gene interactions in various fields: acetic acid metabolism (Sousa et al. 2013), 
pesticide resistance (Gaytan et al. 2013), UV radiation sensitivity (Birrell et al. 2001), 
DNA damage responses (S. pombe) (Pan et al. 2012), telomere capping defects 
(Addinall et al. 2008), among others. In this study I have used Addinall et al. data, 
performed in the yeast S288C background, in order to find a group of genes that 
were relevant to cancer and telomere biology.  
One of the main issues with high-throughput studies is that together with the large 
amount of valuable data it also comes plenty of false positives and false negatives. 
Therefore, data needs to be filtered and validated by more focused experiments 
before major conclusions are taken. In this work, the spot test assay was used to 
validate and follow the high-throughput data. An advantage of the spot test when 
compared to high-throughput assays is the capacity to analyse various dilutions of 
the same cell culture. This analysis of different cell densities allows us to distinguish 
growth differences that might be ignored when only one concentration is analysed. 
Furthermore, the spot tests were performed with strains newly generated by tetrad 
dissection and careful genotyping, as opposed to the screens, where the strains go 
through a very complex sequence of selection, which is more prone to contamination 
with diploid cells. On the other hand, in high-throughput assays, more replicates are 
analysed and unbiased mathematical models are used to detect fitness differences 
(as opposed to the human interpretation, whose judgement can be influenced by the 
expectations regarding the results). Consequently, one should critically compare the 
data from high and low-throughput assays and not assume that one is wrong when 
the data seems divergent. 
DYN1, UFD2, SKI2, INP52, CDC73, BAS1, SLA2, MON1, DOA1, VPS74, FYV10 and 
SUB1 were all deleted in the W303 yeast genetic background to assess interactions 
with cdc13-1 and/or yku70Δ telomere defective strains (Table 3-2). INP52 deletion 
did not cause any fitness alterations in cdc13-1 or yku70Δ cells and was one of the 2 
cases where high-throughput data was not validated by small scale experiments. 
CDC73 and VPS74 showed strong interactions with both cdc13-1 and yku70Δ and 
will be studied in the remaining Chapters of this thesis. The reason why cdc73Δ 
cdc13-1 cells show opposite fitness phenotypes in low and high-throughput 
experiments will be discussed in Chapter 5. 
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It was shown in this Chapter how powerful genome-wide screens can be, since 9 of 
the 11 (cdc13-1 screen) or 5 out of 8 (yku70Δ screen) genes analysed demonstrated 
the same phenotype as suggested by high-throughput studies (Table 3-2). However, 
overall the interactions observed in low-throughout experiments were weaker than 
those suggested by large-scale experiments. Many factors can influence the 
“strength” of the interactions measured in large- versus small-scale experiments. For 
example, the growth conditions: while in small scale experiments 96 well plates are 
used for fitness measurements, in large scale experiments 384 well plates allow 
smaller space for each strain to grow increasing competitiveness and exacerbating 
growth differences between healthy and sick strains. Also, as explained before, high-
throughput experiments have the advantage of taking hundreds of pictures of each 
growing strain, allowing the creation of a growth curve, and the use of mathematical 
models that are sensitive to small differences in growth curves. The spot test assay 
used in small scale experiments is based on one (to three) pictures, or time-points, 
from where one can assess differences between strain fitness. Therefore, the spot 
test ignores what happens in all the other time-points, making it more prone to miss 
small fitness differences. Another important difference between the low and high-
throughput experiments shown in this Chapter is the genetic background. While low-
throughput experiments were performed in the W303 genetic background, the high-
throughput data was obtained from S288c. Phenotypic differences amongst budding 
yeasts with different genetic backgrounds have been described and can be as 
extreme as some genes being essential in only one of the genetic backgrounds 
(Louis 2016). Thus, it is not surprising to see small differences in the strength of 
some genetic interactions when comparing S288c to W303. To assess the role of the 
strain background, low-throughput experiments should be repeated in the S288C 
background. 
3.3.1. DYN1 
DYN1 deletion enhanced the fitness defects of both cdc13-1 and yku70Δ telomere 
defective strains (as suggested by the high-throughput data). DYN1 encodes a 
cytoplasmic heavy chain dynein (Eshel et al. 1993). The human orthologue is DNAH5 
(and the paralogs DNAH1, DNAH2, DNAH3, DNAH9, DNAH10, etc.), which is also a 
dynein (Herrero et al. 2016). Dynein is important for cargo transport along 
microtubules and for the positioning of spindle microtubules, Golgi and mitochondria 
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(Sharp et al. 2000; Asai and Koonce 2001; Barr and Egerer 2005; Frederick and 
Shaw 2007). Interestingly, dynein was shown to be important for telomere clustering 
during meiosis and dynein defects cause chromosome segregation defects 
characteristic of cancer cells (Lee et al. 2015). Since this role in telomere clustering 
was only observed in meiotic division, it is not clear if it relates to the Dyn1 function 
increasing fitness of cdc13-1 and yku70Δ cells. However, it was shown that DDR 
proteins, like Mre11 and ATM, co-precipitate with dynein and microtubules in human 
cell lines (Poruchynsky et al. 2015). Additionally, DNA damage is prolonged when 
dynein is affected (Poruchynsky et al. 2015). Since mre11Δ was shown to enhance 
the fitness defects of cdc13-1 and yku70Δ cells, it is possible that DYN1 deletion 
limits Mre11 access to the nucleus. For instance, lack of dynein would result in less 
Mre11 in the nucleus, leading to an enhancement of the telomere defects of cdc13-1 
and yku70Δ cells (due to prolonged DDR). 
3.3.2. UFD2 
UFD2 deletion suppressed cdc13-1 fitness defects and weakly enhanced yku70Δ 
fitness defects. UFD2 encodes an ubiquitin chain assembly factor (Johnson et al. 
1995). Ubiquitination controls processes such as protein localisation, degradation 
and interactions (Pickart and Eddins 2004). The role of Ufd2 on telomere 
maintenance might be through an effect on DDR or checkpoints proteins, either by 
decreasing/increasing their stability or by affecting localisation and interaction 
partners. Changes in protein levels and stability, like apoptotic signalling proteins and 
DDR proteins, are among the reasons why loss of ubiquitination homeostasis can 
lead to cancer onset/propagation (Shen et al. 2013).  
3.3.3. BAS1, MON1, DOA1 and FYV10 
BAS1, MON1, DOA1, FYV10 all showed very weak genetic interactions with cdc13-1. 
Therefore, it would be hard to understand the basis of so subtle phenotypic 
differences. 
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3.3.4. SUB1 
SUB1 deletion in the cdc13-1 background did not affect cdc13-1 fitness defects at 
27°C. However, it was observed that sub1Δ rad9Δ cdc13-1 cells cannot grow at 
20°C, unlike rad9Δ cdc13-1. This shows that Sub1 increases the fitness of rad9Δ 
cdc13-1 cells at 20°C. Since at 27°C sub1Δ rad9Δ cdc13-1 and rad9Δ cdc13-1 cell 
fitness is similar, Sub1 does not seem to affect the temperature dependent telomere 
resection and the Rad9 checkpoint pathway. This is a puzzling result, nevertheless, it 
shows that Sub1, a transcriptional regulator, does play a role at telomeres and affect 
the DNA damage response to whichever defects cdc13-1 cells have at 20°C.  
Sub1 has been shown to stimulate basal transcription in vitro (Henry et al. 1996). 
ChIP experiments showed Sub1 primarily at RNA pol II and RNA pol III promoters 
(Rosonina et al. 2009). Interestingly, it was suggested that Sub1 and RPA compete 
for similar binding sites, as RPA levels increase at active promoters in sub1Δ cells 
(Sikorski et al. 2011). Therefore, sub1Δ rad9Δ cdc13-1 cells could have a 
temperature-dependent imbalance in the proteins bound to ssDNA (like telomeric 
ssDNA and transcription-associated ssDNA) causing defects that are harder to fix 
due to lack of DDR. Since temperature affects the strength and stability of chemical 
interactions (as protein-protein or protein-DNA interactions) it might happen that 
between 20°C and 23°C, pathways promoting cell viability become more stable. 
3.3.5. SKI2 
SKI2 deletion also showed strong interactions with both cdc13-1 and yku70Δ. Yet, 
follow-up experiments showed that Ski2 role at telomeres might be indirect and 
related to genetic/proteomic instability caused by loss of transcriptional fidelity 
(caused by an impairment in the Ski-related mRNA degradation pathway). Loss of 
transcriptional fidelity can turn into loss of replication fidelity if the proteins 
responsible for proof-reading are defective. Ski2 is part of the Ski complex (with Ski3 
and Ski8) that, together with Ski7, acts as a co-factor for the cytoplasmic exosome to 
degrade mRNAs (Brown et al. 2000; Araki et al. 2001). It was observed that SKI2 
deletion in telomere defective cells led to varied phenotypes (regarding fitness and 
mitochondrial function) in cells with identical genotypes. Nonetheless, with different 
degrees, ski2Δ consistently suppressed cdc13-1 temperature sensitivity. 
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The Ski complex helps RNA degradation in the cytoplasm and it is not known to 
translocate to the nucleus where it could have a direct role degrading RNAs that 
could directly affect telomere biology such as TERRA and TLC1. However, although 
the Ski complex is localised to the cytoplasm, Ski8 was shown to move to the 
nucleus where it plays a role in double-stranded break formation during meiotic 
recombination (Arora et al. 2004). One would expect that lack of Ski2 disrupts the 
complex function, leading to degradation/misfolding/mislocalisation of the remaining 
components. Therefore, the high genetic instability observed in Ski2 mutants might 
be related to this role of Ski8 in meiosis, as Ski8 might lose its function in ski2Δ cells. 
For example, ski mutants with impaired recombination during meiosis might originate 
aneuploid progeny, or progeny with duplicated or lacking chromosome fragments.  
The capacity of Ski8 to translocate to the nucleus is also remarkable, since Ski8 is 
part of the PAF1 complex in humans (Zhu et al. 2005). The yeast PAF1 complex 
(Cdc73, Paf1, Ctr9, Leo1 and Rtf1) is known to be involved in RNA control mainly by 
regulation of transcription and will be further studied in Chapters 5 and 6. If the 
interaction of the Ski complex to the transcription machinery (through Ski8) is 
conserved in yeast, it might happen that ski mutants also have defects in mRNA 
production/transcription (PAF1 complex defects) which would be greatly exacerbated 
by a defect in the RNA degradation pathway (Ski complex defects). 
It was also observed that Ski2 aids the resection of cdc13-1 even at low 
temperatures. This suggests that the decrease in single-stranded telomeric DNA 
might be the main reason why ski2Δ cdc13-1 cells are more resistant to telomere 
uncapping at non-permissive temperatures. The way ski2Δ affects ssDNA might be 
as indirect as affecting the levels of a nuclease or a protein that recruits nucleases to 
telomeres. Consequently, telomere resection would be more inefficient. Another 
option is related to the fact that transcription at telomeres leads to Exo1-dependent 
resection (Balk et al. 2014). For example, if the interaction of Ski8 to the PAF1 
complex is conserved in yeast, ski2Δ mutants might have defective transcription 
leading to less ssDNA. Although one would think that the ssDNA observed in cdc13-
1 cells is just related to telomere uncapping, it is true that ski2Δ affects the ssDNA 
levels of cdc13-1 cells even at the permissive temperature of 23°C. 
Mutations in the SKI2 human orthologue, SKI2VL, leads to Trichohepatoenteric 
syndrome (syndromic diarrhoea), a life-threatening disease (Fabre et al. 2013). 
Mutations in SKI2VL are not known to be a primary cause of cancer, however 
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SKI2VL is found mutated in 0.8% of cancers (Gonzalez-Perez et al. 2013). If the data 
here presented are conserved in humans, perhaps mutations in SKI2VL (leading to 
its inactivation) help cancer cells to thrive by increasing genetic instability and loss of 
quality control over defective mRNAs. Also, a capacity to bypass telomere defects 
would definitely aid tumour progression since telomere maintenance is one of the key 
features of cancers. 
3.4. Future work 
3.4.1. DYN1 
It would be interesting to assess the DNA damage response in dyn1Δ and dyn1Δ 
cdc13-1 cells. For example, by assessing Rad53 and H2A phosphorylation and by 
looking at the presence of Mre11 in the nucleus, it would be possible to see if there 
are any defects in translocation of DNA damage repair proteins to the damage sites.  
3.4.2. UDF2 
Ufd2 is an ubiquitin chain assembly factor and therefore is important to protein 
signalling and degradation. Levels of DDR response proteins could be quantified in 
ufd2Δ cdc13-1 versus cdc13-1 cells to understand if lack of Udf2 is causing an 
unbalance in DDR proteins. Since ufd2Δ cdc13-1 cells do not have less telomeric 
ssDNA than cdc13-1 cells, nucleases are not expected to be affected by ufd2Δ, and 
would not be tested at a first stage. 
3.4.3. SUB1 
Another notable result that would be interesting to address is the sub1Δ rad9Δ 
cdc13-1 cold sensitivity at 20°C. A first step to understand this phenomenon would be 
the deletion of different DDR proteins in the sub1Δ cdc13-1 background. ssDNA 
could also be quantified in sub1Δ rad9Δ cdc13-1 at 20°C versus at 23°C. 
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3.4.4. SKI2 
Deletion of SKI2 in telomere defective cells causes high phenotypic variability. 
Nevertheless, a follow-up study of the ski2Δ cdc13-1 cells that are fit at non-
permissive temperatures might help unravelling the pathways behind cdc13-1 
bypass. For example, the fittest ski2Δ cdc13-1 cells could be backcrossed for a 
couple of generations to understand how the “fit trait” is transmitted. Fit ski2Δ cdc13-
1 strains could then be sequenced to find the mutations responsible for cdc13-1 
bypass. Additionally, chromatin profiling (methylation/ acetylation) could help to 
understand if the changes are genetic or epigenetic. Another way of testing how 
direct is the Ski2 role in decreasing cdc13-1 fitness would be by inserting back SKI2 
in the ski2Δ cdc13-1 genome (or in a plasmid), and test if the fitness defects 
increase. 
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4. Vps74 as a bridge between the Golgi apparatus and the 
DDR 
4.1. Introduction 
In Chapter 3, VPS74 deletion was found to weakly suppress cdc13-1 fitness defects 
and strongly enhance yku70Δ fitness defects (Figure 3-1). Vps74 (Vacuolar Protein 
Sorting 74) is a cytoplasmic protein and was first identified as being needed for 
protein sorting to the vacuole (Bonangelino et al. 2002). Later, Vps74 was shown to 
be needed for the localisation of glycosyltransferases to the Golgi apparatus 
(Schmitz et al. 2008). Glycosyltransferases are responsible for protein glycosylation, 
which is a post-translational modification where a sugar (glycan) chain is attached to 
the protein (Shental-Bechor and Levy 2008). Protein glycosylation contributes to the 
correct folding of some proteins, therefore acting as a quality control mechanism 
(Shental-Bechor and Levy 2008; Xu and Ng 2015). Glycans are also recognised by 
ER-associated degradation (ERAD) receptors, being therefore important for protein 
degradation in both yeast and mammals (Xu and Ng 2015).  
Another important role for the yeast Vps74 is to regulate the levels of 
phosphatidylinositol 4-phosphate (PtdIns4P) by interacting and activating Sac1, a 
phosphoinositide phosphatase membrane protein (Wood et al. 2012). PtdIns4P is 
mainly known to promote protein trafficking in Golgi (Strahl and Thorner 2007). 
Additionally, PtdIns4P is the precursor of the second messengers: 1,2-diacylglycerol 
(DAG) and inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) (Strahl and Thorner 2007). 
Ins(1,4,5)P3 is soluble and diffuses to the nucleus where it is successively 
phosphorylated to originate Ins(1,4,5,6)P4, Ins(1,3,4,5,6)P5 and InsP6 (Figure 4-1). 
The latter was shown to have a role in mRNA export, with a decrease in InsP6 levels 
leading to an accumulation of polyadenylated mRNA in the nucleus (Wera et al. 
2001). 
98 
 
Figure 4-1 Phosphoinositide signalling in yeast. Series of transformations that 
members of the inositol pathway go through in 3 different cell compartments: Golgi 
and Endoplasmic Reticulum; Nucleus; and Plasma Membrane. DAG, diacylglycerol. 
Adapted from (Wera et al. 2001). 
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4.1.1. Inositol signalling and telomeres 
Experiments with the enzymes involved in inositol signalling have suggested that the 
inositol signalling affects telomere length (Saiardi et al. 2005; York et al. 2005). For 
instance, Ins(1,3,4,5,6)P5 and InsP6 can be converted into the diphosphoryl inositols 
PP-IP4 and PP-IP5 through the action of Kcs1 (Saiardi et al. 2000). kcs1Δ cells have 
longer telomeres and low PP-IP4 levels. Also, ipk1Δ (IPK1, inositol polyphosphate 
kinase 1) cells have shorter telomeres and high PP-IP4 levels. Therefore, PP-IP4 
was suggested to be a negative regulator of telomere length (Saiardi et al. 2005; 
York et al. 2005). Inositol levels can also affect the levels of complex sphingolipids 
such as inositol-phosphoceramide (IPC), that are originated by sphingolipid 
maturation in the ER and Golgi (Dickson and Lester 1999). Sphingolipids are part of 
eukaryotic membranes and play a role in signal transduction pathways (Bartke and 
Hannun 2009). A study showed that depletion of a protein involved in sphingolipid 
homeostasis, Arv1, affects the transcription of many genes involved in telomere 
maintenance (such as SIR3 and EST3) (Ikeda et al. 2015).  
4.1.2. Golgi and the DNA damage response 
In 2014, Farber-Katz and colleagues showed that the Golgi responds to DNA 
damage (Farber-Katz et al. 2014). The experiments in mammalian cells showed that 
Golgi became fragmented after camptothecin (CPT)-induced DNA damage. Golgi 
fragmentation would persist even after DNA lesions were repaired. This response to 
DNA damage was dependent on GOLPH3, VPS74 mammalian orthologue, which 
was phosphorylated by DNA-PK (a DNA damage protein kinase), increasing 
GOLPH3-MYO18A interaction (Farber-Katz et al. 2014). MYO18A is a myosin that 
links Golgi membranes to the cytoskeleton (Dippold et al. 2009). These data 
suggested that Golgi can “sense” DNA damage and respond to it, however, it is not 
yet known what are the implications and consequences of this response. 
Interestingly, GOLPH3 is an oncogene, reinforcing the idea that this gene is involved 
in maintaining genetic stability (Scott et al. 2009).  
The yeast Golgi composition is very similar to that of the mammalian Golgi, however 
its organization strongly varies, with the yeast Golgi being more disorganized than 
the mammalian Golgi (Figure 4-2). Also, the kinase DNA-PK, which is the link 
between the nucleus (where the DNA damage occurs) and Golgi (GOLPH3) in 
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mammalian cells, is not conserved in yeast. Thus, it is not clear if/how yeast Golgi 
also responds to DNA damage. Although the mammalian kinases ATM and ATR, 
respectively Tel1 and Mec1 in yeast, were not shown to be required for DNA-
damage-induced Golgi dispersal in mammalian cells, they might be in a simple 
organism like yeast (Farber-Katz et al. 2014). 
The purpose of this Chapter was to better understand, in yeast, the possible Golgi 
(Vps74) role on the DNA damage caused by uncapped telomeres. I was also aiming 
to get new insights on the role of GOLPH3 (the Vps74 human orthologue) as an 
oncogene. 
  
101 
Figure 4-2 Mammalian Golgi versus yeast Golgi. Golgi of mammalian cells (left) 
shows cisternae-like organization, with cis Golgi being closest to the Endoplasmic 
Reticulum (ER)(that surrounds the nucleus) and the trans Golgi being the furthest. 
ER exit sites are the regions from where vesicles are released. Golgi of S. 
cerevisiae (right) is dispersed throughout the cytoplasm with cis Golgi being close to 
Endoplasmic Reticulum exit sites. As Golgi maturates (to medial and trans Golgi) it 
acquires a more disorganized distribution. Adapted from (Verissimo and Pepperkok 
2013) and (Glick 2002). 
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4.2. Results 
4.2.1. Golgi structure changes upon DNA damage 
It was previously shown that the mammalian Golgi is fragmented in response to DNA 
damage (Farber-Katz et al. 2014). Therefore, I asked if yeast Golgi also responds to 
DNA damage. In order to answer that question I used microscopy. Fluorescently 
tagged Rer1 and Sec7, proteins that respectively localise to cis and trans Golgi, were 
used as Golgi markers (Matsuura-Tokita et al. 2006). Centromeric plasmids carrying 
RER1 or SEC7 fused to enhanced green fluorescent protein (EGFP) were 
transformed into WT and cdc13-1 cells (the latter was used to induce telomeric DNA 
damage). A preliminary experiment showed that the EGFP signal obtained was 
highly variable (which I attributed to a variation in plasmid copy number). In order to 
decrease signal variability between cells, the EGFP-RER1 and SEC7-EGFP 
constructs (and ADH1 promoter they were associated with) were cloned into an 
integrative plasmid (inside the URA3 gene). Finally, the constructs EGFP-
RER1::URA3 and SEC7-EGFP::URA3 (and the ADH1 promoter) were integrated at 
the ura3-1 locus in WT and cdc13-1 cells.  
DSBs and replication fork stalling (two forms of DNA damage) were induced by 
addition of 0.1% (w/v) of methyl methanesulfonate (MMS) or 200 mM of hydroxyurea 
(HU), respectively. Additionally, cdc13-1 cells were exposed to 36°C to induce 
telomere uncapping. DNA damage was induced for 180 min before live-cell imaging 
was performed. 
Figure 4-3 shows that both cis (Rer1) and trans (Sec7) Golgi can be observed as an 
organized structure, spread throughout the cell (bright green dots). cdc13-1 cells did 
not show any noticeable structural changes in Golgi upon induction of telomere 
uncapping (by exposure at 36°C, Figure 4-3). Note that cdc13-1 cells after 180 min at 
36°C, showed a dumbbell shape, accompanied by an increase in cell size, which is 
caused by cell cycle arrest in G2/M. MMS and HU-treated cells do not show such a 
strong dumbbell phenotype, likely because they are arresting in S phase (Friedel et 
al. 2009). 
HU treatment did not noticeably cause significant changes in Golgi structure, 
although it might have caused some fragmentation in trans Golgi (Sec7-EGFP), since 
the signal seems slightly weaker. If not a technical issue this might suggest reduced  
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Figure 4-3 Yeast presents Golgi structural changes upon DNA damage. Cultures 
were grown overnight at 23°C until exponential phase (OD600~0.4). Temperature was 
shifted to 36°C and WT cultures were subdivided into 3 cultures, to which HU 
(200mM), MMS (0.1%, w/v) or water was added. WT (with the drugs) and cdc13-1 
cells were photographed (1000X magnification) either before the temperature shift 
(0min) or after 180 min of treatment. A representative sample is shown here and 
additional pictures are in Appendix E. Strains used were: WT EGFP-RER1, 10001; 
cdc13-1 EGFP-RER1, 10003; WT SEC7-EGFP, 10002; and cdc13-1 SEC7-EGFP, 
10004. Pictures were treated as described in section 2.3.23. 
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trans Golgi signal, or less Sec7-EGFP being delivered to trans Golgi. MMS treatment 
seemed to have caused both cis (Rer1) and trans (Sec7) Golgi fragmentation or 
dissolution since the number of brighter dots that stand out from the background is 
reduced. 
Since cdc13-1 cells seem to be arresting at a different phase of the cell cycle, 
compared to MMS and HU-treated cells, it can happen that Golgi 
responsiveness/fragmentation is affected by the cell cycle. Consequently, other 
sources of telomeric DNA damage (for example yku70Δ) should be tested. 
MMS is an alkylating agent that causes base mispairing and replication block while 
HU blocks replication by exhausting the dNTPs pool. The preliminary results here 
presented suggest that Golgi is more sensitive to MMS treatment. It is also possible 
that HU treatment was not efficient and did not cause the same level of DNA damage 
as the MMS treatment. 
Another issue with this experiment is that upon DNA damage induction (by the 
addition of MMS or HU) temperature was also shifted to 36°C. Consequently, the 
cells are exposed to an additional source of stress: temperature. It is therefore 
important to repeat these experiments at 30°C. Additionally, a control for a general 
effect of cell-cycle arrest (independent of DNA damage) needs to be used to control 
for specificity of the Golgi response. Also, a positive control to Golgi disruption should 
be used to better recognise the structural changes that happen when Golgi is 
damaged. 
I conclude that yeast Golgi structure, like mammalian Golgi, gets fragmented upon 
cytotoxic DNA damage (and replication block). I also conclude that Golgi does not 
respond to telomeric DNA damage caused by uncapped telomeres. Importantly, 
these conclusions must be confirmed by performing a better controlled experiment. 
4.2.2. Exo1 and Rad24 decrease, whereas Mre11 increases, vps74Δ cell fitness  
I observed that deletion of VPS74 causes fitness defects at any temperature, but the 
decreased fitness is more evident at 23°C and 38°C (Figure 3-1 and Figure 4-4). 
VPS74 genetically interacts with both cdc13-1 and yku70Δ (Figure 3-1) suggesting a 
role for Vps74 in telomere maintenance and/or in the DDR. To test if vps74Δ fitness 
defects were caused by checkpoint activation, various members of the DDR were 
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deleted in the vps74Δ background. Interactions with rad9Δ, rad17Δ, rad24Δ, exo1Δ 
and mre11Δ were tested (Figure 4-4). Table 4-1 (page 120) summarises these 
genetic interactions and others observed in this Chapter. 
I noted that deletion of either RAD9 or RAD17 did not affect vps74Δ growth at 38°C 
(Figure 4-4A). Surprisingly, deletion of RAD24, that acts in the same pathway as 
RAD17, did suppress vps74Δ fitness defects at 38°C (Figure 4-4A). Also, 
simultaneous deletion of RAD24 and RAD17 suppress vps74Δ fitness defects 
(Figure 4-4A). This suggests that activation of DDR checkpoint proteins causes 
fitness defects at 38°C in vps74Δ cells, indicating that deletion of VPS74 causes 
some sort of DNA damage. The difference between rad17Δ and rad24Δ phenotypes 
suggest that in the vps74Δ context, Rad24 might maintain some function outside the 
common pathway where Rad24 loads Rad17 (and Mec3/Ddc1) to the DNA lesion. It 
is important though to confirm these results with a different arrangement of the 
strains in the plate. This is because the rectangular plate where the spot test was 
performed was arranged in 3 columns (of 4 dilutions each) (Figure 4-4B). In the last 
column, the highly diluted cells had no competition (for nutrients, for example), while 
in the first and second columns they had. The last column had one vps74Δ rad24Δ 
and all the vps74Δ rad17Δ rad24Δ strains, therefore the fitness suppression 
observed might be affected by nutrient accessibility. Nevertheless, the difference 
between vps74Δ rad17Δ rad24Δ cells and vps74Δ cells seems too big to be solely 
due to nutrient accessibility differences.  
EXO1 deletion weakly suppressed vps74Δ fitness defects at 38°C (Figure 4-4C), 
suggesting that VPS74 deletion causes DNA damage that involved Exo1-mediated 
resection. Finally, MRE11 deletion strongly enhanced vps74Δ fitness defects (Figure 
4-4D). mre11Δ also strongly enhances yku70Δ fitness defects and yku70Δ vps74Δ 
are synthetically sick (Figure 3-1) (Maringele and Lydall 2002). This strengthens the 
idea that Yku70 and Vps74 act in parallel to maintain the genome integrity and that 
Mre11 has a role maintaining the viability of yku70Δ and vps74Δ cells. 
I conclude that VPS74 deletion induces fitness defects that are dependent on Exo1, 
and Rad24. On the other hand Mre11 increases the fitness of vps74Δ cells. I suggest 
that Vps74 either promotes genomic stability and/or contributes to the DDR.  
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Figure 4-4 vps74Δ fitness defects are suppressed by exo1Δ and rad24Δ but not 
rad17Δ or rad9Δ, and are enhanced by mre11Δ. A, C and D) Saturated cultures of 
the genotypes indicated were serially diluted across YEPD agar plates and grown 
for 3 days at the temperatures indicated. All strains at each temperature were grown 
on a single plate but have been cut and pasted to allow better comparisons. When 
the strain number is not shown, the number of the spore and the cross is shown. 
These strains were not frozen, but the phenotype is representative of the genotype. 
B) Original plate from the strains in A) at 38°C. 
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4.2.3. Exo1, but not Sae2, contribute to fitness defects of yku70Δ vps74Δ cells 
The most striking result involving Vps74 was perhaps the strong synthetic sickness 
observed in yku70Δ vps74Δ cells, which suggested that Vps74 and Yku70 work 
together to maintain cell fitness by parallel pathways (Figure 3-1). From Figure 4-4 it 
was inferred that Vps74 itself is involved in maintaining genomic integrity since 
deletion of some DDR proteins increased fitness of vps74Δ cells. Exo1 is a major 
player in the cell-cycle arrest that happens in yku70Δ cells, due to its role resecting 
the yku70Δ uncapped telomeres (Maringele and Lydall 2002). Therefore, I 
speculated that the lower fitness of yku70Δ vps74Δ cells could be suppressed by 
exo1Δ. If so, this could suggest that Vps74 is somehow involved in maintaining 
proper telomere capping. 
To test the involvement of Exo1 in yku70Δ vps74Δ fitness defects, EXO1 was 
deleted in yku70Δ vps74Δ cells. SAE2, which encodes for an endonuclease involved 
in DNA repair, was also deleted to better understand the role of different nucleases in 
yku70Δ vps74Δ cells (Figure 4-5). Figure 4-5A shows that exo1Δ strongly 
suppresses yku70Δ vps74Δ fitness defects at 35°C and 36°C. In Figure 4-5B a 
different strain of yku70Δ vps74Δ seems to be even more defective than the 
DLY10017 strain in Figure 4-5A, showing some phenotypic variability between 
yku70Δ vps74Δ cells. In all cases, yku70Δ vps74Δ cells are always substantially less 
fit than yku70Δ or vps74Δ cells and exo1Δ always strongly suppresses yku70Δ 
vps74Δ fitness defects. 
Interestingly, SAE2 deletion did not affect the fitness of yku70Δ vps74Δ cells (Figure 
4-5B). One explanation for such a difference between sae2Δ and exo1Δ, is that 
vps74Δ yku70Δ fitness defects are triggered by accumulation of long molecules of 
ssDNA (dependent of Exo1, but not on Sae2). Additionally, sae2Δ enhanced yku70Δ 
fitness defects but not vps74Δ fitness defects and did not further decrease fitness 
defects of yku70Δ vps74Δ or yku70Δ vps74Δ exo1Δ cells. Such results show that 
Sae2 contributes to the fitness of yku70Δ cells (which is the opposite to the role of 
Exo1 in yku70Δ cells). 
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Figure 4-5 vps74Δ yku70Δ fitness defects are suppressed by exo1Δ but not 
sae2Δ. A and B) Saturated cultures of the genotypes indicated were serially diluted 
across YEPD agar plates and grown for 3 days at the temperatures indicated. All 
strains at each temperature were grown on a single rectangular plate but have been 
cut and pasted to allow better comparisons. When the strain number is not shown, 
the number of the spore and the cross is shown. These strains were not frozen, but 
the phenotype is representative of the genotype. 
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It was also noticeable that vps74Δ sae2Δ strains grow slightly better than vps74Δ 
cells at 37°C (Figure 4-5B). It seems that sae2Δ and exo1Δ suppress vps74Δ fitness 
defects (but not vps74Δ yku70Δ). Such result suggests that vps74Δ fitness defects 
are at least in part due to nuclease activity, independently of the extension of the 
resection. Perhaps vps74Δ cells still have protection mechanism against Exo1 
extensive resection and the small fitness defects observed at 38°C are caused by low 
levels of short ssDNA molecules and consequent DDR activation. 
These data show that Exo1, but not Sae2, contributes to the fitness defects of cells 
simultaneously lacking Yku70 and Vps74. This suggests that increased DNA 
resection might be responsible for yku70Δ vps74Δ poor cell growth. 
4.2.4. Vps74 slightly increases telomeric ssDNA of cdc13-1 cells and 
decreases the ssDNA of yku70Δ cells  
Since yku70Δ vps74Δ fitness defects are suppressed by EXO1 deletion, I 
hypothesized that yku70Δ vps74Δ fitness defects were caused by an increase in 
telomeric ssDNA. To test this hypothesis, the ssDNA of vps74Δ yku70Δ (with and 
without EXO1) was measured by In-gel assay using a telomeric probe. ssDNA of 
vps74Δ cdc13-1 cells was also assessed since those cells grow better than cdc13-1 
cells, which also accumulate high ssDNA levels (Booth et al. 2001). The In-gel assay 
uses a probe that anneals to the telomere end in native telomeres that were 
previously cut with an endonuclease (XhoI in this case). Hypothetically, XhoI will only 
cut dsDNA, therefore the In-gel assay can reveal 2 types of information: 1) the 
amount of ssDNA present in the sample (by the band intensity); and 2) the extension 
of the resection (by the length of the bands) (Appendix D).  
vps74Δ cells, like WT cells, do not show significant levels of telomeric ssDNA (Figure 
4-6A, B). As expected, cdc13-1 cells accumulate long fragments of ssDNA 
(Intermediate) (Figure 4-6A, B). Additionally, yku70Δ cells accumulate small 
fragments of ssDNA (Low). exo1Δ cells, like WT and vps74Δ cells do not show 
increased telomeric ssDNA. Interestingly, VPS74 deletion slightly decreases cdc13-1 
ssDNA (Intermediate), which might explain the weak suppression of cdc13-1 fitness 
defects upon VPS74 deletion (Figure 3-1). yku70Δ vps74Δ cells, when compared to  
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Figure 4-6 vps74Δ decreased telomeric ssDNA of cdc13-1 cells and increased 
yku70Δ ssDNA. A) Cell cultures of the indicated genotypes were grown overnight to 
exponential at 23°C and a further 4h at 36°C. DNA was extracted using the phenol 
method and ssDNA in the TG repeats was measured by In-gel assay. B) The gel in 
A) was horizontally divided in 3 parts (High, Intermediate, and Low). For each lane, 
the signal in each part was quantified and divided by the loading control signal. 
Quantifications were made using the ImageJ software. C) DNA from cultures in A) 
were analysed by Southern Blot using a telomeric probe. 
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yku70Δ or vps74Δ cells, had slightly increased ssDNA levels (Intermediate), and no 
difference in the smaller ssDNA fragments (Low) (Figure 4-6B). As expected, yku70Δ 
exo1Δ, vps74Δ exo1Δ and yku70Δ vps74Δ exo1Δ all have very low levels of 
telomeric ssDNA since Exo1 is a main effector of telomeric resection. Although 
yku70Δ vps74Δ have more of the long telomeric ssDNA products, it does not seem to 
correlate with fitness, since the fitness defects of those cells are quite dramatic. This 
suggests that Vps74 plays a small role in the protection of telomeres against 
resection and that increased telomeric ssDNA in vps74Δ yku70Δ cells is at least part 
of what makes these cells less fit. 
The DNA analysed in Figure 4-6A was further analysed by Southern blot to see if 
Vps74 contributed to telomere length maintenance of normal and uncapped 
telomeres (Figure 4-6C). Due to the nature of the DNA preparation (4h at 36°C 
followed by Phenol extraction), only terminal fragments were observed, nonetheless 
it is clear that vps74Δ cells have telomeres of similar length to the WT cells (Figure 
4-6C). Interestingly, yku70Δ vps74Δ cells have slightly shorter telomeres when 
compared to yku70Δ cells, while yku70Δ vps74Δ exo1Δ telomere length is similar to 
that observed in yku70Δ cells. Although yku70Δ vps74Δ telomeres are not much 
shorter than yku70Δ telomeres, a small difference might be enough to reach a certain 
threshold and trigger a stronger DNA damage response against those defective 
telomeres. Therefore, it is reasonable that extremely short telomeres, together with 
more ssDNA, are a main cause for yku70Δ vps74Δ fitness defects.  
I conclude that Vps74 does not affect the telomere length of wild-type telomeres, but 
plays a minor role increasing the length of yku70Δ cells, with short telomeres. 
Additionally Vps74 plays a minor role in the protection of yku70Δ uncapped 
telomeres against resection having the opposite role in cdc13-1 cells. 
4.2.5. Rad27 contributes to the fitness of vps74Δ cells  
Rad27, a flap endonuclease, was described to be involved in Okazaki fragment 
processing (Rossi and Bambara 2006). Exo1 also displays a 5′ flap endonuclease 
activity (weaker than Rad27) and I found that Exo1 decreases the fitness of vps74Δ 
and vps74Δ yku70Δ cells (Tishkoff et al. 1997; Lee and Wilson 1999). Since exo1Δ 
strongly suppresses vps74Δ yku70Δ fitness defects and weakly suppresses vps74Δ 
fitness defects, I wondered if rad27Δ could also suppress vps74Δ yku70Δ and 
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vps74Δ fitness defects. To test this, RAD27 was deleted in vps74Δ yku70Δ and 
vps74Δ cells, and fitness assessed by spot test. 
Deletion of RAD27 in vps74Δ, yku70Δ and yku70Δ vps74Δ cells seems to be 
associated with a small phenotypic variability in cells with a similar genotype (Figure 
4-7). Such variability can be related to genetic or epigenetic variability (related for 
example to accumulation of mutations or alterations in chromatin modifiers) or can be 
due to variability in the proteome. Indeed, rad27Δ cells were previously shown to 
have telomeric repeat instability, being subjected to expansions and contractions of 
the telomeric repeats (Parenteau and Wellinger 1999). The successive passaging 
and backcross of such strains could help identify the origin of such variability. 
Nevertheless, overall Rad27 contributes to the fitness of vps74Δ and yku70Δ cells in 
a similar extent (Figure 4-7, 36°C). Such result is the opposite of that observed for 
Exo1 (Exo1 decreases the fitness of vps74Δ and yku70Δ vps74Δ cells), supporting 
the idea that the poor fitness of vps74Δ yku70Δ cells is related to increased ssDNA. 
In agreement with such model is the fact that rad27Δ cells have higher levels of 
telomeric ssDNA (Parenteau and Wellinger 1999). It is therefore not surprising that 
rad27Δ enhances yku70Δ vps74Δ fitness defects (at ≥36°C), since it might increase 
the already high levels of telomeric ssDNA.  
I conclude that Rad27, unlike Exo1, contributes to the fitness of vps74Δ cells. I 
suggest that Rad27 helps control the high levels of ssDNA in vps74Δ yku70Δ cells 
(and perhaps in vps74Δ cells). 
4.2.6. Mec1 decreases the fitness of vps74Δ and yku70Δ vps74Δ cells 
To better understand the role of Vps74 (and Yku70) in the DNA damage response, I 
next tested the role of Mec1 in the fitness of cells lacking Vps74 (Figure 4-8). Mec1 is 
a phosphoinositide (PI)-3-kinase-related essential protein kinase (Kato and Ogawa 
1994; Naito et al. 1998). Mec1 plays a central role in the DDR, activating Chk1 and 
Rad53. Despite being an essential gene, MEC1 (and RAD53) can be deleted if SML1 
(which acts downstream of Mec1 and Rad53) is also deleted (Zhao et al. 1998). 
Figure 4-8 shows that mec1Δ (sml1Δ) suppresses both vps74Δ and yku70Δ vps74Δ 
fitness defects, at 38°C and at 35°C, respectively. Also, as previously reported 
mec1Δ (sml1Δ) suppresses yku70Δ fitness defects. This result suggests that Vps74 
has a similar, but parallel, role to Yku70. 
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Figure 4-7 rad27Δ enhances vps74Δ and yku70Δ fitness defects. Saturated 
cultures of the genotypes indicated were serially diluted across YEPD agar plates 
and grown for 3 days at the temperatures indicated. All strains at each temperature 
were grown on a single rectangular plate. When the strain number is not shown, the 
number of the spore and the cross is shown. Cells with RAD27 deleted, were not 
frozen due to the high phenotypic variability. 
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I conclude that Mec1 decreases the fitness of vps74Δ cells. I suggest that vps74Δ 
and vps74Δ yku70Δ cells have telomere defects that activate the Mec1 checkpoint 
protein. Due to the fact that Mec1 also responds to genomic DNA damage and 
replication block, it is also possible that vps74Δ and vps74Δ yku70Δ cells have 
damage outside the telomeres. 
4.2.7.  Sgs1 has no effect on the fitness of vps74Δ cells and Rad53 and Chk1 
decrease the fitness of yku70Δ vps74Δ cells 
During DDR, Mec1 phosphorylates Rad53, Rad9 and Chk1, and in turn Rad9 
stimulates the activation of Rad53 and Chk1 (Emili 1998; Blankley and Lydall 2004; 
Ma et al. 2006). Upstream of Mec1, the Sgs1 helicase and Exo1, have the important 
role of resecting the DNA to initiate the DDR (Balogun et al. 2013). Sgs1, Rad53 and 
Chk1 role in maintaining the fitness of vps74Δ and yku70Δ vps74Δ cells was tested 
in order to better understand the place of Vps74 in the DDR (Figure 4-9). Again, the 
spot test assay was used to understand the effects that deletion of SGS1, RAD53 
and CHK1 have in the fitness of cells lacking Vps74 (and Yku70) (Figure 4-9). 
Figure 4-9A shows that sgs1Δ has little effect on vps74Δ or yku70Δ vps74Δ fitness 
defects, but strongly suppresses yku70Δ temperature sensitivity at 34°C and 36°C. 
This is in agreement with my previous results that showed that EXO1 deletion (which 
works with Sgs1 to resect DNA) more strongly suppresses yku70Δ fitness defects 
than vps74Δ fitness defects (Figure 4-5) (Zhu et al. 2008). These results suggest that 
the nuclease function of Exo1 plays a relevant role decreasing the fitness of vps74Δ 
and yku70Δ vps74Δ cells, and that this function is independent of Sgs1.  
RAD53 deletion suppressed vps74Δ yku70Δ, but not vps74Δ, fitness defects (Figure 
4-9A). This suggests that activation of Rad53 checkpoint is not a major reason for 
vps74Δ fitness defects at 38°C. Rad53 checkpoint activation seems however to be 
important for the decreased fitness of vps74Δ yku70Δ cells. 
As explained in the previous section, Chk1 is doubly activated by Rad9 and Mec1 
upon DDR activation. Figure 4-9B shows that chk1Δ strongly suppresses yku70Δ 
vps74Δ fitness, but does not affect vps74Δ fitness defects at 38°C. It was 
consequently concluded that Chk1 does not affect the cell fitness of vps74Δ cells, but 
decreases the cell fitness of yku70Δ vps74Δ cells. 
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Figure 4-8 mec1Δ sml1Δ suppresses vps74Δ and yku70Δ vps74Δ fitness 
defects. Saturated cultures of the genotypes indicated were serially diluted across 
YEPD agar plates and grown for 3 days at the temperatures indicated. All strains at 
each temperature were grown on a single plate but have been cut and pasted to 
allow better comparisons. When the strain number is not shown, the number of the 
spore and the cross is shown. These strains were not frozen, but the phenotype is 
representative of the genotype. 
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Figure 4-9 rad53Δ and chk1Δ suppress yku70Δ vps74Δ fitness defects. A-C) 
Saturated cultures of the genotypes indicated were serially diluted across YEPD 
agar plates and grown for 3 days at the temperatures indicated. All strains at each 
temperature were grown on a single plate but have been cut and pasted to allow 
better comparisons. When the strain number is not shown, the number of the spore 
and the cross is shown. These strains were not frozen, but the phenotype is 
representative of the genotype. 
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I conclude that Rad53 and Chk1 decrease the fitness of yku70Δ vps74Δ cells but do 
not affect vps74Δ cell fitness. I suggest that the poor fitness of vps74Δ yku70Δ cells 
is due to the activation of the checkpoint pathway that involves Rad53 and Chk1. I 
also see evidence that vps74Δ cells itself do not strongly activate Rad53 and Chk1. 
4.2.8. Vps74 contributes to genome stability 
Table 4-1 shows the genetic interactions described in the previous sections of this 
Chapter. It is clear that fitness of vps74Δ cells is dependent on DDR proteins (or vice 
versa), with mre11Δ and rad27Δ enhancing vps74Δ fitness defects. Suppressors of 
vps74Δ comprise exo1Δ, sae2Δ, rad24Δ and mec1Δ. Although the synthetic 
sickness between yku70Δ and vps74Δ can additionally be suppressed by chk1Δ and 
rad53Δ, those suppressors are also strong suppressors of yku70Δ sickness. This 
could suggest that lack of Vps74 exacerbates the fitness defects of yku70Δ cells, and 
that the fitness defects observed in yku70Δ vps74Δ cells are mainly due to the 
disruption of Yku70-related functions. This could happen if vps74Δ cells have DNA 
damage that is dependent on Yku70 to be efficiently repaired. The role of Vps74 in 
the DDR could be direct or indirect, for example by promoting the transport and 
maturation of relevant proteins. 
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Table 4-1 Genetic interactions between vps74Δ or vps74Δ yku70Δ and 
members of the DDR. Summary of the effects observed in the spot tests presented 
in this Chapter. The effects several deletions (first column) in the fitness of WT, 
yku70Δ, vps74Δ or yku70Δ vps74Δ cells (header) are shown. WT growth was 
considered to be +++++, cells that grow better than the respective header will have 
more “+” (shaded green) and cells that grow worse than the respective header will 
have less “+” (shaded red). Blue means that phenotype was inferred from the 
literature. N.d., not determined. 
 WT yku70Δ vps74Δ vps74Δ yku70Δ 
rad9Δ +++++ +++++++ +++++ N.d. 
exo1Δ +++++ +++++++ ++++++ +++++++ 
rad17Δ +++++ +++++ +++++ N.d. 
rad24Δ +++++ +++++ ++++++ N.d. 
mre11Δ +++ + + + 
sae2Δ +++++ ++++ ++++++ +++++ 
rad27Δ ++++ ++ ++ ++ 
mec1 sml1Δ +++++ +++++++ ++++++ +++++++ 
rad53 sml1Δ ++++ +++++ +++++ +++++++ 
sgs1Δ +++++ ++++++ +++++ +++++ 
chk1Δ +++++ +++++++ +++++ +++++++ 
4.2.9. Vps74 is potentially phosphorylated by Rad53 
The mammalian Vps74 (GOLPH3) is phosphorylated by DNA-PK upon DNA damage 
leading to Golgi dispersal (Farber-Katz et al. 2014). In yeast, Vps74 has not yet been 
associated with DNA damage, but Vps74 seems to have many potential sites that 
could be phosphorylated upon DNA damage (Cherry et al. 2012). Table 4-2 shows 
30 potential phosphorylation sites that I found bioinformatically (the 30 more likely, 
out of 39). It is interesting to find that my analysis retrieved Rad53, a DNA damage 
checkpoint, as a potential kinase.  
Other kinases comprise the WEE kinase group (Swe1), the Haspin kinase group 
(Alk1 and Alk2) and the CAMKL group (Kin4 and Kin2). The three kinase groups 
have been directly or indirectly associated with the DDR: Swe1 was shown to have 
checkpoint function by delaying mitosis through a repressive phosphorylation of 
Cdc28 (Booher et al. 1993); Alk1 and Alk2 are phosphorylated upon DNA damage 
(Nespoli et al. 2006); and members of the CAMKL group of kinases were also shown 
to take part in checkpoint signalling pathways involving cellular division (D'Aquino et 
al. 2005). CK1 (Yck1 and Yck2), a casein kinase, was also found to potentially 
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phosphorylate a considerable number of Vps74 sites. Yck1 and Yck2 are bound to 
the plasma membrane and are most known to respond to glucose changes (Vancura 
et al. 1993; Vancura et al. 1994; Reddi and Culotta 2013).  
The bioinformatics analysis of Vps74 potential phosphorylation sites strengthens the 
idea that Vps74 might be modified in the response to nuclear cues. Vps74 
modifications would activate a downstream signalling pathway in order to respond to 
those nuclear cues. 
 
Table 4-2 Vps74 potential phosphorylation sites. Group-based Prediction System 
(GPS) v3.0 software (available online at http://gps.biocuckoo.org/) was used to find 
potential kinase phosphorylation sites using the Vps74 aminoacid sequence 
available in SGD (Xue et al. 2008; Cherry et al. 2012). Position: the position of the 
site which is predicted to be phosphorylated; Code: the residue which is predicted to 
be phosphorylated; Kinase: the regulatory kinase which is predicted to 
phosphorylate the site; Peptide: the predicted phosphopeptide with 7 amino acids 
upstream and 7 amino acids downstream around the modified residue; Score: the 
value calculated by GPS algorithm to evaluate the potential of phosphorylation. 
Results are organized in descending order according to the score values. In red are 
the sites that were previously reported as being phosphorylated in SGD (not 
necessarily by the kinases identified by the software). 
Position Code Kinase Peptide Score 
260 Y WEE LALICGSYGANVLEN 14 
2 S CK1 ******MSTLQRRRV 11.631 
196 T Haspin VDKGVLRTEMKNFFL 11 
27 T Haspin IHSSANNTKGDKIAN 10 
116 S PEK KIRILDDSARKRFDL 9.909 
339 S CK1 AGVFEVFSRMDMLL* 9.7 
14 S CAMKL RRVNRADSGDTSSIH 9.535 
226 S RAD53 AIKRRVLSVLVSRNM 9.453 
136 T NAK EVIDSSKTGEVLLDE 9.4 
226 S CAMKL AIKRRVLSVLVSRNM 9.203 
236 S CAMKL VSRNMELSYNEYFPE 9.028 
237 Y AGC SRNMELSYNEYFPET 8.667 
270 T RAD53 NVLENVLTTLEYEKR 8.528 
19 S CK1 ADSGDTSSIHSSANN 8.508 
2 S CK1 ******MSTLQRRRV 6.993 
56 S NEK IAYDPEESKLRDNIN 6.393 
259 S WEE TLALICGSYGANVLE 6.333 
124 S Bud32 ARKRFDLSERLIEVI 6.25 
157 S Bud32 NDEPLSISNWIDLLS 6.25 
307 S CK1 KETELGVSVNLNKEV 6.007 
18 S CK1 RADSGDTSSIHSSAN 5.986 
18 S PLK RADSGDTSSIHSSAN 5.708 
2 S RSK ******MSTLQRRRV 5.183 
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133 S ULK RLIEVIDSSKTGEVL 5.077 
282 S RSK EKRDKAISRAEEIMA 4.915 
19 S PLK ADSGDTSSIHSSANN 4.682 
56 S PLK IAYDPEESKLRDNIN 4.636 
22 S STE11 GDTSSIHSSANNTKG 3.318 
14 S CAMK RRVNRADSGDTSSIH 2.752 
292 S STE EEIMAQFSQYPFDLE 2.36 
4.2.10. Vps74 and Sac1 contribute to cell fitness through independent 
pathways 
It was suggested that Vps74 is involved in the DNA damage response, either causing 
the damage, or contributing to its repair (Table 4-1). However, Vps74 is a cytoplasmic 
protein, mainly described as a sensor of PtdIns4P that activates Sac1 by physically 
interacting with Sac1. Therefore, it is extremely unlikely that Vps74 plays a direct role 
at the nucleus to aid DDR (however it cannot be excluded that Vps74 could 
translocate to the nucleus upon a stimulus). There are at least 3 major pathways 
through which Vps74 might affect the DNA damage response: 1) DDR protein 
maturation; 2) Inositol signalling; 3) Vps74 might be an active player in a signal 
transduction pathway that affects DDR. 
The fact that Vps74 affects maturation/levels of DDR proteins is not likely since 
proteins that are known to affect protein maturation in Golgi were not found to 
behave like vps74Δ in high-throughput screens (Addinall et al. 2011). The hypothesis 
that Vps74 affects the DDR through the inositol signalling would likely depend on 
Sac1, since Sac1 is the protein that effectively acts over the PtdIns4P pool. Although 
in the Saccharomyces Genome Database sac1Δ and vps74Δ do not share many 
characteristics (sac1Δ cells seem to have more extensive fitness defects), it is still 
possible that Vps74 and Sac1 work together just in one pathway, but still affect other 
pathways independently. Therefore, to test whether Vps74 is affecting the DDR, in 
the nucleus, by affecting the inositol signalling, Sac1 was deleted in an yku70Δ 
vps74Δ exo1Δ background (Figure 4-10).  
Figure 4-10 clearly shows that vps74Δ and sac1Δ are synthetically sick. The poor 
fitness of vps74Δ sac1Δ cells is already observable during spore germination (Figure 
4-10A). Even at 23°C vps74Δ sac1Δ cells show very low fitness, which is not affected 
by deletions of YKU70 and/or EXO1 (Figure 4-10B). This result clearly shows that 
Vps74 and Sac1 are in different pathways to maintain the fitness of yeast cells.  
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Figure 4-10 vps74Δ and sac1Δ are synthetically sick. A) Diploids were sporulated 
and spores were separated by tetrad dissection and plates were incubated for 5 
days at 23°C before photographing. Representative colonies of each genotype are 
shown. B) Saturated cultures of the genotypes indicated were serially diluted across 
YEPD agar plates and grown for 3 days at the temperatures indicated. All strains at 
each temperature were grown on a single plate but have been cut and pasted to 
allow better comparisons. When the strain number is not shown, the number of the 
spore and the cross is shown. These strains were not frozen, but the phenotype is 
representative of the genotype. 
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Furthermore, yku70Δ vps74Δ are less fit than yku70Δ sac1Δ at 35°C, suggesting that 
Vps74 has a role in telomere defective cells that is independent of Sac1. Additionally, 
SAC1 deletion enhances yku70Δ fitness defects, but not as strongly as VPS74 
deletion. Since Vps74 affects Sac1 activity, and therefore affects inositol levels, but 
Vps74 plays a stronger role maintaining yku70Δ cell fitness than Sac1, it is likely that 
Sac1 too affects yku70Δ fitness independently of the inositol pathway. Sac1 is 
perhaps important for the maturation of DDR-related proteins. 
I conclude that Vps74 and Sac1 act in parallel to maintain cell fitness. Thus, Vps74 
role in DDR/telomere biology is likely independent of the inositol pathway. I also 
showed that Sac1 is needed for the fitness of yku70Δ cells. Consequently, both 
Vps74 and Sac1 contribute to the fitness of yku70Δ, and are simultaneously needed 
for the fitness of WT cells. 
4.2.11. Deletion of SAC1 affects tryptophan intake 
When I first deleted SAC1, I used a hygromycin (HYG) marker to replace the SAC1 
ORF. At the same time, and in the same diploids SAE2 was also deleted with a 
tryptophan (TRP1) marker. After diploid sporulation and tetrad dissection, I noticed 
that sac1::HYG cells were extremely unfit and originated small colonies and 
sac1::HYG sae2::TRP1 cells were much fitter (Figure 4-11, red versus green). 
Although this seemed a very exciting result, sac1::HYG extensive fitness defects 
were not suppressed by exo1::LEU2 (or any other gene I deleted without the TRP1 
marker). Additionally, SAC1 mutants were shown to have low levels of membrane 
phosphatidylserine (PS) (Tani and Kuge 2014). Low PS, in turn, affects tryptophan 
uptake from the surrounding environment, which leads to tryptophan insufficiency 
when the cell cannot internally produce tryptophan (Nakamura et al. 2000). I 
therefore hypothesized that sac1::HYG cells are sick because they lack tryptophan 
and that sae2::TRP1 suppresses sac1::HYG fitness defects due to the TRP1 marker 
(and the capacity to synthesise tryptophan) and not loss of Sae2 function. 
To test if sac1Δ cells are defective in tryptophan uptake I compared the growth of 
sac1::HYG (with and without extra tryptophan supplementation in the medium) to 
sac1::TRP1 (Figure 4-12). Indeed sac1::HYG (c127) grow worse than sac1::TRP1 
(c142) (compare the small colonies to the big colonies within each cross).  
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Figure 4-11 sac1Δ fitness defects are strongly suppressed by sae2Δ. sac1::HYG 
was deleted in the heterozygous diploid vps74::KANMX yku70::HIS3 exo1::LEU2 
sae2::TRP1. Diploid was sporulated and spores were separated by tetrad dissection 
and plates were incubated for 5 days at 23°C before photographing. 
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Supplementation of sac1::HYG cells with 10 mg/mL tryptophan slightly increased 
colony size, but colonies kept growing significantly slower than wild-type colonies. 
Importantly, there is no evidence that vps74Δ cells have any issue uptaking 
tryptophan neither in the literature nor in my results. For example vps74Δ yku70Δ 
fitness defects are suppressed by exo1::LEU2 and exo1::URA3, while sac1::HYG 
fitness defects could only be suppressed by the presence of the TRP1 marker.  
I conclude that the fitness of sac1Δ cells is affected by the TRP1 marker suggesting 
defects in tryptophan uptake. Therefore, to avoid fitness defects related to tryptophan 
levels, SAC1 should be deleted with the TRP1 marker to allow cells to produce 
tryptophan. 
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Figure 4-12 SAC1 deletion affects the cell capacity to uptake tryptophan from 
the medium. Diploids were generated by deleting SAC1 with a hygromycin (c127) or 
a tryptophan (c142) marker. Spores were separated by tetrad dissection and plates 
were incubated for 10 (c127) or 5 (c142) days at 23°C before photographing. Spores 
from c127 were also dissected onto plates supplemented with 200 µL of a 2.5 
mg/mL, 5 mg/mL or 10 mg/mL L-tryptophan solution.  
  
128 
4.3. Discussion/Conclusion 
The work in this Chapter showed that Vps74 plays an important role maintaining cell 
fitness and evidence that in Vps74 absence the DDR is activated. A strong genetic 
interaction between vps74Δ and yku70Δ, together with a milder interaction between 
vps74Δ and cdc13-1, suggested a role for Vps74 at telomeres. VPS74 role at 
telomeres, and indeed in DDR, was especially provocative due to the fact that Vps74 
is not a nuclear protein and up to date no role for the yeast protein has been 
suggested at telomeres. Unfortunately, it was not possible to separate a telomeric 
role of Vps74 from a role elsewhere in the genome. Actually, the data here presented 
points towards a more general role of Vps74 in maintaining genome integrity 
throughout the genome. This is in agreement with the notion that GOLPH3 (Vps74 
mammalian orthologue) is an oncogene since GOLPH3 overexpression could for 
example improve cellular fitness. 
How Vps74 would contribute to the maintenance of genomic stability is not clear, but 
mammalian data showed that increased GOLPH3 levels led to cancer (by activation 
of the mTOR signalling) (Scott et al. 2009). Interestingly, a yeast mTOR orthologue, 
TORC1 (Tor1 and Tor2), has been associated with telomere maintenance and DDR. 
For instance, TORC1 inhibition leads to telomere shortening and decreased Yku70 
levels (Ungar et al. 2011). Also, rapamycin, a drug that inhibits TORC1, could 
strongly suppress cdc13-1 fitness defects after the cells were exposed to 37°C and 
put back to 23°C (Klermund et al. 2014). Such effect of rapamycin on cdc13-1 cell 
fitness was related to the maintenance of checkpoint proteins in an active 
(phosphorylated) state to prevent adaptation/cell division while the cells were at non-
permissive temperatures (Klermund et al. 2014). Interestingly, vps74Δ weakly 
suppresses cdc13-1 fitness defects, in agreement with less active TORC1 caused by 
VPS74 deletion. In yku70Δ vps74Δ cells, prolonged checkpoint activation would 
perhaps justify the poor fitness and the reason why deletion of checkpoint proteins 
suppress the fitness defects. Another more general role for a TORC2 (Tor2) pathway 
is to maintain genome stability upon mild DSB induction (Weisman et al. 2014). This 
role is in agreement with a model where Vps74 and Tor2 (and Tor1) collaborate to 
maintain genome stability. The fact that vps74Δ cells show mild fitness defects even 
at 23°C might suggest slower division/prolonged cell cycle. Prolonged cell cycle could 
happen if cell checkpoints are being activated by DNA damage. 
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Vps74 is a cytoplasmic protein, thus a direct role of this protein in the nucleus is 
unlikely. However, like its human orthologue, it might act as a signal transducer for 
the DNA damage response. If Vps74 was indeed part of a DNA damage signalling 
pathway, lack of Vps74 activation could lead to prolonged DNA damage (TORC1 
activation for instance), perhaps due to delays in the response or lack of activation of 
the DDR effector proteins. Bioinformatic analysis of Vps74 phosphorylation sites 
revealed 39 potential sites (Table 4-2). Indeed Vps74 might be a direct target of 
Rad53, which also has a small presence in the cytoplasm (Table 4-2) (Smolka et al. 
2006). It is therefore possible that Vps74 is important for an effective DDR, being part 
of signalling cascade. Further work will be required to understand the role of Vps74 in 
the DDR. 
Vps74 has also a small effect on telomere length of yku70Δ telomere defective cells. 
Since vps74Δ cells do not have short telomeres, Vps74 role at telomeres is 
dependent on Yku70 absence. A possible explanation is that vps74Δ cells 
accumulate DNA damage sites and the DDR proteins (including Tel1, for example) 
are mobilized to those DNA damage sites throughout the genome. A redistribution of 
some DDR proteins from the telomere to the genome in cells with uncapped 
telomeres (yku70Δ cells) might leave the telomere more prone to resection and less 
prone to amplification. Such redistribution was already shown to happen upon 
replication stress and DNA damage, with fluorescent microscopy analysis revealing 
relocalisation of checkpoint proteins and the Sir complex (Martin et al. 1999; Tkach et 
al. 2012). 
The results here described suggest that Vps74 is involved/affects the DDR (Figure 
4-13). I suggest that Vps74 is part of a signalling pathway that responds to naturally 
occurring DNA lesions (replicative damage or telomere shortening, for example). 
Lack of Vps74 would therefore delay the repair of the DNA lesions or just prolong the 
activation of the DNA damage checkpoints (through the TORC1 pathway, for 
instance). Lack of Vps74 activity could therefore lead to accumulation of unfixed DNA 
lesions.  
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Figure 4-13 Model for a role of Vps74 in the DDR. Natural occurring DNA lesions 
(due to replicative stress) or uncapped telomere ends are recognised by the Ku 
complex. DNA checkpoints are activated and Vps74 is phosphorylated (p-Vps74) by 
a kinase like Rad53, Yck1/Yck2, Alk1/Alk2, etc. p-Vps74 would then initiate a signal 
transduction signal, perhaps through the Tor1/Tor2 to aid the DDR. Vps74 might act 
to amplify the DNA response, without being essential for it. 
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4.4. Future work 
The interactions of VPS74 to various members of the DDR relate Vps74 to the DDR 
pathway. It is still unclear if lack of Vps74 causes DNA damage to induce the DDR or 
if it disrupts an efficient DDR. A way of testing if lack of Vps74 is causing DNA 
damage is to, by western-blot, test the phosphorylation states of Rad53 and histone 
H2A in vps74Δ cells (with and without deletions of the genes here found to 
genetically interact with vps74Δ). Pulse-field gel could also be helpful to detect any 
major chromosomal abnormalities caused by the proposed genomic instability in 
Vps74-defective cells. 
To test whether Vps74 is involved in the DNA damage response, CPT, MMS, HU, UV 
resistance of vps74Δ cells could be tested and later compared to the resistance of 
the double and triple mutants containing vps74Δ generated in this work. Additionally, 
to test whether Vps74 affects genetic stability through the Tor1/Tor2 pathway, 
vps74Δ cells could be exposed to rapamycin. If the Tor1/Tor2 pathway is functional, 
addition of rapamycin should further decrease cell fitness. 
Moreover, since GOLPH3 is phosphorylated in mammalian cells and Vps74 has 
many potential phosphorylation sites, Vps74 phosphorylation could be tested. A 
possible way of testing Vps74 phosphorylation is to tag the protein, and search for a 
gel shift by western blot (using anti-tag antibodies). It would be interesting to see if 
Vps74 is phosphorylated in yku70Δ cells and upon exposure to DNA damaging 
agents. Additionally, how this phosphorylation would change with the deletions that 
suppress vps74Δ yku70Δ fitness defects could also be addressed. Mutation of 
hypothetical phosphorylation sites in Vps74 followed by spot test assay could also 
indicate if Vps74 lack of phosphorylation is responsible for the fitness defects 
observed in vps74Δ cells. Vps74 phosphorylation upon DNA damage would strongly 
suggest this protein as part of the DDR.  
vps74Δ decreased the fitness of otherwise wild-type cells and yku70Δ cells. In 
humans, cancers often show overexpressed GOLPH3 (VPS74 orthologue), which 
confer them resistance to DNA damaging agents (Buschman et al. 2015). It would be 
interesting to see if VPS74 overexpression in WT and telomere defective cells would 
also increase its fitness and resistance to DNA damage agents. If so, further studies 
in yeast could be very helpful for the design of treatment strategies in GOLPH3-
positive cancers. 
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Another useful tool to find a place for Vps74 (together with Yku70) in the DDR is to 
perform a genome wide-screen (SGA, synthetic genetic array) to get a broader view 
of the genetic interactions of vps74Δ vs yku70Δ vs yku70Δ vps74Δ. Such experiment 
would allow the identification of the proteins (or functional group) that contribute to 
the fitness of vps74Δ cells. 
Finally, it would be interesting to see how vps74Δ cells die or arrest at 38°C. A simple 
microscopic examination with DAPI staining of vps74Δ cells at 30°C versus 38°C 
could help define in which cell-cycle phase the cells arrest/die. Knowing when the 
cells arrest/die would help to characterize Vps74 functions in DDR. For example, if 
cells arrest with a dumbbell shape, that might suggest telomere dysfunction. 
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5. Adjacent gene effect reveals synthetic genetic 
interactions between the PAF1 complex and the ESCRT 
machinery 
5.1. Introduction 
The PAF1 complex is an important and widely conserved protein complex, with many 
reported functions that affect transcript levels (Tomson and Arndt 2013). Cdc73 was 
shown to have a role in telomere defective cells (Figure 3-1). Cdc73 together with 
Paf1, Ctr9, Rtf1 and Leo1, is part of the yeast PAF1 complex (Mueller and Jaehning 
2002). In the human PAF1 complex, hRtf1 is not stably associated with the complex 
which contains instead hSki8 (Figure 5-1A) (Zhu et al. 2005; Chu et al. 2013).  
5.1.1. The PAF1 complex and transcription regulation 
The PAF1 complex was first identified as a complex that binds RNA pol II (Wade et 
al. 1996). It localizes in the nucleus where it is involved in transcriptional regulation 
(Squazzo et al. 2002; Chen et al. 2009; Kim et al. 2010; Crisucci and Arndt 2011), 
histone modifications (Krogan et al. 2003a), control of Poly(A) site utilization 
(Penheiter et al. 2005), etc. The PAF1 complex was also associated with the 
generation of double-stranded breaks during meiosis and regulation of promotor 
proximal pausing by RNA pol II (Chen et al. 2015; Gothwal et al. 2015; Yu et al. 
2015). In fission yeast, the PAF1 complex was associated with repression of small-
RNA-mediated epigenetic gene silencing (Kowalik et al. 2015). In budding yeast, 
reduced levels of TLC1 RNA (RNA template required for telomerase function) in 
cdc73Δ, paf1Δ or ctr9Δ cells suggested that loss of telomerase RNA might contribute 
to the cell growth defects of cells depleted of the PAF1 complex components (Singer 
and Gottschling 1994; Betz et al. 2002). Consistent with this, growth and telomere 
length defects of cells depleted of the PAF1 complex components could be partially 
recovered by TLC1 overexpression (Betz et al. 2002).  
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Figure 5-1 The PAF1 complex is conserved between yeast and humans and is 
involved in the Wnt pathway. A) Cartoons representing the composition of the 
PAF1 complex in yeast and human cells (Tomson and Arndt 2013). B) Cartoon 
illustrating the role of Cdc73 in Wnt signalling. Cdc73 dephosphorylation allows 
binding to β-catenin, helping to induce transcription of Wnt target genes. Other 
members of the complex are thought to stabilize Cdc73- β-catenin interaction 
(Takahashi et al. 2011a). 
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5.1.2. The PAF1 complex and cancer 
The PAF1 complex has been implicated in cancer biology since mutations in the 
human CDC73 can cause cancer (Gonzalez-Perez et al. 2013). For instance, 
mutations in human CDC73 (HRPT2, that encodes Parafibromin) lead to 
hyperparathyroidism-jaw tumour syndrome (HPT-JT), parathyroid carcinoma and 
familial isolated hyperparathyroidism (FIHP) (Jackson et al. 2015; Verdelli et al. 
2015). The Cdc73 orthologue in Drosophila melanogaster has been shown to play an 
important role in the canonical Wnt signalling pathway by directly associating with 
Armadillo (β-catenin orthologue in Drosophila) (Figure 5-1B) (Mosimann et al. 2006). 
Co-immunoprecipitation studies have also suggested an indirect interaction between 
Leo1 and β-catenin, suggesting a role for the whole PAF1 complex in the Wnt 
signalling pathway, which is known to be mutated in cancers (Mosimann et al. 2006; 
MacDonald et al. 2009).  
5.1.3. Different roles for different PAF1 complex components 
Although Cdc73, Paf1, Ctr9, Rtf1 and Leo1 form a protein complex, deletion of 
individual PAF1 complex components differently affect the cellular levels of the 
remaining complex members: Ctr9 loss leads to a decrease of Paf1, Rtf1 and Leo1; 
Paf1 loss leads to a decrease of Rtf1, Ctr9 and Cdc73; Cdc73 loss causes a 
decrease of Rtf1; while neither Rtf1 nor Leo1 loss affect the levels of the other 
members of the complex (Mueller et al. 2004). Structural studies have revealed Ctr9 
as the scaffold protein for the PAF1 complex in humans, while studies in yeast 
revealed that upon CDC73 or RTF1 deletions the other members of the complex 
remain associated with each other but do not associate to RNA pol II (Nordick et al. 
2008; Chu et al. 2013).  
Deletion of individual PAF1 complex members in yeast leads to distinct phenotypes 
(Betz et al. 2002). For example, ctr9Δ and paf1Δ cause similarly severe growth 
defects, cdc73Δ and rtf1Δ cause mild growth defects and leo1Δ causes no growth 
defects (Betz et al. 2002). Since both Rtf1 and Cdc73 are required for the association 
of the PAF1 complex with RNA pol II but their deletion does not cause extensive 
growth defects it was suggested that a major role of the PAF1 complex is 
independent of RNA pol II related functions (Mueller and Jaehning 2002; Mueller et 
al. 2004). In humans, hSki8 is a component of both PAF1 complex and the Ski 
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complex (which is needed for the exosome dependent 3’-5’ mRNA decay) which 
reveals a connection between the PAF1 complex and RNA surveillance (Zhu et al. 
2005).  
5.1.4. CDC73 and its adjacent gene, VPS36 
In yeast, CDC73 is adjacent to VPS36, and large-scale surveys have shown that 
cdc73Δ and vps36Δ strains share many characteristics, for example reduced 
telomere length (Askree et al. 2004), heat sensitivity (Betz et al. 2002; Sinha et al. 
2008) and decreased resistance to hygromycin B and hydroxyurea (Betz et al. 2002; 
Dudley et al. 2005; Fell et al. 2011). For these reasons, it has been suggested that 
CDC73 and VPS36 might demonstrate a neighbouring gene effect, or in other words, 
that the deletion of the coding sequence of one gene affects the function of the other 
(Ben-Shitrit et al. 2012). VPS36 is widely conserved among eukaryotes and encodes 
a protein that is part of the ESCRT (Endosomal Sorting Complexes Required for 
Transport)-II complex (Teo et al. 2004). The ESCRT-II complex is composed of Snf8, 
Vps25 and Vps36. The deletion of any of the ESCRT-II members causes short 
telomeres in S. cerevisiae (Rog et al. 2005).  
The ESCRT machinery is composed of ESCRT-0 (Vps27 and Hse1), ESCRT-I 
(Stp22, Mvb12, Vps37 and Vps28), ESCRT-II and ESCRT-III (Snf7, Vps20, Vps24 
and Did4) (Schuh and Audhya 2014). The main described function for the ESCRT 
complex is the remodelling of membranes, which is related to its role in the 
multivesicular body (MVB) pathway and cytokinesis (Schmidt and Teis 2012). One of 
the functions of the MVB pathway is to sort ubiquitylated membrane proteins for 
degradation in lysosomes (Schmidt and Teis 2012). During this process each of the 
ESCRT complexes assemble on endosomes in a sequential manner (Schmidt and 
Teis 2012). More recently the ESCRT III complex has been shown to be required for 
nuclear envelope repair after rupture caused by mammalian cell migration (Raab et 
al. 2016).  
The main aim of this Chapter was to understand if a neighbouring gene effect 
occurred between CDC73 and VPS36 and was responsible, or partly responsible, for 
the phenotypic differences between cdc73Δ cells and cells carrying deletions of other 
components of the PAF1. 
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5.2. Results 
5.2.1. The PAF1 complex affects telomere defective strains 
Genome-wide screens showed cdc73Δ as an enhancer of cdc13-1 fitness defects 
(Addinall et al. 2011). Additionally, leo1Δ and rtf1Δ had similar phenotype to 
cdc73Δ in the screen data (also as enhancers of cdc13-1 fitness defects) (Figure 
5-2). LEO1, RTF1 and CDC73 each encode members of the PAF1 complex 
(together with CTR9 and PAF1), and the similarity of leo1Δ, rtf1Δ and cdc73Δ 
effects on cdc13-1 cells strongly suggested a role for the PAF1 complex on 
telomere defective strains.  
5.2.2. Members of the PAF1 complex interact differently with cdc13-1  
In order to confirm and extend the high-throughput data, all five members of the 
PAF1 complex (CDC73, PAF1, CTR9, RTF1 and LEO1) were deleted in a different 
genetic background (W303) (Figure 5-3). The knockouts were created in diploid cells 
heterozygous for cdc13-1 and rad9Δ (Figure 5-3A) so that after sporulation and 
tetrad dissection one could clarify the role of PAF1 complex when telomeres and/or 
when DNA damage checkpoint pathways are defective. RAD9 encodes a DNA 
damage checkpoint protein, part of the DNA damage response (DDR), and its 
deletion suppresses cdc13-1 fitness defects (Weinert and Hartwell 1993). 
Analysing the colonies derived from each germinated spore it was noticed that 
cdc73Δ, leo1Δ and rtf1Δ spores formed bigger colonies than paf1Δ and ctr9Δ spores 
(squares in Figure 5-3B). This is in agreement with previous reports, which showed 
that paf1Δ and ctr9Δ cells have much more pronounced growth defects than cdc73Δ, 
leo1Δ and rtf1Δ cells (Betz et al. 2002). Deletion of RAD9 had no noticeable effect on 
the fitness of strains with PAF1 complex deletions (pentagons in Figure 5-3B), 
suggesting that the growth defects observed in the PAF1 complex deletion strains 
are likely not due to DNA damage. On the other hand, cdc13-1 seemed to greatly 
enhance the paf1Δ and ctr9Δ growth defects while the effect on cdc73Δ, leo1Δ or 
rtf1Δ fitness was much milder (circles on Figure 5-3B). Triple mutants (triangles on 
Figure 5-3B), containing cdc73Δ, leo1Δ or rtf1Δ deleted in a rad9Δ cdc13-1 
background, revealed no consistent differences on colony size when compared to the 
other mutants shown (single and double mutants: squares, pentagons and circles on  
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Figure 5-2 The PAF1 complex affects telomere defective strains. The yeast 
genome knock out collection (~4200 strains) was crossed with cdc13-1 or ura3Δ. 
Double mutants were then grown on solid agar plates and the fitness was measured 
at 27°C (Addinall et al. 2011). Each dot indicates the effect of a gene deletion (yfgΔ) 
on the fitness of cdc13-1 or ura3Δ. Represented by grey dots are all the deletions 
that did not significantly alter the fitness of cdc13-1. Green dots represent gene 
deletions that are enhancers of the cdc13-1, red dots are suppressors and the 
purple dots represent the fitness of CDC73, RTF1 and LEO1 deletions. 
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Figure 5-3 PAF1 complex genes interact differently with cdc13-1. A) One allele 
of each of the PAF1 complex members (yfgΔ: cdc73Δ, paf1Δ, ctr9Δ, leo1Δ or rtf1Δ) 
was deleted in diploid cells with the genotype RAD9/rad9Δ CDC13/cdc13-1 
(DDY227). B) Resulting diploids were sporulated and tetrads dissected onto YEPD 
plates. Germinated spores grew for 6 days at 23°C before being photographed. 
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Figure 5-3B). However, paf1Δ rad9Δ cdc13-1 and ctr9Δ rad9Δ cdc13-1 formed 
bigger colonies than paf1Δ cdc13-1 and ctr9Δ cdc13-1 respectively (triangles versus 
circles on Figure 5-3B). Since rad9Δ suppresses cdc13-1 growth defects, the bigger 
colonies of paf1Δ rad9Δ cdc13-1 and ctr9Δ rad9Δ cdc13-1 when compared to paf1Δ 
cdc13-1 and ctr9Δ cdc13-1 are expected and confirm that paf1Δ cdc13-1 and ctr9Δ 
cdc13-1 poor fitness is indeed related to telomere defects (Weinert and Hartwell 
1993).  
Overall, these experiments revealed pronounced synthetic growth defects in paf1Δ 
cdc13-1 and ctr9Δ cdc13-1 strains, but not in cdc73Δ cdc13-1, leo1Δ cdc13-1 or 
rtf1Δ cdc13-1 strains, suggesting that paf1Δ and ctr9Δ strains are more sensitive to 
telomere defects than cdc73Δ, leo1Δ or rtf1Δ. The results in W303 strains clearly 
show that the deletion of different PAF1 complex components can have different 
effects on fitness of telomere defective cdc13-1 cells.  
5.2.3. Cdc73, Paf1 and Ctr9 induce TLC1 RNA 
cdc73Δ, paf1Δ and ctr9Δ were all previously shown to cause a decrease in TLC1 
(telomerase component 1) RNA levels and a corresponding decrease in telomere 
length in the BY and JJ yeast genetic backgrounds (Mozdy et al. 2008). In order to 
confirm that the same pattern is observed in the W303 genetic background, I 
measured TLC1 RNA levels and telomere length in cells (W303 genetic background) 
with each of the PAF1 complex components deleted (Figure 5-4). 
Deletion of CDC73, PAF1 and CTR9 caused a decrease in TLC1 RNA to around 
20%, while LEO1 deletion decreased TLC1 RNA to 40% and RTF1 deletion halved 
TLC1 RNA (Figure 5-4A). Accordingly, leo1Δ and rtf1Δ cells have seemingly normal 
telomeres while cdc73Δ, paf1Δ and ctr9Δ cells have short telomeres as observed in 
the Southern bolt in Figure 5-4B. Between cdc73Δ, paf1Δ and ctr9Δ cells, cdc73Δ 
seem to cause the biggest decrease in telomere length, followed by paf1Δ, and 
finally by ctr9Δ.  
I conclude that Cdc73, Paf1 and Ctr9 strongly regulate/induce TLC1 levels while 
Leo1 and Rtf1 play a minor role. Consequently, cells lacking Cdc73, Paf1 or Ctr9 
have short telomeres. 
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Figure 5-4 PAF1 complex increases TLC1 RNA levels in W303. A) qRT-PCR 
analysis of TLC1 RNA expression levels. RNA from two independent strains of each 
genotype was measured. The “error” bars indicate the means of the two strains 
analysed. Each value was normalized to the levels of BUD6 mRNA (Addinall et al. 
2011). WT: DLY8490, 3001; cdc73Δ: DLY8490, 8491; paf1Δ: DLY8757, 8758; ctr9Δ: 
DLY8751, 8752; leo1Δ: DLY8736, 8737; rtf1Δ: DLY8743, 8744. B) Telomeric 
Southern blot was performed using a probe against the Y’+TG sequence (Maringele 
and Lydall 2004) in order to analyse the telomere structure. 
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5.2.4. TEN1 mRNA is increased in paf1Δ and ctr9Δ strains 
paf1Δ, ctr9Δ and cdc73Δ mutations all reduce TLC1 RNA levels to similar amounts, 
and have similar effects on telomere length, but paf1Δ and ctr9Δ strains most 
strongly enhance growth defects of telomere defective cdc13-1 strains (Figure 5-3 
and Figure 5-4). Therefore it was wondered if paf1Δ, ctr9Δ and cdc73Δ affected other 
relevant, telomere related, transcripts. mRNA levels of the three CST complex 
members, CDC13, STN1 and TEN1 were therefore measured (Figure 5-5A). 
Members of the PAF1 complex had little effect on CDC13 mRNA. However, 
interestingly, paf1Δ and ctr9Δ, but not cdc73Δ, increased TEN1 mRNA levels, with 
perhaps also a small increase in STN1 mRNA. This effect of PAF1 and CTR9 on 
TEN1 mRNA might contribute to the poor fitness caused by paf1Δ and ctr9Δ 
mutations in both CDC13 and cdc13-1 backgrounds (Figure 5-3B). Consistent with 
this idea increased Ten1 was shown to inhibit telomerase activity in yeast and plants 
(Qian et al. 2009a; Leehy et al. 2013).  
To test if the high levels of TEN1 in paf1Δ and ctr9Δ cells exacerbate the defects 
caused by lower levels of telomerase (due to reduced levels of TLC1 RNA), leading 
to particularly poor growth of these strains, TEN1 and STN1 were expressed in 
cdc73Δ strains (Figure 5-5B). If higher TEN1 levels, together with low TLC1 RNA 
cause fitness defects in paf1Δ and ctr9Δ strains, and since TLC1 levels are also low 
in cdc73Δ strains, one could expect that expressing TEN1 in cdc73Δ strains, would 
decrease its fitness. However, no significant decrease in cdc73Δ strains expressing 
TEN1 was found when compared to cells expressing the vector plasmid. The lack of 
effect after TEN1 expression might be due to incapacity of the centromeric plasmid 
used to properly increase Ten1 levels. A very low decrease in fitness of cells 
expressing STN1 from a 2 micron plasmid (when compared to the vector) can be 
seen at 23°C and 36°C. Since STN1 is also reported to repress telomerase 
recruitment it seems that cdc73Δ strains slightly benefit from not having high levels of 
the CST components that repress telomerase recruitment (when compared to paf1Δ 
and ctr9Δ) (Grandin et al. 2000). The effects observed after expression of STN1 are 
very modest, suggesting that the main factor(s) that cause PAF1 or CTR9 deletions 
to be much more harmful than CDC73 deletion in cells with uncapped telomeres is 
still to be identified.  
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Figure 5-5 PAF1 and CTR9 regulate TEN1 mRNA. A) qRT-PCR analysis of 
CDC13, STN1 and TEN1 mRNA expression levels in strains with one of the PAF1 
complex members deleted. The mean is indicated and the “error” bars indicate the 
two independent measurements. Each value was normalized to the levels of BUD6 
mRNA (Addinall et al. 2011). WT, 8460 and 3001; cdc73Δ, 8490 and 8491; paf1Δ, 
8757 and 8758; ctr9Δ, 8751 and 8752; leo1Δ, 8736 and 8737; rtf1Δ, 8743 and 8744. 
B) Two independent WT strains and two cdc73Δ strains were transformed with a 
plasmid carrying TEN1 (pDL1495), STN1 (pDL1755) or the corresponding empty 
vector (pDL1726 or pDL1756). From each transformation three pools of >10 colonies 
were tested by spot test: cells were cultivated overnight at 23°C and then serial 
dilutions of the saturated overnight culture were spotted onto solid –URA (TEN1) or 
–LEU (STN1) plates and incubated at different temperatures for 2 days.
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5.2.5. Synthetic sickness and neighbouring gene effect between CDC73 and 
adjacent gene VPS36 
I have confirmed that cdc73Δ, paf1Δ and ctr9Δ similarly regulate TLC1 RNA. It was 
also previously shown that cdc13-1 tlc1Δ survivors, with rearranged telomeres, 
exhibited better growth than cdc13-1 cells with normal telomeres (Tsai et al. 2002). 
Therefore, the substantial higher fitness of cdc73Δ cdc13-1 versus paf1Δ cdc13-1 
and ctr9Δ cdc13-1 cells, led us to think that maybe Cdc73 and Paf1/Ctr9 have an 
additional and distinct role affecting the telomere integrity. One explanation for the 
different phenotypes of cdc73Δ versus paf1Δ and ctr9Δ would be if cdc73Δ affected 
the function of a neighbouring gene, and if the neighbouring gene also affected 
fitness in cdc13-1 strains.  
CDC73 is adjacent to VPS36 (separated by 204 bp) and vps36Δ and cdc73Δ have 
been suggested to cause a neighbouring gene effect (deletion of one ORF affects the 
function of the adjacent gene). To test if interactions between VPS36 and CDC73 
could help explain the unusual properties of cdc73Δ strains, five related gene 
disruption constructs were created (Figure 5-6A). The effects of the constructs were 
analysed in CDC13, cdc13-1 and rad9Δ backgrounds to determine their role on cell 
fitness. Their effects on telomere length and TLC1 RNA levels were also measured. 
The data is shown in Figure 5-6.  
The strongest phenotype observed demonstrates a synthetic genetic interaction 
between CDC73 and VPS36 and comes from analysis of construct 5, which deletes 
the C termini of both proteins, and most likely completely inactivates both proteins 
(Figure 5-6B, D). Construct 5 causes a strong temperature sensitive phenotype in 
CDC+ strains, much stronger than the temperature sensitivity observed in cdc73Δ 
strains (construct 5 versus 1 and 2) (Figure 5-6B). This results shows that Cdc73 and 
Vps36 work in separate pathways to affect cell fitness at high temperatures and that 
a synthetic genetic interaction occurs when both genes are disrupted. 
The spatial organisation of CDC73 and VPS36 suggested that standard, complete 
ORF replacement of CDC73 might affect the 3' UTR of VPS36 and vice versa. The 
fact that construct 5 caused a more severe growth phenotype than construct 1 
suggests that construct 1 only partially reduces Vps36 function. Consistent with this 
hypothesis there is a small difference in fitness between constructs 1 and 2 in all 
combinations of cdc13-1 and rad9Δ backgrounds (Figure 5-6B-E). Importantly,  
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Figure 5-6 CDC73 and its adjacent gene VPS36 interact. A) Map representing the 
relative position of CDC73 and its adjacent gene VPS36, together with 5 different 
constructs used for the deletion of CDC73, VPS36 or both. B, C, D and E) Each of 
the constructs described in A were introduced in the following yeast genetic 
backgrounds: CDC13+ RAD9+ (B), cdc13-1 RAD9+ (C), CDC13+ rad9Δ (D) or cdc13-
1 rad9Δ (E). The resulting strains were cultivated overnight at 23°C. Serial dilutions 
of the saturated overnight cultures were then spotted onto solid YEPD plates and 
incubated at 23°C and 36°C (B and D) or 23°C and 24°C (C and E) for 2 days. At 
each temperature, all strains were grown on the same YEPD plate. Fitness of cdc13-
1 strains was measured as soon as possible after spore germination. Four different 
strains for each genotype were analysed and a representative strain is shown. No 
strain numbers were generated for these specific strains. Strain numbers for 
independent strains with identical genotypes can be found in Appendix A. F) 
Telomeric Southern blot was performed using a probe against the Y’+TG sequence 
(Maringele and Lydall 2004) in order to analyse the telomere structure of the strains 
described in A. G) qRT-PCR analysis of TLC1 mRNA expression levels in the strains 
described in A. mRNA from two independent strains was measured. The mean is 
indicated and the “error” bars indicate the two independent measurements. Each 
value was normalized to the levels of BUD6 mRNA (Addinall et al. 2011). The 
strains used are in the strain table (Appendix A) and were also analysed in F. 
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construct 2 (with VPS36 unaffected, therefore the true cdc73Δ phenotype) is a 
weaker enhancer of decreased cdc13-1 fitness defects than construct 1 (used 
throughout this thesis). The better fitness caused by construct 2 suggests that the 
fitness differences between cdc73Δ and paf1Δ or ctr9Δ cells are not caused by an 
adjacent gene effect, since paf1Δ and ctr9Δ are considerably less fit than cdc73Δ 
(Figure 5-3). 
The three constructs that inactivate Cdc73 each caused short telomeres and 
decreases in TLC1 RNA (constructs 1, 2, 5 Figure 5-6F and G). Interestingly lack of 
Vps36 (constructs 3 and 4) caused slightly increased TLC1 levels and slightly longer 
telomeres (Figure 5-6F and G). Furthermore it seems that construct 5, disrupting 
CDC73 and VPS36 caused slightly longer telomeres than cdc73Δ alone (constructs 1 
and 2). This result is not in agreement with the previously reported short telomere 
phenotype of vps36Δ cells and will be further addressed in section 5.2.7 (Rog et al. 
2005).  
I conclude that the standard cdc73Δ mutation (construct 1) is partially interfering with 
VPS36 activity, most likely by affecting the VPS36 UTR. I see no detectable fitness 
difference between the standard vps36Δ and a VPS36 N terminal disruption in 
cdc13-1 mutants (compare constructs 3 and 4, Figure 5-6C). Overall there are both a 
synthetic genetic interaction between VPS36 and CDC73 and a neighbouring gene 
effect on VPS36 function caused by the standard cdc73Δ construct.  
5.2.6. Expression of VPS36 on a plasmid decreases cdc73Δ cdc13-1 fitness 
To better understand the role of CDC73, VPS36 and YLR419W (the other gene 
adjacent to CDC73) in cdc73Δ cdc13-1 strains, each gene was cloned in a 
centromeric plasmid to permit complementation testing. Heterozygous cdc73Δ 
cdc13-1 diploids were transformed with each plasmid and spores carrying a plasmid 
expressing CDC73, VPS36 or YLR419W were germinated and fitness assessed.  
cdc73Δ cdc13-1 cells carrying an empty plasmid (vector) grow better than cdc13-1 
cells at non-permissive temperatures (27°C and 28°C) (Figure 5-7). This is in 
agreement with the suppressing role of CDC73 observed in Figure 3-1 but is 
opposite to what is observed in Figure 5-6C (cdc73Δ cdc13-1 cells are less fit than 
cdc13-1 cells at 24°C) and in high-throughput screens (Addinall et al. 2011). The 
reasons for this discrepancy will be addressed in Chapter 6.  
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It was observed, as expected, that expression of CDC73 rescued the cdc13-1 fitness 
in cdc73Δ cdc13-1 strains (Figure 5-7). This shows that CDC73 deletion is largely 
responsible for the cdc73Δ cdc13-1 better growth at semi-permissive temperatures. 
The expression of VPS36 from a plasmid enhanced cdc73Δ cdc13-1 thermo-
sensitivity. This effect of the expression of VPS36 on cdc73Δ cdc13-1 fitness might 
be due to an increase of Vps36 in the cells which is reported to cause growth defects 
(Sopko et al. 2006). Therefore it is likely that the cdc73Δ cdc13-1 strains in Figure 
5-7 are expressing more VPS36 than is physiologically typical, showing that the cells 
are very sensitive to changes in Vps36 homeostasis. Since VPS36 is part of a protein 
sorting pathway it is possible that too much Vps36 will lead to the dysregulation of 
protein levels (Bowers and Stevens 2005). Finally, the expression of YLR419W on a 
plasmid both enhanced and suppressed the cdc73Δ cdc13-1 fitness defect (Figure 
5-7). This heterogeneity is typical of a population that might be rearranging their 
telomeres and such phenotype will be explained in Chapter 6. 
Altogether, these results show that Vps36 overexpression enhances the fitness 
defects of cdc73Δ cdc13-1. It was also suggested (from sections 5.2.4 and 5.2.6) that 
cdc73Δ cdc13-1 cells are very sensitive to changes in Vps36 levels perhaps due to 
the fact that CDC73 deletion causes a protein unbalance that would be addressed by 
protein degradation pathways. 
5.2.7. ESCRT-II complex does not affect telomere length in W303 
In contrast to the data here presented, a VPS36 deletion was previously reported to 
cause short telomeres (Figure 5-6) (Askree et al. 2004). Therefore the telomere 
length in snf8Δ or vps25Δ strains, defective in other members of the ESCRT-II 
complex, was also measured. No strong effects on telomere length were observed 
upon deletion of any of the ESCRT-II complex components (Figure 5-8). My 
experiments are performed in the W303 genetic background, and cells were cultured 
at 23oC, whereas the published experiments were in the BY4742 background, and 
cells were most likely cultured at 30oC. It seems that the effect of the ESCRT-II 
complex on telomere length is dependent on the genetic background and/or 
temperature. I conclude that ESCRT-II components do not (always) regulate 
telomere length in yeast. 
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Figure 5-7 Expression of CDC73 adjacent genes in plasmids suggests that 
VPS36 might be affected in cdc73Δ strains. A) Cartoon representing the relative 
organization of CDC73 and its adjacent genes: VPS36 and YLR419W. B) The diploid 
CDC73/cdc73Δ RAD9/rad9Δ CDC13/cdc13-1 was transformed with plasmids 
carrying the CDC73 gene (pDL1562) and each one of its adjacent genes VPS36 
(pDL1649) or YLR419W (pDL1650). The vector was transformed into haploid cells. 
Diploids were sporulated and the strains carrying each of the plasmids were 
selected. These strains were then tested by spot test: cells were cultivated overnight 
at 23°C and then serial dilutions of the saturated overnight culture were spotted onto 
solid -Ura plates and incubated at different temperatures for 5 days. No strain 
numbers were generated for these specific strains. 
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5.2.8. The PAF1 complex regulates VPS36 transcription 
Since Cdc73 is part of the PAF1 complex that is involved in transcriptional regulation 
I wondered whether the interactions between CDC73 and VPS36 were due, in part, 
to transcriptional regulation of VPS36 mRNA by the PAF1 complex. To test this, 
VPS36 mRNA levels were measured in strains with disruptions of CDC73 (constructs 
1 and 2, Figure 5-6A) and in strains with the other PAF1 complex components 
deleted (Figure 5-9A). Interestingly, VPS36 mRNA is decreased when each of the 
PAF1 complex components is deleted, with little difference between deletion and N-
terminal disruption of CDC73 (constructs 1 and 2). Similar to what has been seen in 
other phenotypes, such as growth on germination plates (Figure 5-3B), leo1Δ and 
rtf1Δ disruptions showed milder effects on VPS36 RNA levels. Expression of the 
other adjacent gene to CDC73, YLR419W, was also tested in cdc73Δ cells and found 
to be unaltered (Figure 5-9B). I conclude that VPS36 is a new transcriptional target of 
the PAF1 complex. 
5.2.9. vps36Δ is synthetically lethal with paf1Δ or ctr9Δ but not with cdc73Δ, 
rtf1Δ or leo1Δ 
Given that VPS36 and CDC73 function independently to maintain cell fitness, 
particularly at high temperature, I wanted to know what role, if any, VPS36 played in 
the fitness of other PAF1 complex deletion strains. To address this question, I 
crossed vps36Δ (Figure 5-6A, disruptions 3 and 4) to strains carrying paf1Δ, ctr9Δ, 
rtf1Δ or leo1Δ mutations (Figure 5-10A). Note that fitness of cdc73Δ vps36Δ double 
mutants was previously tested in Figure 5-6B and found to be decreased when 
compared to single mutants. Interestingly, viable vps36Δ paf1Δ or vps36Δ ctr9Δ 
double mutants could not be identified but all other double mutants could. Although 
this synthetic lethality between vps36Δ and paf1Δ or ctr9Δ has not been previously 
reported, both PAF1 and CTR9 deletions were reported to show synthetic growth 
defects with deletions affecting ubiquitination pathways (UBP6) or multivesicular 
body/protein sorting pathways (VPS21, VPS71 and VPS72). Since Vps36 (as part of 
ESCRT-II) is involved in sorting ubiquitinated proteins for degradation through the 
multivesicular body pathway, the findings here reported are in line with the previously 
described genetic interactions of PAF1/CTR9 and members of the multivesicular  
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Figure 5-8 ESCRT-II complex components do not regulate W303 telomere 
length. Telomeric Southern blot was performed as in Figure 5-6F. For each VPS 
mutant, the first two strains (left to right) are described in Appendix A, while the last 
two were taken from germination plates and never frozen. SYBR safe staining was 
used as loading control. 
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Figure 5-9 PAF1 complex controls VPS36 expression. A and B) qRT-PCR 
analysis of VPS36 and YLR419W mRNA expression levels in strains with one of the 
PAF1 complex members deleted. mRNA from two independent strains was 
measured. The mean is indicated and the “error” bars indicate the two independent 
measurements. Each value was normalized to the levels of BUD6 mRNA (Addinall et 
al. 2011). WT, 8460 and 3001; cdc73Δ (1), 8490 and 8491; cdc73 (2), 9191 and 
9192; paf1Δ, 8757 and 8758; ctr9Δ, 8751 and 8752; leo1Δ, 8736 and 8737; rtf1Δ, 
8743 and 8744. 
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body degradation pathway (Krogan et al. 2003b; Teo et al. 2004; Laribee et al. 2005; 
Collins et al. 2007). These results show that Vps36 and the PAF1 complex, 
specifically PAF1 and CTR9, work together to support cell viability. 
PAF1 and CTR9 deletions were shown to decrease TLC1 RNA levels, leading to 
short telomeres (Mozdy et al. 2008). Telomere shortening in ctr9Δ cells could be 
bypassed by overexpression of TLC1. Additionally, deletion of ESCRT components 
in other yeast backgrounds was shown to cause a short telomere phenotype (Askree 
et al. 2004). Although I did not see any decrease in telomere length in ESCRT II 
deletion mutants, I hypothesised that in a paf1Δ/ctr9Δ background, deletion of 
ESCRT mutants caused extensive telomere shortening, causing cell cycle arrest. To 
test this hypothesis I asked if TLC1 RNA could rescue vps36Δ paf1Δ synthetic 
lethality. Importantly, I saw no effect of a TLC1 expressing plasmid (versus vector) on 
the viability of vps36Δ paf1Δ (from 79 viable spores carrying TLC1, none was vps36Δ 
paf1Δ) (Figure 5-10B). 
I conclude that Vps36 and Paf1/Ctr9 work in independent pathways to maintain cell 
viability, with simultaneous lack of function of Vps36 and Paf1 or Ctr9 leading to cell 
death. Furthermore, the synthetic lethality between vps36Δ and paf1Δ is unlikely to 
be related to the decreased levels of TLC1 in paf1Δ cells. These results suggest that 
Paf1 and Ctr9 are more essential for cell viability than the remaining components of 
the PAF1 complex. 
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Figure 5-10 vps36Δ is synthetically lethal with paf1Δ or ctr9Δ but not with rtf1Δ 
or leo1Δ. A) vps36Δ (Figure 5-6A, constructs 3 and 4) were crossed to paf1Δ 
(DLY8757), ctr9Δ (DLY8751), rtf1Δ (DLY8743) or leo1Δ (DLY8736) strains and 
diploid cells were obtained. Diploids were sporulated and tetrads dissected onto 
YEPD plates, where germinated spores grew for 6 days at 23°C before being 
photographed. B) A vps36Δ paf1Δ heterozygous diploid was transformed with a 
centromeric plasmid carrying TLC1 (pDL751) or a vector plasmid (pDL1713). 
Random spore analysis was used to get haploid strains: the diploids carrying the 
plasmids were sporulated and spotted onto –URA plates. After 7 days at 23°C 
colonies were genotyped. The percentage of each genotype in the total was plotted. 
n represents the total number of colonies (cells) genotyped. 
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5.2.10. paf1Δ and ctr9Δ are synthetically lethal with deletions of ESCRT-I, 
ESCRT-II and ESCRT-III components 
To test if the synthetic lethality between paf1Δ/ctr9Δ and vps36Δ is conserved among 
other components of the ESCRT machinery (ESCRT-0 to ESCRT-III), I performed 
random spore analysis of diploids carrying simultaneous deletions of PAF1 complex 
components and ESCRT components. I tested interactions between the PAF1 
complex and VPS27 (ESCRT-0), STP22 (ESCRT-I), SNF8 (ESCRT-II), VPS25 
(ESCRT-II) and SNF7 (ESCRT-III). Interestingly, and in agreement with the 
interactions observed between PAF1/CTR9 and VPS36, PAF1 and CTR9 could not 
be deleted in cells carrying deletions of any of the ESCRT-I, ESCRT-II or ESCRT-III 
components (Figure 5-11). Importantly, 8 (in 88) paf1Δ vps27Δ and 1 (in 35) ctr9Δ 
vps27Δ cells were found alive, suggesting that Vps27 (ESCRT-0) is not as important 
as downstream ESCRT components for the viability of paf1Δ or ctr9Δ cells. 
I conclude that PAF1 complex (through Paf1 and Ctr9) work together with the 
ESCRT machinery to maintain cell viability.  
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Figure 5-11 paf1Δ and ctr9Δ are synthetically lethal with deletions of many 
ESCRT components. A) Schematic representation of the components of the yeast 
ESCRT-0, ESCRT-I, ESCRT-II and ESCRT-III complexes. B-E) Strains carrying 
deletions of different components of the PAF1 complex were crossed with vps27Δ 
(B), stp22Δ (C), snf8Δ (D), vps25Δ (E) or snf7Δ (F) strains. Data was analysed as 
described in Figure 5-10B. 
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5.3. Discussion 
The PAF1 complex binds RNA polymerase, is highly conserved among eukaryotes 
and plays roles in human disease such as cancer. The PAF1 complex affects the 
amount of numerous RNAs by affecting transcriptional and post-transcriptional 
processes (Penheiter et al. 2005; Tomson and Arndt 2013). Here, it was investigated 
how the PAF1 complex affects fitness of yeast cells with defective telomeres to help 
explore the potential relevance of these interactions to cancer.  
The experiments in this Chapter show that the PAF1 complex has numerous effects 
on telomere biology and the data is summarized by Figure 5-12. A new set of 
interactions between the PAF1 complex and components of the ESCRT machinery 
have also been described. For instance, I found that Paf1 and Ctr9 are essential for 
viability in cells with defects in ESCRT-I, ESCRT-II or ESCRT-III complexes. All the 
data here described, and much of the literature, support the view that Ctr9 and Paf1 
are the most critical members of the PAF1 complex. Conversely, Leo1 and Rtf1 are 
the least critical (auxiliary) members of the PAF1 complex, and Cdc73 is somewhere 
in-between.  
Consistent with previous reports, the results here described find that the PAF1 
complex is needed to achieve normal, high levels of TLC1 (telomerase component) 
RNA (Mozdy et al. 2008). Leo1 and Rtf1 have lesser effects than Cdc73, Ctr9 and 
Paf1 on TLC1 levels (Pathway a, Figure 5-12). Also, I show for the first time that all 
the PAF1 complex components induce VPS36 transcript levels, with a stronger role 
for Paf1 and Ctr9 (Pathway b, Figure 5-12). On the other hand Ctr9 and Paf1 reduce 
levels of TEN1 mRNA (affecting a member of the telomere capping complex, CST) 
(Pathway c, Figure 5-12) while other components of the PAF1 complex had 
comparatively small effects. Thus, in summary, PAF1 complex components show 
complex effects on levels of three transcripts that affect telomere biology: TLC1, 
VPS36 (perhaps also through TLC1 RNA regulation) and TEN1. 
CDC73 is adjacent to VPS36 and the pair have been suggested to exhibit a 
neighbouring gene effect. In this Chapter I confirmed that the CDC73 disruption 
partially reduces VPS36 function (and by this criterion is causing a neighbouring 
gene effect) (Pathway d, Figure 5-12). This is in agreement with a model where the 
cdc73Δ mutation affects VPS36 3' UTR.  
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In addition to the neighbouring gene effect, there are other more important (trans) 
interactions between the PAF1 complex and VPS36. First, Cdc73 and the other 
members of the PAF1 complex are required for normal, high VPS36 mRNA levels. In 
addition vps36Δ exacerbates the temperature sensitive phenotype of cdc73Δ 
mutants. Furthermore, there is a synthetic lethal interaction in cells with defective 
ESCRT-I, ESCRT-II and ESCRT-III machineries and ctr9Δ or paf1Δ mutations. This 
suggests that the ESCRT machinery functions redundantly with Ctr9/Paf1 to maintain 
yeast cell viability (Pathway e, Figure 5-12).  
How the PAF1 complex and the ESCRT components function together to maintain 
yeast cell fitness is not clear. The higher sensitivity of ESCRT deletion mutants to 6-
azauracil suggested that the ESCRT pathway plays a role in transcription elongation 
(Song et al. 2014). Importantly, ESCRT proteins physically associate with 3’ regions 
of actively transcribed genes (Song et al. 2014). Thus, since the PAF1 complex 
facilitates transcription, paf1Δ vps36Δ and ctr9Δ vps36Δ might have exacerbated 
transcriptional defects that are not compatible with life.  
Another hypothesis is that double mutants (carrying deletions of both PAF1 and 
ESCRT complex components) could have increased levels of transcription-replication 
fork collisions. Paf1 (together with Ino80) was shown to be important for RNA pol II 
degradation to avoid transcription-replication fork collision (Poli et al. 2016). 
Additionally, many have shown that Rpb1 is ubiquitylated upon DNA damage, 
marking RNA pol II for degradation (Huibregtse et al. 1997; Beaudenon et al. 1999; 
Somesh et al. 2005; Chen et al. 2007). Since the ESCRT machinery is involved in 
the sorting of ubiquitylated proteins for degradation, it is possible that the ESCRT 
complex is involved in the degradation of RNA pol II. If true, the combined effects of 
loss of PAF1 (less signalling for RNA pol II degradation) and loss of ESCRT (less 
capacity to degrade RNA pol II) could cause irreversible stalling in replication forks, 
leading to cell cycle arrest. 
Irrespective of the precise mechanism it is plausible that the synthetic lethal 
interactions between paf1Δ or ctr9Δ and ESCRT component deletions are based, at 
least in part, on their functions at telomeres (Pathways e,f, Figure 5-12). Vps36 and 
the ESCRT II complex are connected with telomere biology. In this Chapter I saw 
slightly higher levels of TLC1 RNA in vps36Δ strains and this correlates with telomere 
length increases, whereas others reported that vps36Δ caused a short telomere 
phenotype (Rog et al. 2005). This discrepancy might be due to a difference in the 
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genetic background, temperature, or other environmental conditions that might be 
different in my experiments when compared to the previously reported experiments. 
Indeed, telomere length can be affected by environmental conditions such as 
temperature and ethanol concentration (Romano et al. 2013). The ESCRT-II complex 
role on telomere function might be due to a role in telomerase turnover, or in the 
turnover of other proteins involved in telomerase turnover/transcription repression. 
An important new insight comes from the observation that Paf1 and Ctr9, the critical 
members of the PAF1 complex, inhibit TEN1 mRNA accumulation. It is known that in 
plant and yeast cells that high levels of Ten1 can inhibit telomerase recruitment (Qian 
et al. 2009a; Leehy et al. 2013). Thus a ctr9Δ mutation causing a reduction in TLC1 
RNA combined with an increase in TEN1 mRNA will be more harmful to telomere 
function, and cell fitness, than a cdc73Δ mutation which just affects TLC1 RNA 
levels. I could only observe a very modest effect on STN1 expression (also a 
telomerase repressor) in cdc73Δ strains, showing that although contributing to cell 
sickness, high Ten1 levels are perhaps just a small fraction of what makes paf1Δ 
cdc13-1 and ctr9Δ cdc13-1 cells sick. Since the PAF1 complex is needed for proper 
levels of hundreds of transcripts, it might just be that one of those altered transcripts 
is required at normal levels in telomere defective strains.  
Finally, the interactions here described between the PAF1 complex and VPS36 might 
be relevant to health in higher eukaryotes. In Drosophila, the VPS36 orthologue was 
reported to affect the Hedgehog (Hh) pathway (Yang et al. 2013). The Hedgehog 
pathway, conserved between vertebrate and invertebrates (Nussleinvolhard and 
Wieschaus 1980; Huangfu and Anderson 2006), is involved in embryonic and post-
embryonic development and has a strong role on neural stem cell maintenance (Ahn 
and Joyner 2005; Balordi and Fishell 2007; Ingham et al. 2011; Briscoe and Therond 
2013). Interestingly, Ctr9 has been shown to regulate dopamine transporter 
trafficking (essential for proper neural function) in mammalian cells (De Gois et al. 
2015), and could therefore potentially play a role like the Hedgehog pathway in 
neural stem cells.  
Furthermore, both Hedgehog (Vps36) and Wnt (PAF1 complex) signalling pathways 
are constitutively active in many cancers (Taipale and Beachy 2001) and common 
regulators like XSufu have been identified in Xenopus (Min et al. 2011).  
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Figure 5-12 Cartoon for the regulation of cell viability by the PAF1 complex. 
The Paf1 complex is composed of Cdc73, Paf1, Ctr9, Leo1 and Rtf1. The Paf1 
complex promotes the expression in trans of both TLC1 (a) and VPS36 (b), while 
Paf1 and Ctr9 repress the expression of TEN1 (c). Additionally, CDC73 and VPS36 
interact in cis (d). Telomere maintenance is essential for cell viability and Ten1 has 
a repressive effect over telomere lengthening while TLC1 promotes telomere 
lengthening. Therefore, the PAF1 complex, mainly through Paf1 and Ctr9, maintains 
cell viability by promoting telomere integrity. Ctr9 and Paf1, together with Vps36, 
contribute to cell viability (e) through a mechanism that I cannot yet define, although 
it might be related to a role of Vps36 at telomeres (f). 
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Thus, a better understanding of the cross-talk between the Hedgehog and Wnt 
pathways could be helpful. The links between the PAF1 complex, Vps36 and 
telomere biology in yeast may help to understand the role of the human PAF1 
complex in cancer. 
5.4. Future work 
It would be interesting to see if TLC1 overexpression rescues the fitness defects of 
paf1Δ cdc13-1 and ctr9Δ cdc13-1 (in comparison to cdc73Δ cdc13-1). This would 
show if the low TLC1 levels (caused by deletion of CDC73, PAF1 and CTR9) have a 
critical role in the low fitness of paf1Δ cdc13-1 and ctr9Δ cdc13-1 cells. A hypothesis 
is that such expression would recover cdc73Δ cdc13-1 fitness defects (at very low 
passage) more than paf1Δ cdc13-1 and ctr9Δ cdc13-1 fitness defects.
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6. PAF1 complex components regulate TERRA and 
telomere function 
6.1. Introduction 
In the previous Chapter it was shown that CDC73 deletion slightly affects the function 
of its adjacent gene VPS36. However it was also concluded that this neighbouring 
gene effect is not responsible for the phenotypic differences caused by deletion of 
CDC73 versus deletion of PAF1 or CTR9. Therefore, the reason why different 
components of the PAF1 complex affect cells with uncapped telomeres so differently 
is still to be addressed. 
6.1.1. The PAF1 complex and RNA metabolism 
The PAF1 complex has been mainly associated with transcription, either by 
facilitating elongation or by stalling RNA pol II at promoter-proximal sites after 
transcription initiation (Tomson and Arndt 2013; Chen et al. 2015). The opposing 
functions of the same complex suggest that the PAF1 complex depends on 
interaction partners to perform some of its functions. Other roles of the PAF1 
complex happen after transcription termination. For instance, the yeast PAF1 
complex was shown to promote normal poly(A) length, with paf1Δ cells having RNAs 
with shorter poly(A) tails (Mueller et al. 2004). The same control over poly(A) length 
was observed in human cells depleted of PAF1 (Nagaike et al. 2011). It was 
suggested that a reduced recruitment of termination factors in cells lacking PAF1 
complex components caused less efficient polyadenylation (Nordick et al. 2008). A 
physical interaction between the PAF1 complex and the most important deadenylase 
complex (CCR4-NOT) was also described in yeast (Chang et al. 1999). Also, 
extended 3’-UTRs have been shown for the nonpolyadenylated small nucleolar 
RNAs (snoRNAs) in paf1Δ cells (Sheldon et al. 2005). An abnormal polyadenylation 
signal is often associated with increased instability and increased RNA decay 
(Garneau et al. 2007). Thus, the PAF1 complex regulates mRNA levels also by 
promoting normal poly(A), since abnormal poly(A) tails are a signal for mRNA 
degradation. 
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Interestingly, in humans, hSki8, a member of the SKI complex (involved in 
cytoplasmic RNA decay) is found to associate with the PAF1 complex (Zhu et al. 
2005). This suggests a direct link between the PAF1 complex (transcription) and 
RNA degradation pathways.  
6.1.2. Different functions for different PAF1c components  
The PAF1 complex components form a multi-protein complex, however there is 
increasing evidence in mammalian cells that different components perform different 
functions. In mouse muscle cells, Rtf1 does not bind other PAF1 complex 
components but another protein, Ski8, does (Yang et al. 2016). In Hela cells, Rtf1 
regulates the expression of a distinct subset of genes to other PAF1 complex 
components (Cao et al. 2015). Furthermore, the idea that different PAF1 components 
perform different functions is suggested by the fact that Cdc73 is more often found 
mutated in cancer than other PAF1 complex components (An et al. 2016). In yeast 
there is also evidence that different PAF1 components perform different functions. In 
S. pombe, the PAF1 complex (through Paf1 and Leo1) influences chromatin state by 
enhancing histone turnover (Sadeghi et al. 2015). Additionally, loss of Cdc73, Paf1 or 
Ctr9 reduces Pol II CTD Ser2-P while loss of Rtf1 or Leo1 have little effect (Nordick 
et al. 2008). Yeast paf1Δ and ctr9Δ cells are very unfit while cdc73Δ, leo1Δ and rtf1Δ 
cells are quite fit (Betz et al. 2002; Mozdy et al. 2008). Despite the evidence that 
different components of the PAF1 complex perform different functions few studies 
have systematically addressed their different functions. The aim of this Chapter is to 
better understand how different PAF1 complex components affect telomere biology in 
budding yeast. 
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6.2. Results 
6.2.1. PAF1 complex components affect fitness in different ways 
To clarify the roles of PAF1 components, the fitness of all five members of the 
complex was tested by spot test. As has been reported before, paf1Δ and ctr9Δ 
caused fitness defects in otherwise wild-type cells, while cdc73Δ, leo1Δ and rtf1Δ 
had minimal effects (Figure 6-1) (Betz et al. 2002). Interestingly, and in contrast to 
published high-throughput data (Figure 5-2), in W303, cdc73Δ cdc13-1 cells were 
clearly fitter than cdc13-1 cells (Figure 6-1) (Addinall et al. 2011). This better fitness 
of cdc73Δ cdc13-1 is also the opposite of what was observed in Figure 5-6C (where 
fitness was assessed very early after spore germination). paf1Δ and ctr9Δ 
demonstrated a strong synthetic sick phenotype with cdc13-1 at 23°C (Figure 6-1). I 
conclude that distinct members of the PAF1 complex play specialized roles in both 
telomere proficient and telomere defective cells.  
6.2.2. Loss of CDC73 in telomere defective strains leads to telomere 
rearrangements 
Telomerase-defective yeast cells use recombination dependent mechanisms to 
rearrange telomeres and bypass the need for telomerase (Lundblad and Blackburn 
1993). It was previously shown that cdc13-1 tlc1Δ strains, lacking telomerase, and 
with rearranged telomeres, grew better than comparable cdc13-1 cells (Tsai et al. 
2002). Furthermore cells with rearranged telomeres can tolerate complete loss of 
CDC13 (Larrivee and Wellinger 2006). Therefore I hypothesised that the cdc73Δ 
cdc13-1 strains shown in Figure 6-1 might be very fit when compared to the high-
throughput data (Figure 3-1A), because the telomeres had rearranged. Consistent 
with this hypothesis, cdc73Δ strains have short telomeres due to low telomerase 
RNA levels (Figure 5-4) (Mozdy et al. 2008). Additionally, in low-throughput 
experiments, many more cell divisions between spore germination on tetrad 
dissection plates and fitness measurements occur than in typical genome-wide 
experiments and this might provide time for telomere rearrangements to occur. 
Consistent with my hypothesis, cdc73Δ cdc13-1 and cdc73Δ yku70Δ strains each 
showed extensively rearranged telomeres, similar to other telomere defective strains, 
mre11Δ yku70Δ and tlc1Δ cells (Figure 6-2B, lanes 9-12). As previously reported,  
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Figure 6-1 Paf1 and Ctr9, but not Cdc73, are needed for fitness of telomere 
defective cells. Serial dilutions (5-fold) of saturated overnight cultures, grown at 
23°C, were spotted onto YEPD plates and incubated for 2 days at the indicated 
temperatures. All strains at each temperature were grown on a single plate but have 
been cut and pasted to allow better comparisons. 
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cdc73Δ strain telomeres were short but not as short as yku70Δ strains (Figure 6-2B, 
lanes 7-8) (Mozdy et al. 2008).  
To possibly relate fitness changes to telomere rearrangements, cdc73Δ yku70Δ and 
cdc73Δ yku80Δ cells were passaged three times and their telomere structure was 
assessed by Southern blot (Figure 6-2C-E). Figure 6-2D shows that both cdc73Δ 
yku70Δ and cdc73Δ yku80Δ cells form colonies of variable sizes by passage 1 (with 
mainly small colonies), recovering by passage 3. Accordingly, cdc73Δ yku70Δ 
telomeres seem to lose terminal fragments and become rearranged with increasing 
passage (Figure 6-2E). Also, it is noticeable at passage 1 that telomeres of cdc73Δ 
yku70Δ and cdc73Δ yku80Δ cells are shorter than telomeres of yku70Δ cells, 
reinforcing the idea that initial cdc73Δ yku70Δ reduced cell fitness is related to 
telomere defects. Again, cdc73Δ cells show slightly shorter telomeres than WT cells 
(Figure 6-2E). I conclude that lack of CDC73 in telomere defective cells (yku70Δ and 
cdc13-1) leads to telomere rearrangements. Therefore, telomere rearrangements in 
cdc73Δ cdc13-1 cells could explain the comparatively high fitness of these cells 
when compared to paf1Δ cdc13-1 and ctr9Δ cdc13-1 cells. 
6.2.3. cdc73Δ cdc13-1 cells recover from fitness defects faster than paf1Δ 
cdc13-1 or ctr9Δ cdc13-1 
cdc73Δ, paf1Δ and ctr9Δ cells have lower TLC1 levels and consequently have 
shorter telomeres (Figure 5-4) (Mozdy et al. 2008). Telomere rearrangements in 
cdc73Δ cdc13-1 cells were confirmed in Figure 6-2 and are very likely to be the 
reason why those cells are so fit. Since paf1Δ and ctr9Δ cause similar telomere 
shortening to cdc73Δ it is possible that paf1Δ cdc13-1 and ctr9Δ cdc13-1 can also 
recover from the extensive fitness defects. To test this hypothesis, cdc73Δ cdc13-1 
and paf1Δ cdc13-1 cells were passaged several times (Figure 6-3A). Additionally, the 
fitness at different passages was assessed by spot test (Figure 6-3B). 
Figure 6-3 shows that cdc73Δ cdc13-1 cells do not present fitness defects at any 
passage (in agreement with the results in Figure 5-3). Also cdc73Δ cdc13-1 cells are 
able to grow at high temperatures from very early passages, suggesting that they 
rearrange their telomeres very early (Figure 6-3B). On the other hand, at 23°C, paf1Δ 
cdc13-1 cells are very unfit at passages 1 and 2, and slightly recover by passage 3. 
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Figure 6-2 cdc73Δ induces telomere rearrangements in telomere defective 
cells. A) The locations of a telomere Southern blot probe as well as XhoI sites 
(adapted from Maringele and Lydall 2004). The probe recognizes both Y’ and TG 
sequences. Distance from the centromeric start of the TG repeats is indicated. B) 
Two independent strains for each genotype were analysed by Southern blot using 
the probe in A) mre11Δ yku70Δ and tlc1Δ strains are type I and type II survivors, 
respectively (Maringele and Lydall 2004). SYBR safe staining used as loading 
control. The strains used were: WT, 8460 and 3001; cdc13-1, 1108 and 1195; 
yku70Δ,1412 and 1366; cdc73Δ, 8490 and 8491; cdc73Δ cdc13-1, 8494 and 8495; 
and cdc73Δ yku70Δ, 8594 and 8595. C) Passage tests were performed by taking 
cells directly from germination plates and spreading them onto a fresh YEPD plate 
(passage 1). The plates were incubated at 30°C for 2 days, and then a pool of 
colonies passaged to a new fresh YEPD plate (passage 2). D) Representative 
colony or group of colonies for each strain passaged in C). For each passage the 
colonies shown were on the same plate. E) Telomere Southern blot as described in 
B). Strains used were: WT, 8460; cdc73Δ, 8490 and 8491. cdc73Δ yku70Δ cells 
were from fresh germination plates and not given strain numbers. 
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Interestingly, although paf1Δ cdc13-1 cells seem to recover fitness with increasing 
passages at 23°C (Figure 6-3A), those cells never grow at non-permissive 
temperatures (as for example cdc73Δ cdc13-1 cells) (Figure 6-3B). This suggests 
that paf1Δ cdc13-1 cannot tolerate the telomere defects caused by cdc13-1. Thus, 
Paf1 might be needed for the fitness of cells with rearranged telomeres. Therefore, it 
is important to confirm that the paf1Δ cdc13-1 cells with improved fitness indeed 
have telomere rearrangements. I conclude that Cdc73 plays a role decreasing the 
fitness of cdc13-1 telomere defective cells. On the other hand, Paf1 increases the 
fitness of cdc13-1 cells. Also, I suggest that Cdc73 and Paf1 (like Ctr9) affect 
telomere biology by a pathway independent of TLC1 RNA regulation. 
6.2.4. Paf1 and Ctr9, but not Cdc73, reduce TERRA levels 
In principal, the short telomere phenotype of cdc73Δ cells, in combination with a 
cdc13-1 induced telomere defect, explains the rapid telomere rearrangements and 
high fitness of cdc73Δ cdc13-1 cells. However, cdc73Δ, paf1Δ and ctr9Δ mutations 
each similarly decrease TLC1 RNA levels and telomere length, while leo1Δ and rtf1Δ 
have smaller effects on TLC1 levels and telomere length (Figure 5-4) (Mozdy et al. 
2008). Yet, Figure 6-1 and Figure 6-3 show that cdc73Δ cdc13-1 cells were very fit, 
and in contrast paf1Δ cdc13-1 and ctr9Δ cdc13-1 cells were very unfit, suggesting 
that these fitness phenotypes were unrelated to TLC1 levels or telomere length.  
Telomere rearrangements occur in telomere defective cells via homologous 
recombination in both mammals and yeast (Bryan et al. 1997; Teng and Zakian 
1999). TERRA (telomeric repeat containing RNA) has been suggested to facilitate 
this recombination, due to the presence of recombination stimulatory RNA-DNA 
hybrids between TERRA and telomeric DNA (Balk et al. 2013; Arora et al. 2014). 
Therefore, it was hypothesized that the effects Cdc73, Paf1 and Ctr9 have on 
TERRA levels might explain the fitness differences between cdc73Δ cdc13-1 versus 
paf1Δ cdc13-1 and ctr9Δ cdc13-1 strains. To test this hypothesis, TERRA levels 
were measured in cdc73Δ, paf1Δ, ctr9Δ, leo1Δ and rtf1Δ strains, as well in sir4Δ 
strains, previously reported to affect TERRA levels (Iglesias et al. 2011). In addition 
yku70Δ and mre11Δ strains with short telomere phenotypes were examined since 
cdc73Δ, paf1Δ and ctr9Δ strains have short telomeres and shortening telomeres 
were suggested to induce TERRA (Cusanelli et al. 2013; Moravec et al. 2016). 
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Figure 6-3 cdc73Δ cdc13-1 do not show fitness defects while paf1Δ cdc13-1 
recover from severe fitness defects by passage 3. A) Passage tests were 
performed as described in Figure 6-2C with the difference that plates were 
incubated at 23°C for 4 days. a, b and c correspond to the strains examined by spot 
test in B). B) A pool of colonies from the strains in A) was inoculated in liquid media, 
grown overnight at 23°C and the fitness was assessed by spot test at different 
temperatures. cdc73Δ and paf1Δ strains at each temperature were grown on a 
single rectangular plate. No strains originated from this experiment were given strain 
numbers. 
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TERRA from several telomeres, including 1L, 10R, 13R and 15L, was measured and 
the results are shown in Figure 6-4. It was found that Paf1 and Ctr9 strongly repress 
TERRA levels, while other PAF1 components had much smaller effects (Figure 6-4B-
G). As previously reported sir4Δ caused increased TERRA levels to values very 
similar to those of paf1Δ and ctr9Δ (Iglesias et al. 2011). Additionally, mre11Δ and 
yku70Δ (which have short telomeres) slightly increased TERRA levels (Figure 6-4D-
G). 
Short telomeres are expected to induce TERRA transcription to promote telomerase 
recruitment and consequent telomere elongation (Cusanelli et al. 2013; Moravec et 
al. 2016). cdc73Δ cells have short telomeres but TERRA levels similar to WT cells 
(Figure 5-4, Figure 6-2 and Figure 6-4) (Mozdy et al. 2008). Since Cdc73 is involved 
in the direct interaction of the PAF1 complex to RNA pol II, I hypothesised that Cdc73 
is required for TERRA transcription (Mueller and Jaehning 2002; Mueller et al. 2004). 
To test this hypothesis, TERRA levels of cdc73Δ paf1Δ and cdc73Δ ctr9Δ cells were 
measured. Deletion of CDC73 in paf1Δ or ctr9Δ cells did not decrease TERRA levels 
(Figure 6-4 D-G), showing that Cdc73 is not needed for high TERRA levels in these 
contexts.  
Figure 6-4H and I shows that Paf1 and Ctr9 do not affect TERRA levels in telomeres 
that contain Y’ repeats. Sir4, involved in histone deacetylation, as reported before, 
does not affect TERRA levels in Y’-telomeres (TERRA in Y’-telomeres was 
suggested to be regulated by Rap1, through Rif1 and Rif2) (Figure 6-4H, I) (Iglesias 
et al. 2011). The lack of increased TERRA from Y’ telomeres together with the similar 
increased TERRA from X telomeres in paf1Δ, ctr9Δ and sir4Δ cells, suggests that 
Paf1 and Ctr9 might regulate TERRA through a similar pathway to Sir4. 
I conclude that Paf1 and Ctr9, but not Cdc73, Rtf1 and Leo1, repress TERRA levels. 
Also, the idea that short telomeres cause increased TERRA levels is not verified in 
cdc73Δ cells, which have short telomeres, but normal levels of TERRA. 
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Figure 6-4 Paf1 and Ctr9, but not Cdc73, repress TERRA expression. A) The 
TERRA loci (blue) on different telomeres (for example telomere 1L, TEL01L) 
amplified during qRT-PCR TERRA measurements. Genes used to assess silencing 
(Figure 6-10) are represented in purple. Distance from the centromeric start of the 
TG repeats is indicated. B-I) RNA from two independent strains of each genotype 
was measured by qRT-PCR. The “error” bars indicate the means of the two strains 
analysed. Each value was normalized to ACT1 mRNA. Values in B) and C) are from 
an independent experiment from D) to I). Strains used were: WT, 8460 and 3001; 
cdc73Δ, 8490 and 8491; paf1Δ, 8757 and 8758; ctr9Δ, 8751 and 8752; leo1Δ, 8736 
and 8737; rtf1Δ, 8743 and 8744; sir4Δ, 5692 and 5693; cdc73Δ paf1Δ, 10959 and 
10960; cdc73Δ ctr9Δ, 10961 and 10962; yku70Δ, 1412 and 1366; and mre11Δ, 2041 
and 4457. 
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6.2.5. Telomere length is not a main regulator of TERRA expression in PAF1 
complex mutants 
The length of yeast telomeres has a heterogeneous nature, varying inside a cell 
population, but also between the telomeres inside the same cell (Shampay and 
Blackburn 1988). Such heterogeneity requires mechanisms of sensing and 
responding to the telomere shortening of a single telomere. TERRA was suggested 
to play such role, being more expressed upon telomere shortening in order to 
nucleate telomerase and promote telomere lengthening in cis (Cusanelli et al. 2013; 
Moravec et al. 2016).  
Since cdc73Δ cells were shown to have, on average, short telomeres, but no 
increase in TERRA levels, I hypothesized that perhaps the particular telomeres 
analysed for TERRA were not short in cdc73Δ cells. To test this hypothesis and to 
test the correlation between TERRA and telomere length, the cells that were 
analysed for TERRA in Figure 6-4 were also analysed for telomere length of the 
telomeres from where TERRA was expressed (Figure 6-5). Telomere length was 
measured by Southern blot using probes against the Y’+TG repeats (for overall 
telomere length assessment) and the 1L, 15L, 10R and 13R telomeres.  
Figure 6-5 shows that, the overall telomere length measured using the Y’+TG probe 
is representative of the telomere lengths of the 1L, 15L, 10R and 13R telomeres. 
cdc73Δ (lanes 3 and 4), paf1Δ (lanes 5 and 6) and ctr9Δ (lane 7) cells have equally 
short telomeres (but differently affect TERRA, Figure 6-4). yku70Δ (lanes 8-10), 
yku80Δ (lanes 19 and 20) and mre11Δ (lanes 11 and 12) have shorter telomeres but 
less TERRA RNA than paf1Δ and ctr9Δ cells. Telomeres of cdc73Δ paf1Δ (lanes 15 
and 16) and cdc73Δ ctr9Δ (lanes 17 and 18) cells are as short as the single mutants 
(and have TERRA levels similar to those of paf1Δ and ctr9Δ cells, Figure 6-4). rif1Δ 
(lane 25) telomere length was measured as a control for long telomeres (Teixeira et 
al. 2004). Interestingly, and opposite to previously published data, sir4Δ cells (lanes 
13 and 14) have slightly long telomeres (Hass and Zappulla 2015). The reason for 
the difference between my data and previously published data is unclear, but my 
data shows that sir4Δ cells with long telomeres can have high TERRA levels. 
I conclude that there is little correlation between telomere length and TERRA levels 
between cdc73Δ, paf1Δ, ctr9Δ, mre11Δ, yku70Δ or sir4Δ cells (Figure 6-4 and Figure 
6-5). 
176 
 
177 
Figure 6-5 Telomere length in strains with PAF1 components deleted. A) 
Cartoon representing the annealing sites of the probes used in B) (red) and the 
TERRA loci (blue) analysed in Figure 6-4. B) Telomeric Southern blot performed 
after XhoI (top 3 panels) or HindIII (bottom 3 panels) digestion. The DNA digested 
with XhoI was first probed for telomere 15L and then for Y’+TG sequences. The DNA 
digested with HindIII was first probed for telomere 1L and then for telomeres 10R 
and 13R. The DNA analysed is from the same cultures that originated the data in 
Figure 6-4 (one exponentially growing culture was divided into two pellets used to 
extract either RNA or DNA). yku80Δ strains are 4310 and 4311; cdc73Δ yku70Δ, 
8594 and 8595; cdc73Δ yku80Δ, 8702 and 8703; rif1Δ, 4451. The remaining strain 
numbers are the same as in Figure 6-4.  
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6.2.6. RNH1 overexpression does not affect paf1Δ cdc13-1 fitness 
Elevated TERRA levels might lead to increased levels of RNA-DNA hybrids (between 
TERRA and the telomere end). RNA-DNA hybrids, or R-loops, are created when an 
RNA molecule anneals to DNA (Thomas et al. 1976). In yeast, RNA-DNA hybrids are 
eliminated by RNase H1 and RNase H2, whose catalytic subunits are encoded by 
RNH1 and RNH201, respectively (Arudchandran et al. 2000; Jeong et al. 2004). R-
loops, are a physical barrier for replication causing activation of the DDR and 
genomic instability (Gan et al. 2011). For example, while the RNA anneals to one of 
the dsDNA molecules, the exposure of the remaining ssDNA molecule can activate 
the DDR (Skourti-Stathaki and Proudfoot 2014). Additionally, accumulation of 
telomeric RNA-DNA hybrids was shown to lead to telomere loss and cellular 
senescence (Balk et al. 2013).  
In section 6.2.4 I showed that Paf1 and Ctr9 repress TERRA levels, while Cdc73 
does not. Furthermore, deletion of PAF1 and CTR9 in a telomere defective 
background (cdc13-1) causes extensive fitness defects while deletion of CDC73 
does not (Figure 6-1). Therefore, I hypothesised that paf1Δ cdc13-1 and ctr9Δ cdc13-
1 cells grow poorly due to an increased number of R-loops which exacerbate cdc13-1 
telomere defects. To test this hypothesis, RNH1 (which resolves RNA-DNA hybrids) 
was overexpressed in a plasmid in paf1Δ cdc13-1 cells (Figure 6-6).  
Figure 6-6 shows that overexpression of RNH1 does not cause visible changes in the 
fitness of paf1Δ and cdc13-1 cells when compared to the cells containing the empty 
vector. Data for paf1Δ cdc13-1 cells are unclear since those cells are extremely sick 
at any temperature. Lack of effect of RNH1 expression in paf1Δ cell fitness could 
suggest that RNA-DNA hybrids are not the reason for the poor growth of paf1Δ 
cdc13-1 and ctr9Δ cdc13-1 cells. However, this experiment lacks a positive control (a 
strain whose fitness undoubtedly benefits from RNH1 overexpression). Thus, in the 
experiment in Figure 6-6 one does not know if overexpression of RNH1 is indeed 
decreasing the levels of RNA-DNA hybrids in paf1Δ cdc13-1 cells. 
I conclude that overexpression of RNH1 in paf1Δ cdc13-1 cells does not cause 
fitness changes. However, whether this is informative about the role of RNA-DNA 
hybrids in cell fitness is unclear. 
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Figure 6-6 RNH1 overexpression does not affect paf1Δ cdc13-1 fitness. The 
strains indicated were independent strains picked from plasmid-bearing spores (from 
diploid DDY598 transformed with pDL1702 or pDL1703). Serial dilutions of the cell 
cultures were spotted on –Ura plates and grown for 5 days before photographing. 
The strains shown do not have strain numbers since they were not frozen. All strains 
at each temperature were grown on a single plate. 
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6.2.7. Paf1 and Ctr9 repress TERRA independently of the Sir complex 
The effects of Paf1 and Ctr9 on TERRA were as strong as Sir4, one of the strongest 
known repressors of TERRA (Figure 6-4) (Iglesias et al. 2011). This led to the 
speculation that Paf1/Ctr9 and the Sir complex regulate TERRA through the same 
pathway. To test this, TERRA levels in sir4Δ paf1Δ and sir4Δ ctr9Δ double mutants 
was assessed (Figure 6-7). Interestingly, sir4Δ paf1Δ and sir4Δ ctr9Δ cells had 
TERRA levels 4 to 8 times higher than the corresponding single mutants. This shows 
that Paf1/Ctr9 represses TERRA through a pathway that is independent of the Sir 
complex. Figure 6-7E shows that the increased levels of TERRA in paf1Δ and ctr9Δ 
cells (compared for instance with cdc73Δ cells) are not due to differences in the 
amount of DNA from where the TERRA is being expressed (caused for example by 
deletions or duplications of a chromosome portion).  
Reports in S. cerevisiae show that increased TERRA expression causes telomere 
shortening while reports in S. pombe suggest that higher TERRA expression 
increases telomere length (Pfeiffer and Lingner 2012; Moravec et al. 2016). Since 
paf1Δ sir4Δ and ctr9Δ sir4Δ cells had extremely high TERRA levels (higher than 
each single mutant), I next tested how TERRA levels correlate with telomere length 
in those cells. Figure 6-8 shows that disruption of SIR4 further reduced the length of 
the already short telomeres of paf1Δ, ctr9Δ or cdc73Δ cells. This suggests that in 
paf1Δ sir4Δ and ctr9Δ sir4Δ cells there is indeed a correlation between high TERRA 
levels and short telomeres. Interestingly, deletion of DOT1 (involved in telomere 
silencing, like SIR4) caused slightly longer telomeres than the WT, just like sir4Δ 
(Figure 6-8) (Takahashi et al. 2011b). Such result supports a model where disruption 
of telomere silencing promotes telomere lengthening (more like what is observed in 
S. pombe).  
I conclude that Paf1 and Ctr9 repress TERRA independently of the Sir complex. I 
also found a correlation between extremely high levels of TERRA and very short 
telomere length in paf1Δ sir4Δ and ctr9Δ sir4Δ cells. However it is not clear which 
feature appears first: if short telomeres cause high TERRA, or if high TERRA causes 
telomere shortening (data in literature is also not concordant in this matter). 
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Figure 6-7 Paf1 and Ctr9 repress TERRA expression independently of the Sir 
complex.  A - D) RNA from two independent strains of each genotype was 
measured by qRT-PCR. The “error” bars indicate the means of the two strains 
analysed. Each value was normalized to ACT1 mRNA. E) qPCR analysis of Y’3, 
TEL01L and TEL15L loci. DNA from two independent strains of each genotype was 
measured. The “error” bars indicate the two positions of the means of the two strains 
analysed. Each value was normalized to the levels of ACT1 DNA. WT, paf1Δ, ctr9Δ 
and sir4Δ strain numbers are the same as in Figure 6-4. sir4Δ paf1Δ strains are 
11154 and 11155 and sir4Δ ctr9Δ strains are 11156 and 11157. 
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Figure 6-8 sir4Δ shortens paf1Δ and ctr9Δ telomeres. Telomeric Southern blot 
performed as described in Figure 6-2. Strain numbers as described in Figure 6-4 
and Figure 6-7. yku70Δ mre11Δ strain is 1845; tlc1Δ is 2146; and dot1Δ are 7850 
and 7851. 
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6.2.8. Paf1, Ctr9 and Cdc73 have distinct roles in telomere silencing 
The PAF1 complex binds RNA pol II and controls RNA levels via a number of routes 
including regulation of histone modifications, transcription, poly(A) processing and 
promoter-proximal pausing of RNA pol II (Penheiter et al. 2005; Crisucci and Arndt 
2011; Chen et al. 2015). Systematic analysis of paf1Δ and ctr9Δ strains shows that 
the PAF1 complex reduces about three times as many transcripts as it increases 
(Penheiter et al. 2005). Interestingly, in the context of regulating TERRA levels, Paf1 
and Rtf1 have been reported to help silence telomeres (Krogan et al. 2003a). 
Therefore, it was hypothesised that the PAF1 complex could be regulating TERRA 
levels by silencing telomeres through a parallel pathway to the Sir complex. To test 
telomere silencing, URA3 expression near the 7L telomere was measured (Figure 
6-9) (Gottschling et al. 1990; Fourel et al. 1999).  
Figure 6-9B shows that paf1Δ, ctr9Δ and rtf1Δ cells were unable to silence 
expression from the telomere 7L while cdc73Δ and leo1Δ cells were proficient at 
silencing. These results confirm and extend previous experiments that showed that 
Paf1, Ctr9 and Rtf1 promote telomere silencing (the role of other members of the 
PAF1 complex was not tested) (Krogan et al. 2003a; Marton and Desiderio 2008). 
Once again it was observed that different PAF1 complex components have different 
functions. Furthermore there was a clear lack of correlation between telomere 
silencing and TERRA expression, in particular rtf1Δ cells were perhaps the most 
defective at silencing 7L (most similar to sir4Δ mutants), but had very small effects on 
TERRA levels (Figure 6-4). It was however plausible that the lack of correlation 
between silencing and TERRA levels was an artefact of the artificial telomere used to 
measure silencing. 
Interestingly, sir4Δ suppressed the fitness defects of paf1Δ and ctr9Δ cells at 34°C 
(Figure 6-9, SC media), even though paf1Δ sir4Δ and ctr9Δ sir4Δ cells have shorter 
telomeres than paf1Δ or ctr9Δ cells (Figure 6-8). Perhaps it is relevant to note that 
rtf1Δ, which is important for telomere silencing (Figure 6-9), also represses paf1Δ 
fitness defects (Mueller and Jaehning 2002; Krogan et al. 2003a). Therefore one 
hypothesis is that loss of telomere silencing increases paf1Δ and ctr9Δ cell fitness 
(maybe due to chromatin remodelling caused by an unbalanced acetylation/ 
methylation ratio).  
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Figure 6-9 Paf1, Ctr9 and Rtf1, but not Cdc73 and Leo1, affect telomere 
silencing. A) Insertion of a URA3 gene at the ADH4 locus to measure telomere 
silencing (Gottschling et al. 1990; Fourel et al. 1999). B) Silencing was measured by 
growth on plates lacking uracil (-URA), containing 5-Fluoroorotic acid (5-FOA) or 
synthetic complete media (SC). All strains have the TEL07L::URA3 construct. All 
strains at each temperature were grown on a single plate. 
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I conclude that Paf1, Ctr9 and Rtf1 promote telomere silencing, while Cdc73 and 
Leo1 do not. Such conclusion is in agreement with previously reported data, although 
my data is the first systematic analysis of the role of each PAF1 complex component 
in telomere silencing. 
6.2.9. Paf1 and Ctr9 repress TERRA transcription more than other telomeric 
transcripts  
To further investigate the relationship between TERRA and silencing I examined 
natural telomere silencing by measuring transcripts from telomeres 1L (YAL068W-A) 
and 15L (YOL166W-A) (Figure 6-10). To distinguish gene silencing from TERRA, 
transcripts on opposite strands were measured (Figure 6-10A). Interestingly, at 
natural telomeres, the roles of Paf1 and Ctr9 were different to Rtf1 and to Sir4. As 
expected sir4Δ cells show high levels of both telomeric ORF transcripts and TERRA, 
consistent with a general telomere-silencing defect. paf1Δ and ctr9Δ cells showed 
moderately increased ORF transcript levels near telomeres, but much larger increase 
of RNA from the opposite strand (TERRA) (sir4Δ, paf1Δ and ctr9Δ have similarly high 
TERRA). This confirms the idea that Paf1 and Ctr9 strongly repress TERRA but have 
a weaker effect on general telomeric gene silencing, which is consistent with the spot 
test assays in Figure 6-9. Interestingly, Rtf1 had a similar effect to Paf1 and Ctr9 in 
repressing YAL068W-A transcription at the 1L telomere, and barely any effect on 
YOL166W-A transcription, suggesting a role for Rtf1 in telomere silencing, but not in 
TERRA transcription. 
I conclude that Paf1, Ctr9 and Rtf1 contribute broadly and similarly to telomere gene 
silencing, while Cdc73 and Leo1 do not. However, Paf1 and Ctr9 strongly repress 
TERRA, by a Sir4-independent pathway, while Cdc73, Leo1 and Rtf1 play smaller 
roles repressing TERRA. 
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Figure 6-10 Paf1 and Ctr9 repression of telomeric transcript does not perfectly 
correlate with TERRA repression.A) To compare transcription from ORFs in the 
AC-rich (antisense) strand (YAL068W-A) versus the TG-rich (sense) strand 
(TERRA), two independent cDNA synthesis reactions were performed. For 
YAL068W-A mRNA measurements, the reverse primer (m4274) was used. For 
TERRA measurements, the forward primer (m4273) was used. qPCR was then 
performed to each cDNA using both forward and reverse primers. B and C) qRT-
PCR to measure telomeric RNA at YAL068W-A (B) and YOL166W-A loci (C), as 
described in A). Purple bars represent the transcription from the AC-rich DNA strand 
and blue bars represent transcription from the TG-rich DNA strand (TERRA). RNA 
from two independent strains of each genotype was measured and “error” bars 
indicate the means of the two strains analysed. Each value was normalized to ACT1 
mRNA. Strain numbers as described in Figure 6-4. 
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6.2.10. The PAF1 complex does not regulate mating locus silencing 
To test if the PAF1 complex components also affect mating type locus silencing I 
quantified the expression of the a1 factor in MATα strains (Figure 6-11). If the mating 
type locus is properly silenced, MATα cells should not express the a1 factor from the 
mating type locus, since a1 is only expressed in MATa cells (Herskowitz 1989). 
Figure 6-11 shows that indeed deletion of each of the PAF1 complex components in 
Matα strains did not affect repression of the a1 factor in those cells.  
I conclude that, opposite to what happens at telomeres, none of the PAF1 complex 
components promote, or is essential, for mating locus silencing. I suggest that the 
PAF1 complex play a specialized role at telomeres, perhaps by interaction with 
telomeric proteins. 
6.2.11. Paf1 promotes RNA, especially TERRA, degradation 
RNA levels can be regulated by at least two different ways: transcription and 
degradation. The Sir complex, a histone deacetylase complex, represses 
transcription and regulates TERRA by this pathway (Iglesias et al. 2011). Paf1 and 
Ctr9 were shown to repress TERRA by an independent pathway to the Sir complex 
(Figure 6-7) and were also shown to repress TERRA more strongly than telomere 
ORFs (Figure 6-10). Consequently, I hypothesised that Paf1 and Ctr9 were 
repressing TERRA by promoting TERRA degradation. To test this hypothesis, RNA 
decay was measured in paf1Δ versus WT cells using the Anchor-Away technique 
(Haruki et al. 2008). In the version of the Anchor-Away technique used here, a 
subunit of RNA pol II (Rpb1) is removed from the nucleus upon addition of 
rapamycin, stopping transcription (Haruki et al. 2008). This allows the determination 
of the RNA half-life for different transcripts (Table 6-1, Figure 6-12). 
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Figure 6-11 Deletion of PAF1 components in MATα cells does not affect a1 
mRNA levels. qRT-PCR analysis of a1 RNA expressed from the MAT locus. One 
strain for each mating type was used. Data is presented in the Log10 scale. Strains 
are as described in Figure 6-4. For each genotype the smaller strain number 
corresponds to the MATa strain. 
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Figure 6-12 shows that in WT (Anchor-Away background) or paf1Δ cells addition of 
DMSO did not cause major changes in RNA levels. In WT cells addition of rapamycin 
caused the RNA to decrease over time suggesting that indeed transcription stopped 
after rapamycin addition (Figure 6-12). Additionally, in WT cells, TERRA half-life was 
similar to ACT1 and BUD6 mRNA (housekeeping) (Table 6-1). Interestingly, in paf1Δ 
cells, an overall increase in RNA half-life was observed, with the half-life of 
housekeeping genes increasing 2 to 6 fold (Table 6-1). However, a much more 
severe effect on TERRA half-life could be observed in paf1Δ cells, with basically no 
degradation of TERRA from telomeres 1L, 10R and 15L, corresponding to a 600 fold 
increase in half-life of TERRA RNA (Figure 6-12 and Table 6-1).  
I concluded that Paf1 (and presumably Ctr9) repress TERRA levels likely by 
promoting RNA degradation. I also show that Paf1 promotes degradation of RNAs 
throughout the genome but plays a stronger role at telomeres. The stronger effect at 
telomeres is in agreement with the role of the PAF1 complex in silencing telomeres 
but not the mating type locus (Figure 6-9 and Figure 6-11). I suggest that the PAF1 
complex plays a specialized role at telomeres. 
 
Table 6-1 RNA half-life. RNA half-life was calculated as described in Materials and 
Methods using the graphs in Figure 6-12. A half-life of 20000 min was given when 
no RNA decrease was observed over 60 min (a positive slope was observed). Fold 
changes of the paf1Δ half-life relative to the WT averages can be found in brackets. 
N. d., not determined.  
 Half-life (min) 
 WT 1 (11213) WT 2 (11213) paf1Δ (11218) paf1Δ (11232) 
ACT1 25 26 85 (3.3X) 45 (1.8X) 
BUD6 15 17 91 (5.6X) 104 (6.5X) 
1L TERRA 21 21 19694 (938X) 68 (3.2X) 
10R TERRA 36 N. d. 20000 (555X) 20000 (555X) 
15L TERRA 21 32 20000 (755X) 20000 (755X) 
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Figure 6-12 Paf1 promotes RNA degradation. qRT-PCR of ACT1, BUD6 and 
TERRA from 3 different telomeres (1L, 10R and 15L) in WT and paf1Δ strains (in the 
Anchor-Away background). Total RNA was isolated from cells harvested at 0, 10, 
20, 40 and 60 min after rapamycin (blue) was added to the media or 0, 20, 40 and 
60 min after addition of DMSO (red). RNA levels were measured for each time-point 
and normalized for the amount of 7S RNA. The fold change from the 0 min time 
point was obtained and the data was plotted as a function of time starting from the 
10 min time-point. The line that best represent each set of data is represented 
(defined by Microsoft Excel) and the equation (y=mx+b) of the line for the rapamycin 
experiment is shown. Two independent experiments were performed: experiment 1: 
WT1 (11213) and paf1Δ (11218); experiment 2: WT2 (11213) and paf1Δ (11232).  
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6.2.12. Nmd2 and Ski2 do not strongly affect TERRA levels 
RNA quality control is an essential mechanism to maintain cell function as it prevents 
the generation of defective proteins (van Hoof and Wagner 2011). mRNA quality is 
assessed at various stages, from transcription initiation/elongation, to splicing and 
polyadenylation (Garneau et al. 2007). Consequently, the cell has a variety of mRNA 
surveillance-pathways acting both in the nucleus as well as in the cytoplasm 
(Garneau et al. 2007). Since Paf1 (and likely Ctr9) is repressing TERRA levels at 
least in part by promoting its degradation I decided to measure TERRA levels in cells 
defective in two independent mRNA decay pathways: the nonsense-mediated mRNA 
decay and the cytoplasmic exosome. 
Figure 6-13 shows that NMD2 (part of the nonsense-mediated mRNA decay) deletion 
slightly increases TERRA RNA from 1L and 15L but to a much lesser extent than 
PAF1 deletion. SKI2 (adaptor of the cytoplasmic exosome) deletion did not affect 
TERRA levels at telomeres 1L or 15L. I conclude that Paf1 represses TERRA by 
promoting its degradation by a pathway that is likely independent of the nonsense-
mediated mRNA decay and the cytoplasmic exosome-dependent pathways. 
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Figure 6-13 Nmd2 weakly represses TERRA and Ski2 does not affect TERRA. 
qRT-PCR analysis of TERRA RNA in nmd2Δ (A) and ski2Δ (B) strains. Strain 
numbers are: WT, 8460 and 3001; paf1Δ, 8757 and 8758; nmd2Δ, 4528 and 4765; 
paf1Δ nmd2Δ, 10117 and 10118; and ski2Δ, 8844 and 8845.  
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6.3. Discussion 
In order to understand the role of the different components of the PAF1 complex in 
telomere biology, each component was assessed for a role in: a) fitness of telomere 
defective cells; b) telomere length; and c) TERRA regulation. I could clearly show 
that components of the PAF1 complex play distinct roles in regulating telomere 
biology, as summarised in Figure 6-14A. Paf1 and Ctr9 contribute most to fitness of 
wild-type cells and telomere defective cdc13-1 cells. Interestingly, Cdc73, which like 
Paf1 and Ctr9 affects telomerase levels, has the opposite effect and reduces fitness 
of cdc13-1 cells. Leo1 and Rtf1 have minimal effects on fitness. Paf1 and Ctr9 
strongly reduce TERRA levels, while Cdc73, Leo1 and Rtf1, the other PAF1 
components, play a minor role in this context. Paf1, Ctr9 and Rtf1 affect telomere 
gene silencing while Cdc73 and Leo1 do not. Overall the data in this Chapter 
suggests that Paf1 and Ctr9 are the core components of the Paf1 complex, affecting 
TERRA and with other components affecting specific aspects of telomere biology 
such as telomere silencing and TLC1 RNA levels. 
I propose a model where the PAF1 complex affects telomere function by at least 
three pathways (p1, p2, p3) (Figure 6-14). p1 affects TERRA levels, p2 affects 
histone modifications and transcription, but does not greatly affect TERRA, and p3 
affects TLC1 RNA abundance and therefore telomerase activity. My experiments 
show that the Paf1/Ctr9 dependent p1 affects TERRA levels through an alternative 
pathway to the Sir complex. RNA decay experiments suggested that p1 promotes 
TERRA degradation. Paf1, Ctr9 and Rtf1-dependent p2 affects silencing and is 
distinguished from p1 by the fact Rtf1 effects on TERRA are much milder than 
Paf1/Ctr9 (Figure 6-14A). Rtf1 is required for H3K4 and H3K79 methylation, via 
recruitment of COMPASS and Dot1 (Krogan et al. 2003a) and p2 might work via this 
route. Paf1, Ctr9 and Cdc73 affect TLC1 RNA levels, telomerase activity and 
telomere length in p3.  
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Figure 6-14 The role the PAF1 complex components in telomere function. A) 
Effects caused by deletions of PAF1 complex components. “++++” are the values of 
“Fitness”, “TLC1/Telomere length”, “TERRA” or “Silencing” (first column) observed in 
WT cells. Mutations that cause a decrease in the parameters in the first column will 
have less “+” (shaded red), while more “+” (shaded green) represent an increase in 
the parameters in the first column. B) Model for how the PAF1 complex affects 
telomere biology. Paf1 and Ctr9 are needed for the integrity of the PAF1 complex 
and all its functions. A major role for Paf1 and Ctr9 is to affect TERRA levels (p1). A 
TERRA-TLC1 interaction impairs telomerase function causing fitness defects. Rtf1, 
Paf1 and Ctr9 stimulate histone methylation to reduce RNA Pol II transcription (p2). 
Cdc73, Paf1 and Ctr9, affect TLC1 levels (p3). Leo1 (gray) is the least important 
Paf1 component and has the mildest phenotypes. 
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How Paf1 promotes TERRA degradation (more than BUD6 and ACT1 mRNA for 
example) is not totally clear. One hypothesis is that lack of Paf1 function would 
decrease TERRA polyadenylation (in yeast all TERRA RNA is adenylated) (Luke et 
al. 2008). It has been suggested both in budding and fission yeast that 
polyadenylated TERRA does not tend to anneal to the telomere ends, while non-
adenylated, G-rich TERRA does (Porro et al. 2010; Moravec et al. 2016). It is 
possible that in paf1Δ cells TERRA is bound to the telomere more tightly (RNA:DNA 
hybrids), stabilizing and protecting it from degradation, and therefore increasing its 
half-life. A challenge to such a model is the fact that altered poly(A) tail length, by 
mutations in polyadenylation proteins, was shown to destabilize TERRA (Luke et al. 
2008; Porro et al. 2010). The RNA half-life increase in paf1Δ cells observed for ACT1 
and BUD6, must be related to an overall role of Paf1 controlling poly(A) tail length, 
but due to the special nature of TERRA and telomeres (a noncoding RNA), TERRA 
might be more strongly stabilized than other coding RNAs in paf1Δ cells. Additionally, 
the fact that in paf1Δ cells I cannot see an increase in ACT1 and BUD6 mRNA levels 
(while half-life increase 3-6 fold) suggests that cells can compensate for that 
increased half-life (maybe decreasing transcription rate). Another hypothesis is that 
Paf1 directly regulates the levels or presence at telomeres of a member of the RNA 
decay pathway, promoting TERRA degradation. A difference in effect at telomeres 
(TERRA) versus the remaining chromosome (BUD6 and ACT1) might be again due 
to the special composition in proteins/interactions at telomeres. I suggest that the 
PAF1 complex has an essential role maintaining telomere homeostasis particularly 
due the unique telomere microenvironment. 
Early experiments suggested that telomere length is not a major regulator of TERRA 
levels (Iglesias et al. 2011) while more recent experiments suggested that it might be 
(Arnoult et al. 2012; Cusanelli et al. 2013; Moravec et al. 2016). My data supports the 
view that telomere length is not a primary regulator of TERRA because there is little 
correlation between telomere length and TERRA levels in PAF1 complex mutants, 
mre11Δ or yku70Δ strains. However, interestingly it was observed that paf1Δ sir4Δ 
mutants, with very high levels of TERRA, had very short telomeres, suggesting that 
under certain conditions telomere length does relate to TERRA levels. Whether 
telomere shortening is a cause or consequence of increased TERRA levels, is not 
clear. 
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There are many reasons for yeast strains to grow poorly but the fitness defects 
caused by loss of PAF1, CTR9 or CDC73 can be partially rescued by overexpression 
of TLC1, showing that fitness defects are due at least in part to low levels of TLC1 
(Betz et al. 2002). It is notable that paf1Δ and ctr9Δ cells are less fit than cdc73Δ 
strains, both with and without cdc13-1. In the previous Chapter, Paf1 and Ctr9 were 
shown to be important to maintain low levels of TEN1 and STN1 mRNA. I suggest 
that the poor fitness caused by paf1Δ and ctr9Δ in telomere defective cells is 
because of the high levels of TERRA, Ten1 and Stn1. High levels of TERRA, Ten1 
and Stn1 in paf1Δ and ctr9Δ mutants could directly interfere with telomere capping 
function and/or further reduce the amount of active telomerase in such cells. TERRA 
inhibits telomerase activity in vitro (Redon et al. 2010) and telomerase contributes 
directly to making a functional telomere cap (Vega et al. 2007). Additionally, Ten1 
represses telomerase recruitment to the telomere (Qian et al. 2009a; Leehy et al. 
2013). It is also known that increased levels of TERRA can interact with Ku, even 
though this interaction does not affect the binding capacity of Ku to TLC1 or the 
telomere, it promotes telomere shortening (Pfeiffer and Lingner 2012) and consistent 
with this I have shown the very high levels of TERRA, in paf1Δ sir4Δ and ctr9Δ sir4Δ 
cells correlate with very short telomeres. Finally, telomeres have complex 
relationships with DNA damage proteins, because DNA damage proteins, like Ku, 
ATM and ATR, are important for telomere physiology, yet in the context of telomeres 
do not induce their usual DNA damage responses such as NHEJ or cell cycle arrest. 
The PAF1 complex too interacts with DDR proteins, to avoid replication-transcription 
fork collision (Poli et al. 2016). Perhaps in paf1Δ and ctr9Δ cells, the high levels of 
TERRA (causing R-loops, increasing transcription) and low levels of TLC1 (maybe 
slowing down telomere replication), together with less efficient mechanism to avoid 
replication-transcription fork collision, leads to replication block and activation of the 
DDR. Still, such a model might not explain how paf1Δ sir4Δ cells, with very short 
telomeres and very high TERRA levels are fitter than paf1Δ cells (that have longer 
telomeres and lower TERRA). 
The observation that loss of Cdc73 suppresses the fitness defects of telomere 
defective cdc13-1 strains is striking. Similar effects in human cells may help explain 
why large numbers of mutations in Cdc73, but not other PAF1 components, are 
found in human cancers (An et al. 2016). For instance, cdc73Δ cells are able to 
maintain cell division even when the telomeres are defective (which is a major signal 
for cell cycle arrest), just like cancer cells. It is perhaps the capacity of cdc73Δ cells 
199 
to maintain normal levels of TERRA, Ten1 and Stn1, that allows those cells to avoid 
extensive DDR activation upon Cdc13 inactivation. My results also clarified some of 
the specific roles of each PAF1 complex component, and reinforced the reason why 
this complex evolved to be as it is. For instance, the PAF1 complex plays such an 
important role promoting cell fitness through Paf1 and Ctr9, that it seems that Cdc73 
functions as a “brake”, to decrease fitness and avoid proliferation of defective cells. 
Since the PAF1 complex has such a broad role controlling the expression of so many 
transcripts, it just makes sense that the complex has its own “supervisor”, Cdc73, a 
protein with seemingly opposing functions to the main complex proteins. 
6.4. Future work 
Future work will be required to understand the mechanism(s) by which Paf1 and Ctr9 
promote TERRA degradation. Northern blot and/or sequencing could help 
understand if TERRA polyadenylation is altered in paf1Δ/ctr9Δ cells. Cross of rat1-1 
mutants, which are known to degrade TERRA (Luke et al. 2008), to paf1Δ and ctr9Δ 
cells would maybe say if Paf1 and Ctr9 are promoting TERRA degradation by the 
Rat1 pathway. It would also be interesting to show the amount of TERRA that is 
annealed to telomeres versus the TERRA that is free and able to diffuse in the 
nucleus. This could be done by comparing TERRA RNA in samples treated with 
Rnh1 and/or Rnh201 versus untreated samples, or by measuring TERRA in a soluble 
fraction versus an insoluble (chromatin) fraction. Finally, RNA immunoprecipitation 
assays could help to define if the increased levels of TERRA molecules are 
interacting with telomerase.
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7. Overall Perspectives 
My data shows that yeast genome-wide screens are a good starting point to find 
relevant interactions between a variety of cellular processes, telomere function and 
cancer. I briefly demonstrated a role at telomeres for proteins involved in mRNA 
decay, ubiquitination and cellular transport. I further described a set of complex 
interactions between a Golgi component (Vps74) and the telomeres as well as 
members of the DDR. Perhaps, my most interesting findings showed a set of intricate 
interactions between a transcription auxiliary complex (PAF1 complex) and various 
components of telomere biology. My data on both VPS74 and CDC73 (member of 
the PAF1 complex) helped to elucidate the role of their human orthologues in cancer. 
Shortly, Vps74 (oncogene) seems to be involved in DDR and promotes cell fitness, 
and Cdc73 (tumour suppressor gene) seems to decrease cell fitness and regulate 
telomere function.  
Of important note are the differences in the fitness defects caused by the same gene 
deletions in distinct yeast genetic backgrounds (S288C and W303). In most cases I 
saw that deletions in the W303 background caused less severe fitness defects than 
deletions in the S288C background, but the trend was maintained. CDC73 deletion in 
the cdc13-1 background was the only deletion that caused opposite effects in the two 
genetic backgrounds (W303 and S288C). I attributed the higher fitness of cdc73Δ 
cdc13-1 W303 cells to telomere rearrangements that happened due to the different 
way of obtaining these strains (compared to the S288C strains used in the high-
throughput screens). Nevertheless, this comparison between two yeast genetic 
backgrounds shows that one must be cautious when generalizing the results 
observed in one genetic background to all S. cerevisiae genetic backgrounds (or 
higher eukaryotes). The use of different genetic backgrounds and techniques to 
validate results seems to be a minimum requirement to reach conclusions that can 
be generalised with a higher degree of certainty.  
7.1. VPS74 
The genetic interactions described in Chapter 4, between Vps74, Yku70 and various 
members of the DDR response did not give much away about the molecular 
mechanism behind such interactions. Nevertheless it is tempting to speculate on how 
Vps74, a cytoplasmic protein involved in Golgi homeostasis, interacts with the DDR 
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and/or telomeres. I suggest that Vps74 affects the DNA damage response and that it 
is important to maintain genomic stability.  
Although the most obvious cases of DNA damage come from external factors, like 
UV and drugs such as MMS or HU, yeast also have internal sources of DNA 
damage. Yeast cells grown in the lab have access to high nutrient levels which 
allows those cells to replicate fast with a doubling time of around 90 min at 30°C 
(Herskowitz 1988). During this period, replication and transcription happen 
simultaneously and the cells rely on DDR proteins to promote RNA poll degradation 
and avoid fork collision which could lead to replication defects (Poli et al. 2016). Also, 
replication of some DNA regions is inherently more difficult and prone to breakage 
(Azvolinsky et al. 2009). Telomeres are sources of replication stress as are 
secondary DNA structures, chromatin compaction, misincorporation of 
ribonucleotides, etc. (Mazouzi et al. 2014). Thus, I suggest that Vps74, by a 
mechanism that is still not clear, helps the cell to cope with natural occurring DNA 
lesions. Lack of Vps74 would perhaps lead to DNA damage accumulation and 
chromosome instability. One possibility is that Vps74, like GOLPH3, stimulates the 
TORC1 pathway affecting the DDR (Scott et al. 2009). Vps74 inactivation decreases 
TORC1 activity, which in turn, as previously reported, affects checkpoint activation 
(prolongs Rad53 phosphorylation) (Klermund et al. 2014). Interference with Rad53 
activation could as a result increase genomic instability and decrease cell fitness (by 
checkpoint activation and cell cycle arrest). 
Similar to other oncogenes, GOLPH3 (VPS74 in yeast) overexpression is observed 
in many cancers and is associated with increased resistance to DNA damaging 
agents (Buschman et al. 2015). Such observation is in agreement with my findings 
that lack of Vps74 (hypothetically the opposite to VPS74 overexpression) causes 
slower growth, promotes genetic instability and decreases the fitness of yku70Δ cells 
with uncapped telomeres. Perhaps overexpression of GOLPH3 leads to telomere 
protection and increased resistance to genetic instability. Also if GOLPH3/Vps74 
concentration is high, and since it is a DNA-PK target, it could be titrating important 
checkpoint kinases in detriment of the activation of more important DDR pathways. It 
cannot also be excluded that overexpression of GOLPH3 leads to loss of the protein 
function (by for example GOLPH3 protein aggregation).  
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7.2. PAF1 complex 
Chapters 5 and 6 demonstrated how the PAF1 complex and how its components 
perform different, and sometimes seemingly opposing, functions at telomeres (Figure 
7-1). I showed that Paf1 and Ctr9 are the core components of the PAF1 complex in 
all the parameters studied: repressors of TERRA (p1), TEN1 and STN1 (p2) (m)RNA, 
inducers of VPS36 (p3) and TLC1 (p5) transcription and telomere silencing (p6) and 
important for cell fitness (Figure 7-1). I also found evidence that Paf1 (and likely Ctr9) 
repress TERRA by promoting its degradation. Cdc73 induced TLC1 (p5) transcription 
and had an important role reducing the fitness of telomere defective cells. I also show 
a neighbouring gene effect between CDC73 and VPS36 (p4). The reason why Paf1 
and Ctr9 are more important to many of the cellular functions I studied is not totally 
clear. It might be because Paf1 and Ctr9 are the proteins that hold the complex 
together, and without them all the PAF1 complex functions are compromised. Such 
idea is supported by the decreased levels of all other components in paf1Δ or ctr9Δ 
cells, but is challenged by the fact that rtf1Δ suppresses paf1Δ fitness defects 
(Mueller and Jaehning 2002; Mueller et al. 2004). Paf1 and Ctr9 might also be 
essential for a set of specific protein-protein interactions that are important for 
telomere maintenance. 
Vps36, a member of the ESCRT-II complex, is involved in protein sorting for 
degradation, as part of a multi-step pathway that involves five ESCRT complexes 
(ESCRT-0, -I, -II, -III and the Vps4 complex) (Schmidt and Teis 2012). I described for 
the first time a synthetic lethality between vps36Δ (ESCRT-II) and paf1Δ or ctr9Δ in 
budding yeast. Importantly, this interaction was conserved among other members of 
the ESCRT machinery (ESCRT-I, -II, -III). The reason for such interaction (ESCRT 
complex components with PAF1/CTR9) is not clear, but it might be related to a 
common role in the DDR and protein degradation. For instance, Paf1 was shown to 
be important for RNA pol II degradation to avoid replication-transcription fork collision 
(Poli et al. 2016). So maybe the PAF1 complex and the ESCRT complex work in 
parallel to aid RNA pol II degradation and avoid fork stalling and DDR. Additionally, 
mammalian data showed that during cell migration DNA damage increases while the 
nuclear envelope opens, and those transient openings are repaired by the ESCRT-III 
(Raab et al. 2016). Although in yeast the nuclear envelope remains closed during 
mitosis, it is not unlikely that ESCRT-III still plays some kind of role maintaining 
nuclear envelope integrity, perhaps related to telomere clustering at the nuclear 
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periphery for example (Smoyer and Jaspersen 2014). Since ESCRT-II and ESCRT-III 
are part of the same pathway, Vps36 can be contributing to avoid DNA damage 
response activation and Paf1 and Ctr9 to keep the telomeres intact.  
The PAF1 complex has many functions and it is still striking how cells lacking Cdc73, 
having short telomeres, can so easily maintain their fitness when their telomeres are 
damaged. This strongly suggests that Cdc73 contributes to the mechanism that 
induce cell cycle arrest or death of defective cells, in agreement with a described 
tumour suppressor gene role in humans. Interestingly, cdc73Δ cells, with short 
telomeres, can maintain their TERRA levels at a normal level, suggesting that, if 
conserved in humans, cancers triggered by CDC73 depletion will have normal R-loop 
distribution. cdc73Δ cells might benefit from low TERRA levels, since TERRA is also 
suggested to activate the DDR (by promoting Mre11 recruitment to uncapped 
telomeres in humans), and maybe cdc73Δ cells can proliferate by avoiding extensive 
activation of DDR mechanisms (Porro et al. 2014). In this line, it would be interesting 
to see how cdc73Δ cdc13-1 cells would react to a forced increase in TERRA RNA. 
Interestingly, R-loops seem to be increased in telomerase-negative cancers (Arora et 
al. 2014). It would therefore be interesting to understand the characteristics of the 
cancers caused by HPRT2 (CDC73) mutations, to see if some of the characteristics 
are as I see in yeast (telomerase-, ALT+, normal TERRA). 
Overall, I show that the yeast orthologues of two important cancer-related proteins 
(Vps74 and Cdc73) play important roles maintaining telomere biology in yeast. I 
suggest that Vps74 plays a role in general DDR and Cdc73 has an important role at 
telomeres, decreasing the fitness of telomere defective cells. Importantly, I unravelled 
an important telomere role for Cdc73 complex partners, Paf1 and Ctr9. Paf1 and Ctr9 
repress TERRA, Ten1 and Stn1 and strongly increase the fitness of telomere 
defective cells.
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Figure 7-1 Model for the many roles of the different PAF1 complex components at telomeres.  Paf1 and Ctr9 repress TERRA 
(p1), TEN1 and STN1 (p2). TERRA, Ten1 and Stn1 negatively affect telomerase function. Paf1 and Ctr9 also induce VPS36 (p3). 
VPS36 in turn is part of a neighbouring gene effect with CDC73 (p4). Paf1, Ctr9 and Cdc73 induce TLC1 (p5). Paf1, Ctr9 and Rtf1 
promote telomere silencing (p6).
205 
Appendix A 
List of the strains used in this thesis. All strains are in the W303 background. 
DLY Genotype Origin 
159 MATa, rad24::TRP1 Lydall collection 
1108 MATa cdc13-1-int Lydall collection 
1195 MATalpha cdc13-1-int Lydall collection 
1255 MATa cdc13-1int rad9::HIS3 Lydall collection 
1257 MATa cdc13-1int rad24::TRP1 Lydall collection 
1258 MATalpha cdc13-1int rad24::TRP1 Lydall collection 
1273 MATalpha exo1::LEU2 RAD5 Lydall collection 
1296 MATa cdc13-1-int exo1::LEU2 Lydall collection 
1297 MATalpha cdc13-1-int exo1::LEU2 Lydall collection 
1366 MAT alpha yku70::HIS3 RAD5 Lydall collection 
1408 MAT a yku70::HIS3 exo1::LEU2 RAD5 Lydall collection 
1412 MATa yku70::HIS3 RAD5 Lydall collection 
1585 MAT alpha rad9::KANMX Lydall collection 
1696 MATalpha exo1::LEU2 cdc13-1-int rad24::TRP1 Lydall collection 
1697 MATalpha exo1::LEU2 cdc13-1-int rad24::TRP1 Lydall collection 
1700 MATa exo1::LEU2 rad24::TRP1 Lydall collection 
1701 MATalpha exo1::LEU2 rad24::TRP1 Lydall collection 
1845 MAT a yku70::HIS3 mre11::hisG::URA3 RAD5 Lydall collection 
2041 MATalpha mre11::hisG::URA3 RAD5 Lydall collection 
2147 MAT alpha tlc1::HIS3 RAD5 Lydall collection 
2234 MATa rad9::LEU2 RAD5 CDC+ Lydall collection 
2821 MATalpha yku70::LEU2 ebs1::KANMX6 ADE+ Lydall collection 
3001 MATalpha ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3 GAL+ psi+ ssd1-d2 RAD5 
Lydall 
collection 
4026 hmi1::KANMX6 Lydall collection 
4310 MATalpha yku80::HIS3 Lydall collection 
4311 MATa yku80::HIS3 Lydall collection 
4451 MATalpha rif1::URA3 Lydall collection 
4457 MATalpha mre11::URA3 Lydall collection 
5692 MAT a sir4::HIS3 Lydall collection 
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5693 MAT a sir4::HIS3 Lydall collection 
7850 DELho DELhml::ADE1 MATalpha DELhmr::ADE1 ade1 leu2-3,112 lys5 trp1::hisG ura3-52 ade3::GAL10::HO dot1::KANMX6 
Lydall 
collection 
7851 DELho DELhml::ADE1 MATalpha DELhmr::ADE1 ade1 leu2-3,112 lys5 trp1::hisG ura3-52 ade3::GAL10::HO dot1::KANMX6 
Lydall 
collection 
8460 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3 GAL+ psi+ ssd1-d2 RAD5 
Lydall 
collection 
8490 MATa cdc73::KANMX6 This work 
8491 MATalpha cdc73::KANMX6 This work 
8492 MATa cdc73::KANMX6 rad9::HIS3 This work 
8493 MATalpha cdc73::KANMX6 rad9::HIS3 This work 
8494 MATa cdc13-1 int cdc73::KANMX6 This work 
8495 MATalpha cdc13-1 int cdc73::KANMX6 This work 
8496 MATa cdc13-1 int cdc73::KANMX6 rad9::HIS3 This work 
8497 MATalpha cdc13-1 int cdc73::KANMX6 rad9::HIS3 This work 
8594 MATa yku70::HIS3 cdc73::KANMX6 This work 
8595 MATalpha yku70::HIS3 cdc73::KANMX6 This work 
8596 MATa rad24::TRP1 cdc73::KANMX6 This work 
8597 MATlpha rad24::TRP1 cdc73::KANMX6 This work 
8598 MATa cdc13-1int rad24::TRP1 cdc73::KANMX6 This work 
8599 MATalpha cdc13-1int rad24::TRP1 cdc73::KANMX6 This work 
8607 MATa cdc73::KANMX6 cdc13-1 p::URA3::CDC73 This work 
8608 MATa acdc73::KANMX6 rad9::HIS3 cdc13-1 p::URA3::CDC73 This work 
8609 MATa cdc73::KANMX6 cdc13-1 p::URA3 This work 
8610 MATa cdc73::KANMX6 rad9::HIS3 cdc13-1 p::URA3 This work 
8702 MATa yku80::HIS3 cdc73::KANMX6 This work 
8703 MATalpha yku80::HIS3 cdc73::KANMX6 This work 
8732 MATa cdc73::KANMX6 exo1::LEU2 This work 
8733 MATalpha cdc73::KANMX6 exo1::LEU2 This work 
8734 MATa cdc73::KANMX6 exo1::LEU2 cdc13-1 This work 
8735 MATalpha cdc73::KANMX6 exo1::LEU2 cdc13-1 This work 
8736 MATa leo1::KANMX6 This work 
8737 MATalpha leo1::KANMX6  This work 
8738 MATalpha leo1::KANMX6 ra9::HIS3 This work 
8739 MATa leo1::KANMX6 cdc13-1 This work 
8740 MATalpha leo1::KANMX6 cdc13-1 This work 
8741 MATa leo1::KANMX6 rad9::HIS3 cdc13-1 This work 
8742 MATalpha leo1::KANMX6 rad9::HIS3 cdc13-1 This work 
8743 MATa rtf1::KANMX6 This work 
8744 MATalpha rtf1::KANMX6 This work 
8745 MATa rtf1::KANMX6 rad9::HIS3 This work 
8746 MATalpha rtf1::KANMX6 rad9::HIS3 This work 
8747 MATa rtf1::KANMX6 rad9::HIS3 cdc13-1 This work 
8748 MATalpha rtf1::KANMX6 rad9::HIS3 cdc13-1 This work 
8749 MATa rtf1::KANMX6 cdc13-1 This work 
8750 MATalpha rtf1::KANMX6 cdc13-1 This work 
8751 MATa ctr9::KANMX6 This work 
8752 MATalpha ctr9::KANMX6 This work 
8752 MATalpha ctr9::KANMX6 This work 
8753 MATa ctr9::KANMX6 rad9::HIS3 This work 
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8753 MATa ctr9::KANMX6 rad9::HIS3 This work 
8753 MATa ctr9::KANMX6 rad9::HIS3 This work 
8753 MATa ctr9::KANMX6 rad9::HIS3 This work 
8754 MATalpha ctr9::KANMX6 rad9::HIS3 This work 
8755 MATalpha ctr9::KANMX6 cdc13-1 This work 
8756 MATa ctr9::KANMX6 rad9::HIS3 cdc13-1 This work 
8757 MATa paf1::KANMX6 This work 
8758 MATalpha paf1::KANMX6 This work 
8759 MATa paf1::KANMX6 rad9::HIS3 This work 
8760 MATalpha paf1::KANMX6 rad9::HIS3 This work 
8761 MATalpha paf1::KANMX6 cdc13-1 This work 
8762 MATa paf1::KANMX6 rad9::HIS3 cdc13-1 This work 
8763 MATalpha paf1::KANMX6 rad9::HIS3 cdc13-1 This work 
8768 MATa cdc73::KANMX6 est1::natMX This work 
8769 MATalpha cdc73::KANMX6 est1::natMX This work 
8803 MATa vps36::KANMX6 This work 
8804 MATalpha vps36::KANMX6 This work 
8805 MATa vps36::KANMX6 rad9::HIS3 This work 
8806 MATalpha vps36::KANMX6 rad9::HIS3 This work 
8807 MATa vps36::KANMX6 cdc13-1 int This work 
8808 MATalpha vps36::KANMX6 cdc13-1 int This work 
8809 MATa vps36::KANMX6 rad9::HIS3 cdc13-1 int This work 
8810 MATalpha vps36::KANMX6 rad9::HIS3 cdc13-1 int This work 
8811 MATa ylr419w::KANMX6 This work 
8812 MATalpha ylr419w::KANMX6 This work 
8812 MATalpha ylr419w::KANMX6 This work 
8813 MATa ylr419w::KANMX6 rad9::HIS3 This work 
8814 MATalpha ylr419w::KANMX6 rad9::HIS3 This work 
8815 MATa ylr419w::KANMX6 cdc13-1 int This work 
8816 MATalpha ylr419w::KANMX6 cdc13-1 int This work 
8817 MATa ylr419w::KANMX6 cdc13-1 int rad9::HIS3 This work 
8818 MATalpha ylr419w::KANMX6 cdc13-1 int rad9::HIS3 This work 
8828 bas1::KANMX6 This work 
8829 bas1::KANMX6 This work 
8830 bas1::KANMX6 rad9::HIS3 This work 
8831 bas1::KANMX6 rad9::HIS3 This work 
8832 bas1::KANMX6 cdc13-1 int This work 
8833 bas1::KANMX6 cdc13-1 int This work 
8834 bas1::KANMX6 rad9::HIS3 cdc13-1 int This work 
8835 bas1::KANMX6 rad9::HIS3 cdc13-1 int This work 
8836 ufd2::KANMX6 This work 
8837 ufd2::KANMX6 This work 
8838 ufd2::KANMX6 rad9::HIS3 This work 
8839 ufd2::KANMX6 rad9::HIS3 This work 
8840 ufd2::KANMX6 cdc13-1 int This work 
8841 ufd2::KANMX6 cdc13-1 int This work 
8842 ufd2::KANMX6 rad9::HIS3 cdc13-1 int This work 
8843 ufd2::KANMX6 rad9::HIS3 cdc13-1 int This work 
8844 MATalpha ski2::KANMX6 This work 
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8845 MATa ski2::KANMX6 This work 
8846 ski2::KANMX6 rad9::HIS3 This work 
8847 ski2::KANMX6 rad9::HIS3 This work 
8848 ski2::KANMX6 cdc13-1 int This work 
8849 ski2::KANMX6 cdc13-1 int This work 
8850 ski2::KANMX6 rad9::HIS3 cdc13-1 int This work 
8851 ski2::KANMX6 rad9::HIS3 cdc13-1 int This work 
8852 sla2::KANMX6 This work 
8853 sla2::KANMX6 This work 
8854 sla2::KANMX6 cdc13-1 int This work 
8855 sla2::KANMX6 cdc13-1 int This work 
8856 sla2::KANMX6 rad9::HIS3 cdc13-1 int This work 
8857 sla2::KANMX6 rad9::HIS3 cdc13-1 int This work 
8858 dyn1::KANMX6 This work 
8859 dyn1::KANMX6 This work 
8860 dyn1::KANMX6 rad9::HIS3 This work 
8861 dyn1::KANMX6 rad9::HIS3 This work 
8862 dyn1::KANMX6 cdc13-1 int This work 
8863 dyn1::KANMX6 cdc13-1 int This work 
8864 dyn1::KANMX6 cdc13-1 int rad9::HIS3 This work 
8865 dyn1::KANMX6 cdc13-1 int rad9::HIS3 This work 
8866 inp52::KANMX6 This work 
8867 inp52::KANMX6 This work 
8868 inp52::KANMX6 rad9::HIS3 This work 
8869 inp52::KANMX6 rad9::HIS3 This work 
8870 inp52::KANMX6 cdc13-1 int This work 
8871 inp52::KANMX6 cdc13-1 int This work 
8872 inp52::KANMX6 rad9::HIS3 cdc13-1 int This work 
8873 inp52::KANMX6 rad9::HIS3 cdc13-1 int This work 
8874 fyv10::KANMX6 This work 
8875 fyv10::KANMX6 This work 
8876 fyv10::KANMX6 rad9::HIS3 This work 
8877 fyv10::KANMX6 rad9::HIS3 This work 
8878 fyv10::KANMX6 cdc13-1 int This work 
8879 fyv10::KANMX6 cdc13-1 int This work 
8880 fyv10::KANMX6 rad9::HIS3 cdc13-1 int This work 
8881 fyv10::KANMX6 rad9::HIS3 cdc13-1 int This work 
9008 MATa yku70::HIS3 bas1::KANMX6 This work 
9009 MATalpha yku70::HIS3 bas1::KANMX6 This work 
9010 MATa yku80::HIS3 bas1::KANMX6 This work 
9011 MATalpha yku80::HIS3 bas1::KANMX6 This work 
9012 MATa yku70::HIS3 ufd2::KANMX6 This work 
9013 MATalpha yku70::HIS3 ufd2::KANMX6 This work 
9014 MATa yku80::HIS3 ufd2::KANMX6 This work 
9015 MATalpha yku80::HIS3 ufd2::KANMX6 This work 
9016 MATa yku70::HIS3 ski2::KANMX6 This work 
9017 MATalpha yku70::HIS3 ski2::KANMX6 This work 
9018 MATa yku80::HIS3 ski2::KANMX6 This work 
9019 MATalpha yku80::HIS3 ski2::KANMX6 This work 
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9020 MATa yku70::HIS3 dyn1::KANMX6 This work 
9021 MATalpha yku70::HIS3 dyn1::KANMX6 This work 
9022 MATa yku80::HIS3 dyn1::KANMX6 This work 
9023 MATalpha yku80::HIS3 dyn1::KANMX6 This work 
9024 MATa yku70::HIS3 inp52::KANMX6 This work 
9025 MATalpha yku70::HIS3 inp52::KANMX6 This work 
9026 MATa yku80::HIS3 inp52::KANMX6 This work 
9027 MATalpha yku80::HIS3 inp52::KANMX6 This work 
9028 MATa yku70::HIS3 fyv10::KANMX6 This work 
9029 MATalpha yku70::HIS3 fyv10::KANMX6 This work 
9030 MATa yku80::HIS3 fyv10::KANMX6 This work 
9031 MATalpha yku80::HIS3 fyv10::KANMX6 This work 
9183 MATa vps74::KANMX6 This work 
9184 MATalpha vps74::KANMX6 This work 
9185 MATa vps74::KANMX6 rad9::HIS3 This work 
9186 MATalpha vps74::KANMX6 rad9::HIS3 This work 
9187 MATa vps74::KANMX6 cdc13-1 This work 
9188 MATalpha vps74::KANMX6 cdc13-1 This work 
9189 MATa vps74::KANMX6 cdc13-1 rad9::HIS3 This work 
9190 MATalpha vps74::KANMX6 cdc13-1 rad9::HIS3 This work 
9191 MATa cdc73(41-90)::KANMX6 This work 
9192 MATalpha cdc73(41-90)::KANMX6 This work 
9193 MATa cdc73(41-90)::KANMX6 cdc13-1 This work 
9194 MATalpha cdc73(41-90)::KANMX6 cdc13-1 This work 
9195 MATa vps36(1302-1701)-cdc73(782-1182)::KANMX6 This work 
9196 MATalpha vps36(1302-1701)-cdc73(782-1182)::KANMX6 This work 
9197 MATa cdc73(41-90)::KANMX6 cdc13-1 This work 
9198 MATalpha cdc73(41-90)::KANMX6 cdc13-1 This work 
9199 MATa vps36(1-90)::KANMX6 This work 
9200 MATalpha vps36(1-90)::KANMX6 This work 
9201 MATa vps36(1-90)::KANMX6 cdc13-1 This work 
9202 MATalpha vps36(1-90)::KANMX6 cdc13-1 This work 
9421 vps74::KANMX6 exo1::LEU2 This work 
9422 vps74::KANMX6 exo1::LEU2 This work 
9423 MATa doa1::HPH This work 
9424 MATalpha doa1::HPH This work 
9425 MATa doa1::HPH cdc13-1 This work 
9426 MATa doa1::HPH cdc13-1 This work 
9427 MATa doa1::HPH rad9::HIS3 This work 
9428 MATalpha doa1::HPH rad9::HIS3 This work 
9429 MATa doa1::HPH ufd2::KANMX6 This work 
9430 MATalpha doa1::HPH ufd2::KANMX6 This work 
9431 MATa doa1::HPH ufd2::KANMX6 rad9::HIS3 This work 
9432 MATalpha doa1::HPH ufd2::KANMX6 rad9::HIS3 This work 
9433 MATa doa1::HPH ufd2::KANMX6 cdc13-1 This work 
9434 MATalpha doa1::HPH ufd2::KANMX6 cdc13-1 This work 
9435 MATa doa1::HPH ufd2::KANMX6 rad9::HIS3 cdc13-1 This work 
9436 MATalpha doa1::HPH ufd2::KANMX6 rad9::HIS3 cdc13-1 This work 
9437 MATa doa1::HPH rad9::HIS3 cdc13-1 This work 
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9438 MATalpha doa1::HPH rad9::HIS3 cdc13-1 This work 
9536 MATa ski7::natMX This work 
9537 MATalpha ski7::natMX This work 
9538 MATa ski7::natMX cdc13-1int This work 
9539 MATalpha ski7::natMX cdc13-1int This work 
9540 MATa ski7::natMX rad9::HIS3 This work 
9541 MATalpha ski7::natMX rad9::HIS3 This work 
9542 MATa ski7::natMX ski2::KANMX6 This work 
9543 MATalpha ski7::natMX ski2::KANMX6 This work 
9544 MATa ski7::natMX ski2::KANMX6 cdc13-1int This work 
9545 MATalpha ski7::natMX ski2::KANMX6 cdc13-1int This work 
9546 MATa ski7::natMX ski2::KANMX6 rad9::HIS3 This work 
9547 MATalpha ski7::natMX ski2::KANMX6 rad9::HIS3 This work 
9548 MATa ski7::natMX rad9::HIS3 cdc13-1int This work 
9549 MATalpha ski7::natMX rad9::HIS3 cdc13-1int This work 
9550 MATa ski7::natMX ski2::KANMX6 rad9::HIS3 cdc13-1int This work 
9551 MATalpha ski7::natMX ski2::KANMX6 rad9::HIS3 cdc13-1int This work 
9552 MATa ski8::TRP1 This work 
9553 MATalpha ski8::TRP1 This work 
9554 MATa ski8::TRP1 cdc13-1int This work 
9555 MATalpha ski8::TRP1 cdc13-1int This work 
9556 MATa ski8::TRP1 rad9::HIS3 This work 
9557 MATalpha ski8::TRP1 rad9::HIS3 This work 
9558 MATa ski8::TRP1 ski2::KANMX6 This work 
9559 MATalpha ski8::TRP1 ski2::KANMX6 This work 
9560 MATa ski8::TRP1 ski2::KANMX6 cdc13-1int This work 
9561 MATalpha ski8::TRP1 ski2::KANMX6 cdc13-1int This work 
9562 MATa ski8::TRP1 ski2::KANMX6 rad9::HIS3 This work 
9563 MATalpha ski8::TRP1 ski2::KANMX6 rad9::HIS3 This work 
9564 MATa ski8::TRP1 ski2::KANMX6 cdc13-1int This work 
9565 MATalpha ski8::TRP1 ski2::KANMX6 cdc13-1int This work 
9566 MATa ski8::TRP1 ski2::KANMX6 rad9::HIS3 cdc13-1int This work 
9567 MATalpha ski8::TRP1 ski2::KANMX6 rad9::HIS3 cdc13-1int This work 
9568 MATa vps74::KANMX6 rad17::LEU2 This work 
9569 MATalpha vps74::KANMX6 rad17::LEU2 This work 
9570 MATa vps74::KANMX6 rad24::TRP1 This work 
9571 MATalpha vps74::KANMX6 rad24::TRP1 This work 
9572 MATa vps74::KANMX6 rad17::LEU2 cdc13-1 This work 
9573 MATalpha vps74::KANMX6 rad17::LEU2 cdc13-1 This work 
9574 MATa vps74::KANMX6 rad24::TRP1 cdc13-1 This work 
9575 MATalpha vps74::KANMX6 rad24::TRP1 cdc13-1 This work 
9576 MATa vps74::KANMX6 rad24::TRP1 rad17::LEU2 This work 
9577 MATalpha vps74::KANMX6 rad24::TRP1 rad17::LEU2 This work 
9578 MATa vps74::KANMX6 rad24::TRP1 rad17::LEU2 cdc13-1int This work 
9579 MATalpha vps74::KANMX6 rad24::TRP1 rad17::LEU2 cdc13-1int This work 
9580 MATa vps74::KANMX6 rad9::HIS3 This work 
9581 MATalpha vps74::KANMX6 rad9::HIS3 This work 
9832 MATalpha vps36::HPH This work 
9833 MATa vps36(1-90)::HPH This work 
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9834 MATalpha vps36(1-90)::HPH This work 
9894 ade1-14, his3-200, leu2-3-112, trp1-289 PSI+ Mick Tuite 
9895 ade1-14, his3-200, leu2-3-112, trp1-289 PSI- Mick Tuite 
9987 MATa cdc13-1 int ski2::KANMX6 This work 
9988 MATalpha cdc13-1 int ski2::KANMX6 This work 
9989 MATa ski2::KANMX6 exo1::LEU2 This work 
9990 MATalpha ski2::KANMX6 exo1::LEU2 This work 
9991 MATa ski2::KANMX6 exo1::LEU2 cdc13-1 int This work 
9992 MATalpha ski2::KANMX6 exo1::LEU2 cdc13-1 int This work 
9993 MATa ski2::KANMX6 exo1::LEU2 rad24::TRP1 This work 
9994 MATalpha ski2::KANMX6 exo1::LEU2 rad24::TRP1 This work 
9995 MATa ski2::KANMX6 exo1::LEU2 rad24::TRP1 cdc13-1 int This work 
9996 MATalpha ski2::KANMX6 exo1::LEU2 rad24::TRP1 cdc13-1 int This work 
9997 MATalpha paf1::KANMX6 cdc13-1 This work 
9998 MATalpha ctr9::KANMX6 cdc13-1 This work 
9999 MATalpha rtf1::KANMX6 cdc13-1 This work 
10000 MATalpha leo1::KANMX6 cdc13-1 This work 
10001 MATa ura3::EGFP-RER1::URA3 GAL+ psi+ ssd1-d2 RAD5 This work 
10002 MATa ura3::SEC7-EGFP::URA3 GAL+ psi+ ssd1-d2 RAD5 This work 
10003 MATa ura3::EGFP-RER1::URA3 GAL+ psi+ ssd1-d2 RAD5 cdc13-1-int This work 
10004 MATa ura3::SEC7-EGFP::URA3 GAL+ psi+ ssd1-d2 RAD5 cdc13-1-int This work 
10017 MATa vps74::KANMX6 yku70::LEU2 This work 
10018 MATalpha vps74::KANMX6 yku70::LEU2 This work 
10019 MATalpha vps74::KANMX6 yku80::HIS3 This work 
10020 MATalpha vps74::KANMX6 yku80::HIS3 This work 
10021 MATa vps74::KANMX6 yku80::HIS3 yku70::LEU2 This work 
10022 MATalpha vps74::KANMX6 yku80::HIS3 yku70::LEU2 This work 
10055 MATalpha leo1::KANMX6 nmd2::HIS3 This work 
10056 MATalpha leo1::KANMX6 nmd2::HIS3 This work 
10057 MATalpha leo1::KANMX6 nmd2::HIS3 cdc13-1 This work 
10058 MATalpha leo1::KANMX6 nmd2::HIS3 cdc13-1 This work 
10059 MATalpha cdc73::KANMX6 nmd2::HIS3 This work 
10060 MATalpha cdc73::KANMX6 nmd2::HIS3 This work 
10061 MATalpha cdc73::KANMX6 nmd2::HIS3 cdc13-1 This work 
10062 MATalpha cdc73::KANMX6 nmd2::HIS3 cdc13-1 This work 
10063 MATalpha rtf1::KANMX6 nmd2::HIS3 This work 
10064 MATalpha rtf1::KANMX6 nmd2::HIS3 This work 
10065 MATalpha rtf1::KANMX6 nmd2::HIS3 cdc13-1 This work 
10066 MATalpha rtf1::KANMX6 nmd2::HIS3 cdc13-1 This work 
10113 ctr9::KANMX6 nmd2::HIS3 This work 
10114 ctr9::KANMX6 nmd2::HIS3 This work 
10115 ctr9::KANMX6 nmd2::HIS3 cdc13-1 This work 
10116 ctr9::KANMX6 nmd2::HIS3 cdc13-1 This work 
10117 paf1::KANMX6 nmd2::HIS3 This work 
10118 paf1::KANMX6 nmd2::HIS3 This work 
10119 paf1::KANMX6 nmd2::HIS3 cdc13-1 This work 
10120 paf1::KANMX6 nmd2::HIS3 cdc13-1 This work 
10155 MATa ura3::URA3::EGFP-RER1 GAL+ psi+ ssd1-d2 RAD5 cdc13-1 This work 
10157 MATa ura3::URA3::EGFP-RER1 GAL+ psi+ ssd1-d2 RAD5 cdc13-1 This work 
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10158 MATalpha ura3::URA3::EGFP-RER1 GAL+ psi+ ssd1-d2 RAD5 This work 
10159 MATalpha ura3::URA3::EGFP-RER1 GAL+ psi+ ssd1-d2 RAD5 This work 
10160 MATalpha ura3::URA3::EGFP-RER1 GAL+ psi+ ssd1-d2 RAD5 This work 
10161 MATalpha mon1::KANMX6 This work 
10162 MATalpha mon1::KANMX6 This work 
10163 MATa mon1::KANMX6 cdc13-1 This work 
10164 MATalpha mon1::KANMX6 cdc13-1 This work 
10165 MATa mon1::KANMX6 rad9::HIS3 This work 
10166 MATalpha mon1::KANMX6 rad9::HIS3 This work 
10167 MATa mon1::KANMX6 rad9::HIS3 cdc13-1 This work 
10168 MATalpha mon1::KANMX6 rad9::HIS3 cdc13-1 This work 
10169 MATa sub1::KANMX6 This work 
10170 MATalpha sub1::KANMX6 This work 
10171 MATa sub1::KANMX6 cdc13-1 This work 
10172 MATalpha sub1::KANMX6 cdc13-1 This work 
10173 MATa sub1::KANMX6 rad9::HIS3 This work 
10174 MATalpha sub1::KANMX6 rad9::HIS3 This work 
10175 MATa sub1::KANMX6 rad9::HIS3 cdc13-1 This work 
10176 MATalpha sub1::KANMX6 rad9::HIS3 cdc13-1 This work 
10177 MATa sbp1::HPH This work 
10178 MATalpha sbp1::HPH This work 
10179 MATa sbp1::HPH cdc13-1 This work 
10180 MATalpha sbp1::HPH cdc13-1 This work 
10181 MATa sbp1::HPH rad9::HIS3 This work 
10182 MATalpha sbp1::HPH rad9::HIS3 This work 
10183 MATa sbp1::HPH rad9::HIS3 cdc13-1 This work 
10184 MATa sbp1::HPH rad9::HIS3 cdc13-1 This work 
10240 vps74::KANMX6 yku70::HIS3 exo1::LEU2 This work 
10241 vps74::KANMX6 yku70::HIS3 exo1::LEU2 This work 
10414 MATa snf8::HYG This work 
10415 MATalpha snf8::HYG This work 
10416 MATa snf8::HYG cdc13-1 This work 
10417 MATalpha snf8::HYG cdc13-1 This work 
10418 MATa snf8::HYG rad9::HIS3 This work 
10419 MATalpha snf8::HYG rad9::HIS3 This work 
10420 MATa snf8::HYG rad9::HIS3 cdc13-1 This work 
10421 MATalpha snf8::HYG rad9::HIS3 cdc13-1 This work 
10422 MATa vps25::NAT This work 
10423 MATalpha vps25::NAT This work 
10424 MATa vps25::NAT cdc13-1 This work 
10425 MATalpha vps25::NAT cdc13-1 This work 
10426 MATa vps25::NAT rad9::HIS3 This work 
10427 MATalpha vps25::NAT rad9::HIS3 This work 
10428 MATa vps25::NAT rad9::HIS3 cdc13-1 This work 
10429 MATalpha vps25::NAT rad9::HIS3 cdc13-1 This work 
10458 MATalpha his4-1, kar1-1 L-A, M1, L-BC This work 
10540 MATa ski2::KANMX6 nmd2::HIS3 This work 
10541 ski2::KANMX6 nmd2::HIS3 This work 
10542 ski2::KANMX6 rad24::TRP1 This work 
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10543 ski2::KANMX6 rad24::TRP1 This work 
10740 MATa vps74::KANMX6 sae2::TRP1 This work 
10741 MATalpha vps74::KANMX6 sae2::TRP1 This work 
10742 MATa vps74::KANMX6 yku70::HIS3 sae2::TRP1 This work 
10743 MATalpha vps74::KANMX6 yku70::HIS3 sae2::TRP1 This work 
10744 MATa vps74::KANMX6 exo1::LEU2 sae2::TRP1 This work 
10745 MATalpha vps74::KANMX6 exo1::LEU2 sae2::TRP1 This work 
10746 MATa vps74::KANMX6 yku70::HIS3 exo1::LEU2 sae2::TRP1 This work 
10747 MATalpha vps74::KANMX6 yku70::HIS3 exo1::LEU2 sae2::TRP1 This work 
10748 MATa vps74::KANMX6 mre11::URA3 This work 
10749 MATalpha vps74::KANMX6 mre11::URA3 This work 
10750 MATa vps74::KANMX6 yku70::HIS3 mre11::URA3 This work 
10751 MATalpha vps74::KANMX6 yku70::HIS3 mre11::URA3 This work 
10752 MATa vps74::KANMX6 exo1::LEU23 mre11::URA3 This work 
10753 MATalpha vps74::KANMX6 exo1::LEU23 mre11::URA3 This work 
10754 MATa vps74::KANMX6 yku70::HIS3 exo1::LEU23 mre11::URA3 This work 
10755 MATalpha vps74::KANMX6 yku70::HIS3 exo1::LEU23 mre11::URA3 This work 
10763 ski2::KANMX6 nmd2::HIS3 cdc13-1 int This work 
10764 ski2::KANMX6 nmd2::HIS3 cdc13-1 int This work 
10765 ski2::KANMX6 nmd2::HIS3 exo1::LEU2 This work 
10766 ski2::KANMX6 nmd2::HIS3 exo1::LEU2 This work 
10767 MATalpha ski2::KANMX6 nmd2::HIS3 rad24::TRP1 This work 
10768 MATalpha ski2::KANMX6 nmd2::HIS3 rad24::TRP1 This work 
10769 MATa ski2::KANMX6 nmd2::HIS3 exo1::LEU2 cdc13-1 This work 
10770 ski2::KANMX6 nmd2::HIS3 exo1::LEU2 cdc13-1 This work 
10771 ski2::KANMX6 ski2::KANMX6 nmd2::HIS3 exo1::LEU2 rad24::TRP1 cdc13-1 This work 
10772 MATalpha ski2::KANMX6 ski2::KANMX6 nmd2::HIS3 exo1::LEU2 rad24::TRP1 
cdc13-1 This work 
10773 MATa ski2::KANMX6 sac1::HYG sae2::TRP1 This work 
10774 MATalpha ski2::KANMX6 sac1::HYG sae2::TRP1 This work 
10786 MATalpha ski2::KANMX6 sac1::HYG sae2::TRP1 This work 
10787 MATalpha ski2::KANMX6 sac1::HYG sae2::TRP1 This work 
10788 MATa ski2::KANMX6 sac1::HYG sae2::TRP1 vps74::KANMX6 This work 
10959 cdc73::HPH paf1::KANMX6 This work 
10960 cdc73::HPH paf1::KANMX6 This work 
10961 cdc73::HPH ctr9::KANMX6 This work 
10962 cdc73::HPH ctr9::KANMX6 This work 
10995 MATa sac1::TRP1 This work 
10996 MATalpha sac1::TRP1 This work 
10997 MATalpha vps74::KANMX6 mec1::TRP1 This work 
10998 MATa vps74::KANMX6 yku70::LEU2 mec1::TRP1 This work 
10999 MATa vps74::KANMX6 yku70::LEU2 mec1::TRP1 This work 
11000 MATa vps74::KANMX6 mec1::TRP1 sml1::HIS3 This work 
11001 MATalpha vps74::KANMX6 mec1::TRP1 sml1::HIS3 This work 
11002 MATa vps74::KANMX6 yku70::LEU2 mec1::TRP1 sml1::HIS3 This work 
11003 MATalpha vps74::KANMX6 yku70::LEU2 mec1::TRP1 sml1::HIS3 This work 
11004 MATa vps74::KANMX6 sml1::HIS3 This work 
11005 MATalpha vps74::KANMX6 sml1::HIS3 This work 
11006 MATa vps74::KANMX6 chk1::HIS3 This work 
11007 MATalpha vps74::KANMX6 chk1::HIS3 This work 
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11008 MATa vps74::KANMX6 yku70::LEU2 chk1::HIS3 This work 
11009 MATalpha vps74::KANMX6 yku70::LEU2 chk1::HIS3 This work 
11010 MATa vps74::KANMX6 sgs1::NatMX This work 
11011 MATa vps74::KANMX6 yku70::LEU2 sgs1::NatMX This work 
11012 MATalpha vps74::KANMX6 yku70::LEU2 sgs1::NatMX This work 
11013 MATa vps74::KANMX6 yku70::LEU2 mec1::TRP1 This work 
11014 MATa mec1::TRP1 This work 
11015 MATalpha mec1::TRP1 yku70::LEU2 This work 
11016 MATa vps74::KANMX6 mec1::TRP1 yku70::LEU2 This work 
11017 MATa rad53::HIS3 yku70::LEU2 This work 
11018 MATa rad53::HIS3 This work 
11019 MATa rad53::HIS3 This work 
11020 MATalpha rad53::HIS3 yku70::LEU2 This work 
11021 MATalpha rad53::HIS3 yku70::LEU2 vps74::KANMX6 This work 
11022 MATalpha vps74::KANMX6 rad53::HIS3 sml1::URA3 This work 
11023 MATalpha vps74::KANMX6 rad53::HIS3 sml1::URA3 This work 
11024 MATa vps74::KANMX6 yku70::LEU2 rad53::HIS3 sml1::URA3 This work 
11025 MATa vps74::KANMX6 yku70::LEU2 rad53::HIS3 sml1::URA3 This work 
11038 yku70::LEU2 rad53::HIS3 sml1::URA3 This work 
11039 yku70::LEU2 rad53::HIS3 sml1::URA3 This work 
11040 sac1::TRP This work 
11041 sac1::TRP This work 
11042 sac1::TRP yku70::HIS3 This work 
11043 sac1::TRP yku70::HIS3 This work 
11044 sac1::TRP vps74::KANMX6 This work 
11045 sac1::TRP vps74::KANMX6 This work 
11046 sac1::TRP exo1::LEU2 This work 
11047 sac1::TRP exo1::LEU2 This work 
11048 sac1::TRP vps74::KANMX6 exo1::LEU2 This work 
11049 sac1::TRP vps74::KANMX6 exo1::LEU2 This work 
11050 sac1::TRP vps74::KANMX6 yku70::HIS3 This work 
11051 sac1::TRP vps74::KANMX6 yku70::HIS3 This work 
11052 sac1::TRP vps74::KANMX6 yku70::HIS3 exo1::LEU2 This work 
11053 sac1::TRP vps74::KANMX6 yku70::HIS3 exo1::LEU2 This work 
11151 MATalpha vps74::KANMX6 sgs1::NatMX This work 
11152 MATa sir4::HIS3 cdc73::KANMX6 This work 
11153 MATalpha sir4::HIS3 cdc73::KANMX6 This work 
11154 MATa sir4::HIS3 paf1::KANMX6 This work 
11155 MATalpha sir4::HIS3 paf1::KANMX6 This work 
11156 sir4::HIS3 ctr9::KANMX6 This work 
11157 sir4::HIS3 ctr9::KANMX6 This work 
11158 MATa -535 telVII-L URA3 cdc73::KANMX6 This work 
11159 MATa -535 telVII-L URA3 cdc73::KANMX6 This work 
11160 MATa -535 telVII-L URA3 cdc73::KANMX6 This work 
11161 MATa -535 telVII-L URA3 paf1::KANMX6 This work 
11162 MATa -535 telVII-L URA3 paf1::KANMX6 This work 
11163 MATa -535 telVII-L URA3 paf1::KANMX6 This work 
11164 MATa -535 telVII-L URA3 ctr9::KANMX6 This work 
11165 MATa -535 telVII-L URA3 ctr9::KANMX6 This work 
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11166 MATa -535 telVII-L URA3 ctr9::KANMX6 This work 
11167 MATa -535 telVII-L URA3 leo1::KANMX6 This work 
11168 MATa -535 telVII-L URA3 leo1::KANMX6 This work 
11169 MATa -535 telVII-L URA3 rtf1::KANMX6 This work 
11170 MATa -535 telVII-L URA3 rtf1::KANMX6 This work 
11171 MATa -535 telVII-L URA3 rtf1::KANMX6 This work 
11213 MATalpha tor1-1 fpr1::NAT RPL13A-2*FKBP12::TRP1 Rpb1-FRB-KANMX6  
11218 MATalpha tor1-1 fpr1::NAT RPL13A-2*FKBP12::TRP1 Rpb1-FRB-KANMX6 paf1::HPH  
11232 MATalpha tor1-1 fpr1::NAT RPL13A-2*FKBP12::TRP1 Rpb1-FRB-KANMX6 paf1::HPH  
11220 MATa -535 telVII-L URA3 cdc73::KANMX6 sir4::HPH This work 
11221 MATa -535 telVII-L URA3 cdc73::KANMX6 sir4::HPH This work 
11222 MATa -535 telVII-L URA3 paf1::KANMX6 sir4::HPH This work 
11223 MATa -535 telVII-L URA3 paf1::KANMX6 sir4::HPH This work 
11224 MATa -535 telVII-L URA3 ctr9::KANMX6 sir4::HPH This work 
11225 MATa -535 telVII-L URA3 ctr9::KANMX6 sir4::HPH This work 
11226 MATa -535 telVII-L URA3 leo1::KANMX6 sir4::HPH This work 
11227 MATa -535 telVII-L URA3 leo1::KANMX6 sir4::HPH This work 
11228 MATa -535 telVII-L URA3 rtf1::KANMX6 sir4::HPH This work 
11229 MATa -535 telVII-L URA3 rtf1::KANMX6 sir4::HPH This work 
11230 MATa -535 telVII-L URA3 sir4::HPH This work 
11231 MATa -535 telVII-L URA3 sir4::HPH This work 
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Appendix B 
List of the primers used in this thesis. When a reference is not shown, the oligo was 
designed by me. 
Gene Primer (m) Sequence Use (reference) 
Y’12* 395 ACAGCACTTCTACATAGCCCTAAATAGCCCTAAAT TERRA RNA measurements. 
Y’12* 396 GCTTTTGGTTGAACATCCGGGTAAGAG TERRA RNA measurements. 
CDC13 550 TTGGCACGATGATGATTCCGG 
RFLP analysis of cdc13-1 
versus CDC13. (Zubko and 
Lydall 2006) 
CDC13 551 TTCGATCAGGCTTTTCCAGT 
RFLP analysis of cdc13-1 
versus CDC13. (Zubko and 
Lydall 2006) 
KANMX6 1485 CGGATGTGATGTGAGAACTGTATCC Confirm deletion. (Lydall collection) 
STN1 1734 TCGAGCAACTGCAAGAAGAA RT-qPCR. (Addinall et al. 2011) 
STN1 1735 CGAAATGACAAGGAATGCAC RT-qPCR. (Addinall et al. 2011) 
TEN1 1794 ATACACCAAAGTCCGCCAAT RT-qPCR. (Addinall et al. 2011) 
TEN1 1795 CACCAAGTGGTGATTTGACA RT-qPCR. (Addinall et al. 2011) 
TEL15L 2335 TATCCTACTCCACTGCCACTTACCCTG TERRA RNA measurements. Southern Blot probe. 
TEL15L 2336 TGTTAGCGTTTCAATATGGTGGGTAGA TERRA RNA measurements. 
CDC73 2864 AGAATAATAATTTGAGCAAGAAACTGGTGAAAAAATTATGCGGATCCCCGGGTTAATTAA Disruption with KANMX6. 
CDC73 2866 TTCAATGGCCGAAATACCATTCTTCCGTTTATCGTATTCAGAATTCGAGCTCGTTTAAAC Disruption with KANMX6. 
CDC73 2868 CAACTCATCGAACACCGAGAC Insertion check. 
CDC73 2870 GCGGCACTTGAGTCCTTATTC Insertion check. 
CDC73 2872 TTTCCACTTTGCCGGTGATTC Insertion check. 
CDC73 2873 ATCAAACTGGACGCTAGGTATC Insertion check. 
CDC73 2885 ACCGCGGTGGCGGCCGCATAGGCCACTAGTGGATCTGATATCATCGATGTGGGCTTTGAGCTTTCTGTC Insertion in plasmid. 
CDC73 2886 CAATTTATAAAGACTGGAGGCAATCACAAACCTCCTGCTCGACGGATCTGTTCTTGGATGAGATTGCGAG Insertion in plasmid. 
LEO1 2887 AAAGTAATCCAATTAGATATACTGGACTATAATTAAGATGCGGATCCCCGGGTTAATTAA Disruption with KANMX6 
LEO1 2888 TGTACATACTAATATATATAAACAAAGTAACGTCTCCTCTGAATTCGAGCTCGTTTAAAC Disruption with KANMX6. 
LEO1 2889 TCAATGAGGGTAACACTGCAAC Insertion check. 
LEO1 2890 GATTTGCTCCTTCTGTGGTTGA Insertion check. 
LEO1 2891 CGACGATGAGGAAGAGGAGG Insertion check. 
LEO1 2892 GGAATGAGAAAGGGTCAACTGAG Insertion check. 
RTF1 2893 AATTGTATTGCACTAATTTGTTGAGAGCACTATAGAAATGCGGATCCCCGGGTTAATTAA Disruption with KANMX6. 
RTF1 2894 AAATATATTTTTACAAACACTGAAATTGTCCTGCCTACTAGAATTCGAGCTCGTTTAAAC Disruption with KANMX6. 
RTF1 2895 TGTTCGCTGCCTTGAATCATG Insertion check. 
RTF1 2896 GTGCTCTCTGTCGCTCTCATC Insertion check. 
RTF1 2897 ACTAGGCGAGTTGACCTCTAAG Insertion check. 
RTF1 2898 CCTTGGCACGAAACCATTCA Insertion check. 
PAF1 2899 CAATAGAACAGTGCTCATAATAGTATAAAGGGTCACAATGCGGATCCCCGGGTTAATTAA Disruption with KANMX6. 
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PAF1 2900 CAGGTTTAAAATCAATCTCCCTTCACTTCTCAATATTCTAGAATTCGAGCTCGTTTAAAC Disruption with KANMX6. 
PAF1 2901 CACGCAATGAGAACCCTAACC Insertion check. 
PAF1 2902 CATCAAATCAACCGGCATACCT Insertion check. 
PAF1 2903 GGAGCAACCAGAAGACGTTAAG Insertion check. 
PAF1 2904 GTGTCAGTGTAACTGCTGGTG Insertion check. 
CTR9 2905 GTCTGGTCCATTTGTGTTGAGAGCAAGAAAAAAAAACATGCGGATCCCCGGGTTAATTAA Disruption with KANMX6. 
CTR9 2906 TTTCTTTAAAAGTCTTGATTCTAACCCTCGCCTCTTCTTAGAATTCGAGCTCGTTTAAAC Disruption with KANMX6. 
CTR9 2907 ACCTAGTTCTCACTTCAGGTAC Insertion check. 
CTR9 2908 CAAGTGCAATGGTCAACCAA Insertion check. 
CTR9 2909 CGAGGATGACGATGATGTGG Insertion check. 
CTR9 2910 GATCTCAATGCAGACTCGACC Insertion check. 
VPS36 2975 AAGTGTGTTTTGAAAGTCATTCTTTTTTTTTCAAAAGATGCGGATCCCCGGGTTAATTAA Disruption with KANMX6. 
VPS36 2976 GTATTACGAGCAGGTAATCAAACCATGCATTTATTACTTAGAATTCGAGCTCGTTTAAAC Disruption with KANMX6. 
VPS36 2977 CATGTCTGGTGCAGTGTATGTAAG Insertion check. 
VPS36 2978 GCTAGATCGTCCAATTCCAACC Insertion check. 
VPS36 2979 TGTGTCGATGAAGGCGATTTAC Insertion check. 
VPS36 2980 CTACTATTTCCACTTTGCCGGTG Insertion check. 
VPS36 2981 ACCGCGGTGGCGGCCGCATAGGCCACTAGTGGATCTGATATCATCGATGCTTATAGCGTCCTTCGATGATG Insertion in plasmid. 
VPS36 2982 CAATTTATAAAGACTGGAGGCAATCACAAACCTCCTGCTCGACGGATGTTTCCGATCCAGTTGTGGTG Insertion in plasmid. 
YLR419W 2983 ACTTTACATCGCAATTGCTTTCATTAATTTTTGATAAATGCGGATCCCCGGGTTAATTAA Disruption with KANMX6. 
YLR419W 2984 ATAATTATTATACAGGGACTACAGTAGGAACTGATTACTAGAATTCGAGCTCGTTTAAAC Disruption with KANMX6. 
YLR419W 2985 GTCTCGGTGTTCGATGAGTTG Insertion check. 
YLR419W 2986 GGTTGGATCGTTCATTCTTGCA Insertion check. 
YLR419W 2987 CTATTCATTCACCGGGCATCG Insertion check. 
YLR419W 2988 GTTGTATTATCGACGGAGGGTTG Insertion check. 
YLR419W 2989 ACCGCGGTGGCGGCCGCATAGGCCACTAGTGGATCTGATATCATCGATTTGTTTCCACCACAACTGGATC Insertion in plasmid. 
YLR419W 2990 CAATTTATAAAGACTGGAGGCAATCACAAACCTCCTGCTCGACGGATGAGGCAGCATGACATGAGTG Insertion in plasmid. 
BAS1 2991 AACAAAATTAGTTTTGTTTAAAACTTTTGTTGTAGCGTTTCGGATCCCCGGGTTAATTAA Disruption with KANMX6. 
BAS1 2992 AACAATTGAAAGATTTGTGTTTTTTTTCGGCCTTGCCTTCGAATTCGAGCTCGTTTAAAC Disruption with KANMX6. 
BAS1 2993 GGTCCGAACAATGCGATGAG Insertion check. 
BAS1 2994 CTCCTTTGCGGATTCGTTTACT Insertion check. 
UFD2 2995 AAAAGTTAACTTTGAAAGTAGAACCCTCATTCCATAGATCCGGATCCCCGGGTTAATTAA Disruption with KANMX6. 
UFD2 2996 ATTAGGGTCAATTTTGCAATTTATTCTATCACTTATTCATGAATTCGAGCTCGTTTAAAC Disruption with KANMX6. 
UFD2 2997 AGTATTCGTCAGAGGCGATAGTC Insertion check. 
UFD2 2998 GGAAGGATCGGTGGTGATTTG Insertion check. 
SKI2 3000 AACCTAACTCACAAAATTTACTGTACTAATACTAATTTATCGGATCCCCGGGTTAATTAA Disruption with KANMX6. 
SKI2 3001 CTTTTATAAACATGACTCACATTGAGAATAAATGAGCTCTGAATTCGAGCTCGTTTAAAC Disruption with KANMX6. 
SKI2 3002 CTTGTCTCAGAACGCCCATC Insertion check. 
SKI2 3003 CTTTGGTTCATCGGTGCTCTC Insertion check. 
SLA2 3004 CCATAGCAGTAGTAGTGATAGTACTAGCAGCTAGAACAGGCGGATCCCCGGGTTAATTAA Disruption with KANMX6. 
SLA2 3005 ATTAACGTTTATCTTTATATATAAAAAGTACAATTCATGAGAATTCGAGCTCGTTTAAAC Disruption with KANMX6. 
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SLA2 3006 CCGACCCGTTATTGGTGATAATAC Insertion check. 
SLA2 3007 CGTGCTTTCTCTTAGGTGCG Insertion check. 
DYN1 3008 GAGCTTAAATTGGAAAGTACGTCAAAACGTTTTTTAGGCACGGATCCCCGGGTTAATTAA Disruption with KANMX6. 
DYN1 3009 AGAAAACCGCGGACAAGCAAGACACGCGTACCTGAAAAGGGAATTCGAGCTCGTTTAAAC Disruption with KANMX6. 
DYN1 3010 CGATCCCTGCGAAACTATGTTAC Insertion check. 
DYN1 3011 GTCGAACTCTCTCCCATCCAATA Insertion check. 
INP52 3012 ACGCAAAGGCAGCAGAATCAAAAACAAATACTCAGTAGCTCGGATCCCCGGGTTAATTAA Disruption with KANMX6. 
INP52 3013 TGATACATATTCTATAAATGCGTAATTTTAGTAACACAATGAATTCGAGCTCGTTTAAAC Disruption with KANMX6. 
INP52 3014 TTGTTTGGCGGTTAGTGACG Insertion check. 
INP52 3015 CAGCTTTCGGAACCAATTCCA Insertion check. 
FYV10 3016 CAGAGAAAATGATTATAAATTATAGGAAAGTAGGTAAGCCCGGATCCCCGGGTTAATTAA Disruption with KANMX6. 
FYV10 3017 AAATCTTTATATAAAAAAATGCATATAGCTTGAAACTATTGAATTCGAGCTCGTTTAAAC Disruption with KANMX6. 
FYV10 3018 TCCCTGGCACTCTCTCTTTC Insertion check. 
FYV10 3019 CTAGTGCCAACTCGTCGTGCT Insertion check. 
CMK2 3020 ATATTGTTCAAGATCAGCAGAACTTCAATTCGTTGATCAAGAATTCGAGCTCGTTTAAAC Disruption with KANMX6. 
CMK2 3021 CATGAAATTCAGAATTTATGACCTCTGACTCCTTGGGCATGCACTGAGCAGCGTAATCTG Disruption with KANMX6. 
CMK2 3022 AGCGCGAAGAGAATAATTGAGG Insertion check. 
CMK2 3023 CGTAAGATTCAGGTTGACCGC Insertion check. 
INP52 3024 CTCGCTTCATATAGTCTCAACATATTTTTGTTCGCAGAATGAATTCGAGCTCGTTTAAAC Disruption with KANMX6. 
INP52 3025 CTATCTTTCTAGTTTGCTGTTTCGATAGGAGTATTTTCATGCACTGAGCAGCGTAATCTG Disruption with KANMX6. 
SLA2 3026 CATATATAAATATATATAAAGAATAGTGAAACAATAGAAAGAATTCGAGCTCGTTTAAAC Insertion check. 
SLA2 3027 TTTTAAGCGCTTTCTGCAGATCTGAATCTATTCTGGACATGCACTGAGCAGCGTAATCTG Insertion check. 
CDC73 N-
terminal 3120 
ATGGCGAACTCATTAGACAGACTGAGAGAACACTTAAAGACG
GATCCCCGGGTTAATTAA Disruption with KANMX6. 
CDC73 N-
terminal 3121 
CATCACTGGATAGAGTTTCTACCATGGTTGCTTTCGTAATGAA
TTCGAGCTCGTTTAAAC Disruption with KANMX6. 
VPS36 3122 ATGGAGTACTGGCATTATGTGGAAACTACGTCATCGGGCCCGGATCCCCGGGTTAATTAA Disruption with KANMX6. 
VPS36 3123 CTCTGTCGCTGTAGAATCTTAGATTTGCCATGGTAAAGACGAATTCGAGCTCGTTTAAAC Disruption with KANMX6. 
VPS36 and 
CDC73 3124 
CCGAGTTTAAAGATTTGAACAGTGATACCAACTATATGATCGG
ATCCCCGGGTTAATTAA Disruption with KANMX6. 
VPS36 and 
CDC73 3125 
CAATTTTAACTGTTGCAAATATAAAACAGTTCCTGCTGGAGAA
TTCGAGCTCGTTTAAAC Disruption with KANMX6. 
VPS36 3151 AAGTGTGTTTTGAAAGTCATTCTTTTTTTTTCAAAAGATGCGGATCCCCGGGTTAATTAA Disruption with KANMX6. 
VPS36 3152 ATTCTGCCCCTCTGTCGCTGTAGAATCTTAGATTTGCCATGAATTCGAGCTCGTTTAAAC Disruption with KANMX6. 
VPS74 3153 TTCAAACAAAAACTATCTAAAAAAATACAAAGCAAAAATCCGGATCCCCGGGTTAATTAA Disruption with KANMX6. 
VPS74 3154 TTTTCCTTATGTTTCAAAGAGAGGATTTTTGTTGTTATTTGAATTCGAGCTCGTTTAAAC Disruption with KANMX6. 
VPS74 3155 TTGCTTTCTGGGTACGTTGAC Insertion check. 
VPS74 3156 GTATCTCCAGAATCCGCCCTAT Insertion check. 
Telomere 3157 CCCACCACACACACCCACACCC Probe for In-Gel. 
SKI3 3213 ACTAAGAACACAGAAAAGAAACACGAAGAGCAGAGGAAATCGTACGCTGCAGGTCGACGG Disruption with Hygromycin. 
SKI3 3214 GTTACATTAAGGTTTGATTGACTATCTCGAATCCAAATTTTCGATGAATTCGAGCTCGTT Disruption with Hygromycin. 
SKI3 3215 TCAGACCATCCTCATCCTCATC Insertion Check. 
SKI3 3216 GGAACTAATTTGGCAGCGGA Insertion check. 
SKI7 3217 TACGAGGAGGTGGTCTTCGAAACTTACAGTACCACCTGACCGTACGCTGCAGGTCGACGG Disruption with Nourseothricin. 
SKI7 3218 AATAAGTATGAATGCCTAGTATAATTTCTTAGTTGTAGGATCGATGAATTCGAGCTCGAT Disruption with Nourseothricin. 
SKI7 3219 ATCATAATCTGCCATCGCTGTG Insertion check. 
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SKI7 3220 GAGACTGGTCCGCACTTAAA Insertion check. 
SKI8 3221 AGACAAGAAACGAAAAAGAGGTTAATCAAGTATTGGAAAAGGAAGATATTCTTTATTGAA Disruption with Triptofan. 
SKI8 3222 TTGTAAGGTTACATGCAATATATCAAGATATTACTAGAGAACAAAATATTAACGTTTACA Disruption with Triptofan. 
SKI8 3223 TGGTGCTTCCTACATCTCTCTC Insertion check. 
SKI8 3224 GTGGTAGCAACAAGGCAT Insertion check. 
DOA1 3225 TCATGTGTGATAGTAAGGTGTAGAGCAGCAGATTTGGAGTCGTACGCTGCAGGTCGACGG Disruption with Hygromycin. 
DOA1 3226 ATCTAGACATTATGTGTTTTATATGATTGCTGTAAAAGTATCGATGAATTCGAGCTCGTT Disruption with Hygromycin. 
DOA1 3227 TTGCTGACCTTGGCATTTCC Insertion check. 
DOA1 3228 CATCCCATACAGAGGCATTGTG Insertion check. 
SKI3 3257 ATATGTCGGATATTAAACAGCTATTGAAGGAAGCCAAACACGTACGCTGCAGGTCGACGG Disruption with Hygromycin. 
SKI3 3258 TCCAAATTTTTAGAAACATTCGTTTAGCGCCTTCACTGCATCGATGAATTCGAGCTCGT Disruption with Hygromycin. 
TLC1 3261 AATGTGCCCCGTACATCGAA RT-qPCR. 
TLC1 3262 CGCAAACCTAACCGATGCTT RT-qPCR. 
CDC73 3263 CTATCAGTGGAATTCGCCACA RT-qPCR. 
CDC73 3264 ATTCCATTGCTGCACGTGTT RT-qPCR. 
YLR419W 3267 TGAAGCCGAGAGCAGATTCTA RT-qPCR. 
YLR419W 3268 GCAGCTTTCAGGCGTTTATG RT-qPCR. 
VPS36 3271 GAACTCGCTTGGGTTGGAAT RT-qPCR. 
VPS36 3272 GGGGTCCTTGAAAAACAGGA RT-qPCR. 
BUD6 3275 GACCGGGCACATTTAATCAG RT-qPCR internal control. 
BUD6 3276 TCAGCCTTGTCAATAGCTTCG RT-qPCR internal control. 
TEL01L 3556 CGGTGGGTGAGTGGTAGTAAGTAGA TERRA RNA measurements. (Balk et al. 2013) 
TEL01L 3557 ACCCTGTCCCATTCAACCATAC 
TERRA RNA measurements. 
Southern Blot probe. 
(Balk et al. 2013) 
SBP1 3610 CCCCCAAAAGAAAGAAGAAAACCCTCAAACGAAGAAAAATCGTACGCTGCAGGTCGACGG Disruption with Hygromycin. 
SBP1 3611 AAAAACTCAAGTTAGAAATAGGGATGTGGGTAAGAAGTAATCGATGAATTCGAGCTCGTT Disruption with Hygromycin. 
SBP1 3612 TCACAGGTTGTGGCATAAAGG Insertion check. 
SBP1 3613 CCACTGAAAGTGACAAATGCC Insertion check. 
OPI1 3614 TGTATCAGGACAGTGTTTTTAACGAAGATACTAGTCATTGGGAAGATATTCTTTATTGAA Disruption with Tryptophan. 
OPI1 3615 TTACTGGTGGTAATGCATGAAAGACCTCAATCTGTCTCGGACAAAATATTAACGTTTACA Disruption with Tryptophan. 
OPI1 3616 AAGAATATGACCGCCTGCAAG Insertion check. 
OPI1 3617 CATTCTTCAGCCTTGCCCAA Insertion check. 
SCS2 3618 TGTAGCAGAAGGGTATTCTACAATCTCCGCGAACCTAAGTCGTACGCTGCAGGTCGACGG Disruption with Nourseothricin. 
SCS2 3619 AATATATATTTAGAATACAGCTATATCCTCAATCTCCCTATCGATGAATTCGAGCTCGAT Disruption with Nourseothricin. 
SCS2 3620 AAACGTGCGTGGTGATCTTAC Insertion check. 
SCS2 3621 GCTGTTGGACGTTTGCTTCT Insertion check. 
MON1 3713 CTATCAAAGTACACAAACGTAGAATCAGTACATCGGAACTCGGATCCCCGGGTTAATTAA Disruption with KANMX6. 
MON1 3714 ATTAAAGGAAAAAATAATAAAATAACCTCCCTGTCACAAGGAATTCGAGCTCGTTTAAAC Disruption with KANMX6. 
MON1 3715 AAGCAGTTCAAGCTCACATCC Insertion check. 
MON1 3716 GCTCTTTGCCAAATCTGCTGA Insertion check. 
SUB1 3717 TACACATCAATTTTTCGACATATATACAAACACAAGCGCTCGGATCCCCGGGTTAATTAA Disruption with KANMX6. 
SUB1 3718 TGGAAGACGTTGACATAAGCAAGCTCAACTTCCAGGACTAGAATTCGAGCTCGTTTAAAC Disruption with KANMX6. 
SUB1 3719 ATAGCACTGCACACACACAC Insertion check. 
SUB1 3720 CTTTGGGCTGTTCTTGTCCTT Insertion check. 
SNF8 3844 AAAATGCTTGGCGTAACAGCCAACTTCGAAACTCACTAACCGTACGCTGCAGGTCGACGG Disruption with Hygromycin. 
220 
SNF8 3845 ACTTAACGCTCATCCACCATTCCTGTTCAAGTCAACTATCTCGATGAATTCGAGCTCGTT Disruption with Hygromycin. 
SNF8 3846 AAGTCCACGTTTCAGGCTTG Insertion check. 
SNF8 3847 GCTGCCAGTCCAAACTGTTT Insertion check. 
VPS25 3848 CTCAGAATTATTCTTGTTGCGCTAATATAGCAAGTGTATTCGTACGCTGCAGGTCGACGG Disruption with Nourseothricin. 
VPS25 3849 AATAGTTTTATTTTATCCTCTCGCTCGTGTTTTAAACAACTCGATGAATTCGAGCTCGAT Disruption with Nourseothricin. 
VPS25 3850 TTGAGTGAAGTGGGACAGAAC Insertion check. 
VPS25 3851 CTTCTTTGGTCATTTGCGACC Insertion check. 
SAC1 3869 ACGATAATATTTATATACACGTATATTTTCTCGTCTAGATCGTACGCTGCAGGTCGACGG Disruption with Hygromycin. 
SAC1 3870 GGATTTACAATAATCATCATTTTATCACATATAGAACTCATCGATGAATTCGAGCTCGTT Disruption with Hygromycin. 
SAC1 3871 ATCGTGCCCTTTAAGTGTTGC Insertion check. 
SAC1 3872 GACCCGAACACCTTGATCTT Insertion check. 
SAC1 4076 ACGATAATATTTATATACACGTATATTTTCTCGTCTAGATGGAAGATATTCTTTATTGAA Disruption with Tryptophan. 
SAC1 4077 GGATTTACAATAATCATCATTTTATCACATATAGAACTCAACAAAATATTAACGTTTACA Disruption with Tryptophan. 
TEL10R 4089 CGGTTATGGTGGACGGTGGATG TERRA RNA measurements. (Iglesias et al. 2011) 
TEL10R 4090 CCTAACCCTATTCTAATCCAACCCTGATAA 
Southern Blot probe. 
TERRA RNA measurements. 
(Iglesias et al. 2011) 
TEL13R 4093 ACGGTTATGGTGCACGATGGG TERRA RNA measurements. (Iglesias et al. 2011) 
TEL13R 4094 TTACCCTCCATTACGCTACCTCC TERRA RNA measurements.  (Iglesias et al. 2011) 
Y' 6 4095 GGCTTGGAGGAGACGTACATG TERRA RNA measurements. (Iglesias et al. 2011) 
Y' 6 4096 CTCGCTGTCACTCCTTACCCG TERRA RNA measurements. (Iglesias et al. 2011) 
Y' 4 4097 GGCTTGGAGGAGACGTAAATG TERRA RNA measurements. (Iglesias et al. 2011) 
Y' 4 4098 CCAACTCTCTCTCATCTACCTTTACTCG TERRA RNA measurements. (Iglesias et al. 2011) 
Y' 3 4099 GGCTTGGAGGAGACGTACATG TERRA RNA measurements. (Iglesias et al. 2011) 
Y' 3 4100 CCACACACTCTCTCACATCTACCTC TERRA RNA measurements. (Iglesias et al. 2011) 
ACT1 4101 GTAACATCGTTATGTCCGGTGGTAC TERRA RNA measurements. (Iglesias et al. 2011) 
ACT1 4103 CCAAGATAGAACCACCAATCCAGAC TERRA RNA measurements. (Iglesias et al. 2011) 
CA 4104 CACCACACCCACACACCACACCCACA cDNA production. (Iglesias et al. 2011) 
TEL10R 4105 TGACTTAACCTTGGCAGCTTC Southern Blot probe. (Iglesias et al. 2011) 
TEL10R 4108 CGTTTCCGATCTGGATGCTAT Southern Blot probe. (Iglesias et al. 2011) 
TEL1L 4109 ATTAACTTCAATCGCCGCTGG Southern Blot probe. (Iglesias et al. 2011) 
TEL13R 4113 TGGGCTTTATGGGTAAATGG Southern Blot probe. (Iglesias et al. 2011) 
TEL13R 4116 TACCCTGATTTAGCATGTCTCTTA Southern Blot probe. (Iglesias et al. 2011) 
TEL15L 4118 AGTGGAAACGTGATAAACTGC Southern Blot probe. (Iglesias et al. 2011) 
SIR4 4226 GCTTCAACCCACAATACCAAAAAAGCGAAGAAAACAGCCACGTACGCTGCAGGTCGACGG Disruption with hygromycin. 
SIR4 4227 GGTACACTTCGTTACTGGTCTTTTGTAGAATGATAAAAAGTCGATGAATTCGAGCTCGTT Disruption with hygromycin. 
SIR4 4228 TTACCATGCTCAAACCGAACC Insertion check. 
SIR4 4229 CAATGGGCAGCCTTCAAAGAT Insertion check. 
a1 4240 GGCGGAAAACATAAACAGAACTCTG RT-qPCR (Panday et al. 2015). 
a1 4241 CCGTGCTTGGGGTGATATTGATG RT-qPCR (Panday et al. 2015). 
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YOL166W-
A (TEL15L) 4269 
GCTTGCCTCAGCGGTCTAT 
 
TERRA and Silencing 
measurements. 
YOL166W-
A (TEL15L) 4270 
TGGGCCGCCAAATGAGATA 
 
TERRA and Silencing 
measurements. 
YAL068W-A 
(TEL01L)*** 4273 
TACCCATAACGCCCATCATT 
 
TERRA and Silencing 
measurements. 
YAL068W-A 
(TEL01L)*** 4274 TGGTGCAAAAGTGGTATAACG 
TERRA and Silencing 
measurements. 
7S RNA 4275 GGCAGGAGGCGTGAGGAATC RT-qPCR. 
7S RNA 4276 CCTAACAGCGGTGAAGGTGGAG RT-qPCR. 
*Conserved in 12 different telomeres 
**Conserved in 3 different telomeres 
***Also recognises TEL03L 
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Appendix C 
List of the plasmids used in this thesis. 
Plasmid 
number 
(pDL) 
Description Reference 
1042 pFA6a-KANMX6 (Longtine et al. 1998) 
1453 
pAG36::CAN1. CAN1 cloned as an Xho1, 4.4kb fragment, from 535, into Sal1 site of 
1223. For PCR amplification of dominant drug resistance cassette. Nourseothricin 
resistance gene cloned into pAG22 (pRS316) 
(Goldstein and 
McCusker 
1999) 
1467 
pLD1453 was digested with Asc1 and Sph1. Blunt-ends were generated using DNA 
polymerase I, Large Klenow fragment (5’ fill-in and 3’ overhang removal). PDL1467 
was then obtained by self-circularization of the linearized vector. 
Lydall 
collection 
1495 Plasmid harbouring TEN1. Made by cloning TEN1 into pDL1726 (digested with AscI and SphI) 
Lydall 
collection 
1562 
pDL1467::CDC73. pDL1467 was digested with AscI and then co-transformed in 
yeast with a PCR fragment obtained by the amplification of genomic DNA with 
m2885 and m2886 (CDC73 +/- 800bp).  
This work 
1583 pFA6-hphNT1 (Janke et al. 2004) 
1584 pFA6a-natNT2 (Janke et al. 2004) 
1614 Expresses GFP-Rer1 fusion protein under the control of the TDH3 promoter 
(Matsuura-
Tokita et al. 
2006) 
1615 Expresses mRFP-Gos1 fusion protein under the control of the TDH3 promoter. 
(Matsuura-
Tokita et al. 
2006) 
1616 Expresses Sec7-mRFP fusion protein under the control of the ADH1 promoter. 
(Matsuura-
Tokita et al. 
2006) 
1618 Expresses Sec7-GFP fusion protein under the control of the ADH1 promoter 
(Matsuura-
Tokita et al. 
2006) 
1649 
pDL1467::VPS36. pDL1467 was digested with AscI and then co-transformed in 
yeast with a PCR fragment obtained by the amplification of genomic DNA with 
m2981 and m2982 (VPS36 +/- 800bp).  
This work 
1650 
pDL1467::YLR419W. pDL1467 was digested with AscI and then co-transformed in 
yeast with a PCR fragment obtained by the amplification of genomic DNA with 
m2989 and m2990 (YLR419W +/- 800bp).  
This work 
1667 
pRS406_eGFPRER1. Vector (pDL745) and Insert (pDL1614) were digested with 
BamHI and XhoI. Insert contained the TDH3 promoter, eGFP-RER1 and CMK1 
terminator.  
This work 
1671 
pRS406_SEC7eGFP. Vector (pDL745) and Insert (pDL1618) were digested with 
BamHI and XhoI. Insert contained the TDH3 promoter, SEC7-eGFP and CMK1 
terminator.  
This work 
1726 pDL1453 was digested with Mlu1 and vector was purified after gel extraction. pDL1726 was obtained by self-circularization of the linearized vector. 
Lydall 
collection 
1755 pVL1066. Plasmid containing STN1 and its native promotor. (Gasparyan et al. 2009) 
1756 YEplac181. Control vector to use with pDL1755 (Gasparyan et al. 2009) 
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Appendix D 
Cartoon to aid In-Gel interpretation. 
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